קוד ATC code - ATC
××¤×ª× ×§××× ATC
Anatomical Therapeutic Chemical (ATC) Classification System
××¤×ª× ×× ×× ×××× ××צר×× ××ר×× ×¨××× ××ס××××× ×ª×ת ס×××× ATCvet â (Anatomical Therapeutic Chemical Classification System for veterinary medicinal products)
×××©× ××××¨× A / B / C / D / G / H / J / L / M / N / P / R / S / V
- ××××× × ××ª× ×ª ××××× ××¤× ×× ××ת ×××¢××××ת
| 1st level | 2nd level | 3rd level | 4th level | 5th level | Contents |
|---|---|---|---|---|---|
| âA | Alimentary tract and metabolism | ||||
| A01 | Stomatological preparations | ||||
| A01A | Stomatological preparations | ||||
| A01AA | Caries prophylactic agents | ||||
| A01AA01 | Sodium fluoride | ||||
| A01AA02 | Sodium monofluorophosphate | ||||
| A01AA03 | Olaflur | ||||
| A01AA04 | Stannous fluoride | ||||
| A01AA30 | Combinations | ||||
| A01AA51 | Sodium fluoride, combinations | ||||
| A01AB | Anti-infectives and antiseptics for local oral treatment | ||||
| A01AB02 | Hydrogen peroxide | ||||
| A01AB03 | Chlorhexidine | ||||
| A01AB04 | Amphotericin B | ||||
| A01AB05 | Polynoxylin | ||||
| A01AB06 | Domiphen | ||||
| A01AB07 | Oxyquinoline | ||||
| A01AB08 | Neomycin | ||||
| A01AB09 | Miconazole | ||||
| A01AB10 | Natamycin | ||||
| A01AB11 | Various | ||||
| A01AB12 | Hexetidine | ||||
| A01AB13 | Tetracycline | ||||
| A01AB14 | Benzoxonium chloride | ||||
| A01AB15 | Tibezonium iodide | ||||
| A01AB16 | Mepartricin | ||||
| A01AB17 | Metronidazole | ||||
| A01AB18 | Clotrimazole | ||||
| A01AB19 | Sodium perborate | ||||
| A01AB21 | Chlortetracycline | ||||
| A01AB22 | Doxycycline | ||||
| A01AB23 | Minocycline | ||||
| A01AC | Corticosteroids for local oral treatment | ||||
| A01AC01 | Triamcinolone | ||||
| A01AC02 | Dexamethasone | ||||
| A01AC03 | Hydrocortisone | ||||
| A01AC54 | Prednisolone, combinations | ||||
| A01AD | Other agents for local oral treatment | ||||
| A01AD01 | Epinephrine | ||||
| A01AD02 | Benzydamine | ||||
| A01AD05 | Acetylsalicylic acid | ||||
| A01AD06 | Adrenalone | ||||
| A01AD07 | Amlexanox | ||||
| A01AD08 | Becaplermin | ||||
| A01AD11 | Various | ||||
| A02 | Drugs for acid related disorders | ||||
| A02A | Antacids | ||||
| A02AA | Magnesium compounds | ||||
| A02AA01 | Magnesium carbonate | ||||
| A02AA02 | Magnesium oxide | ||||
| A02AA03 | Magnesium peroxide | ||||
| A02AA04 | Magnesium hydroxide | ||||
| A02AA05 | Magnesium silicate | ||||
| A02AA10 | Combinations | ||||
| A02AB | Aluminium compounds | ||||
| A02AB01 | Aluminium hydroxide | ||||
| A02AB02 | Algeldrate | ||||
| A02AB03 | Aluminium phosphate | ||||
| A02AB04 | Dihydroxialumini sodium carbonate | ||||
| A02AB05 | Aluminium acetoacetate | ||||
| A02AB06 | Aloglutamol | ||||
| A02AB07 | Aluminium glycinate | ||||
| A02AB10 | Combinations | ||||
| A02AC | Calcium compounds | ||||
| A02AC01 | Calcium carbonate | ||||
| A02AC02 | Calcium silicate | ||||
| A02AC10 | Combinations | ||||
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | ||||
| A02AD01 | Ordinary salt combinations | ||||
| A02AD02 | Magaldrate | ||||
| A02AD03 | Almagate | ||||
| A02AD04 | Hydrotalcite | ||||
| A02AD05 | Almasilate | ||||
| A02AF | Antacids with antiflatulents | ||||
| A02AF01 | Magaldrate and antiflatulents | ||||
| A02AF02 | Ordinary salt combinations and antiflatulents | ||||
| A02AG | Antacids with antispasmodics | ||||
| Empty | |||||
| A02AH | Antacids with sodium bicarbonate | ||||
| Empty | |||||
| A02AX | Antacids, other combinations | ||||
| Empty | |||||
| A02B | Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | ||||
| A02BA | H2-receptor antagonists | ||||
| A02BA01 | Cimetidine | ||||
| A02BA02 | Ranitidine | ||||
| A02BA03 | Famotidine | ||||
| A02BA04 | Nizatidine | ||||
| A02BA05 | Niperotidine | ||||
| A02BA06 | Roxatidine | ||||
| A02BA07 | Ranitidine bismuth citrate | ||||
| A02BA08 | Lafutidine | ||||
| A02BA51 | Cimetidine, combinations | ||||
| A02BA53 | Famotidine, combinations | ||||
| A02BB | Prostaglandins | ||||
| A02BB01 | Misoprostol | ||||
| A02BB02 | Enprostil | ||||
| A02BC | Proton pump inhibitors | ||||
| A02BC01 | Omeprazole | ||||
| A02BC02 | Pantoprazole | ||||
| A02BC03 | Lansoprazole | ||||
| A02BC04 | Rabeprazole | ||||
| A02BC05 | Esomeprazole | ||||
| A02BC06 | Dexlansoprazole | ||||
| A02BC07 | dexrabeprazole | ||||
| A02BC08 | vonoprazan | ||||
| A02BC09 | tegoprazan | ||||
| A02BC10 | fexuprazan | ||||
| A02BC11 | ilaprazole | ||||
| A02BC12 | zastaprazan | ||||
| A02BC51 | omeprazole, combinations | ||||
| A02BC53 | lansoprazole, combinations | ||||
| A02BC54 | rabeprazole, combinations | ||||
| A02BD | Combinations for eradication of Helicobacter pylori | ||||
| A02BD01 | Omeprazole, amoxicillin and metronidazole | ||||
| A02BD02 | Lansoprazole, tetracycline and metronidazole | ||||
| A02BD03 | Lansoprazole, amoxicillin and metronidazole | ||||
| A02BD04 | Pantoprazole, amoxicillin and clarithromycin | ||||
| A02BD05 | Omeprazole, amoxicillin and clarithromycin | ||||
| A02BD06 | Esomeprazole, amoxicillin and clarithromycin | ||||
| A02BD07 | Lansoprazole, amoxicillin and clarithromycin | ||||
| A02BD08 | Bismuth subcitrate, tetracycline and metronidazole | ||||
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | ||||
| A02BX01 | Carbenoxolone | ||||
| A02BX02 | Sucralfate | ||||
| A02BX03 | Pirenzepine | ||||
| A02BX04 | Methiosulfonium chloride | ||||
| A02BX05 | Bismuth subcitrate | ||||
| A02BX06 | Proglumide | ||||
| A02BX07 | Gefarnate | ||||
| A02BX08 | Sulglicotide | ||||
| A02BX09 | Acetoxolone | ||||
| A02BX10 | Zolimidine | ||||
| A02BX11 | Troxipide | ||||
| A02BX12 | Bismuth subnitrate | ||||
| A02BX13 | Alginic acid | ||||
| A02BX51 | Carbenoxolone, combinations excluding psycholeptics | ||||
| A02BX71 | Carbenoxolone, combinations with psycholeptics | ||||
| A02BX77 | Gefarnate, combinations with psycholeptics | ||||
| A02X | Other drugs for acid related disorders | ||||
| Empty | |||||
| A03 | Drugs for functional gastrointestinal disorders | ||||
| A03A | Drugs for functional gastrointestinal disorders | ||||
| A03AA | Synthetic anticholinergics, esters with tertiary amino group | ||||
| A03AA01 | Oxyphencyclimine | ||||
| A03AA03 | Camylofin | ||||
| A03AA04 | Mebeverine | ||||
| A03AA05 | Trimebutine | ||||
| A03AA06 | Rociverine | ||||
| A03AA07 | Dicycloverine | ||||
| A03AA08 | Dihexyverine | ||||
| A03AA09 | Difemerine | ||||
| A03AA30 | Piperidolate | ||||
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds | ||||
| A03AB01 | Benzilone | ||||
| A03AB02 | Glycopyrronium | ||||
| A03AB03 | Oxyphenonium | ||||
| A03AB04 | Penthienate | ||||
| A03AB05 | Propantheline | ||||
| A03AB06 | Otilonium bromide | ||||
| A03AB07 | Methantheline | ||||
| A03AB08 | Tridihexethyl | ||||
| A03AB09 | Isopropamide | ||||
| A03AB10 | Hexocyclium | ||||
| A03AB11 | Poldine | ||||
| A03AB12 | Mepenzolate | ||||
| A03AB13 | Bevonium | ||||
| A03AB14 | Pipenzolate | ||||
| A03AB15 | Diphemanil | ||||
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | ||||
| A03AB17 | Tiemonium iodide | ||||
| A03AB18 | Prifinium bromide | ||||
| A03AB19 | Timepidium bromide | ||||
| A03AB21 | Fenpiverinium | ||||
| A03AB53 | Oxyphenonium, combinations | ||||
| A03AC | Synthetic antispasmodics, amides with tertiary amines | ||||
| A03AC02 | Dimethylaminopropionylphenothiazine | ||||
| A03AC04 | Nicofetamide | ||||
| A03AC05 | Tiropramide | ||||
| A03AD | Papaverine and derivatives | ||||
| A03AD01 | Papaverine | ||||
| A03AD02 | Drotaverine | ||||
| A03AD30 | Moxaverine | ||||
| A03AE | Serotonin receptor antagonists | ||||
| A03AE01 | Alosetron | ||||
| A03AE02 | tegaserod (New ATC code A06AX06) | ||||
| A03AE03 | Cilansetron | ||||
| A03AE04 | prucalopride (New ATC code A06AX05) | ||||
| A03AX | Other drugs for functional gastrointestinal disorders | ||||
| A03AX01 | Fenpiprane | ||||
| A03AX02 | Diisopromine | ||||
| A03AX03 | Chlorbenzoxamine | ||||
| A03AX04 | Pinaverium | ||||
| A03AX05 | Fenoverine | ||||
| A03AX06 | Idanpramine | ||||
| A03AX07 | Proxazole | ||||
| A03AX08 | Alverine | ||||
| A03AX09 | Trepibutone | ||||
| A03AX10 | Isometheptene | ||||
| A03AX11 | Caroverine | ||||
| A03AX12 | Phloroglucinol | ||||
| A03AX13 | Silicones | ||||
| A03AX30 | Trimethyldiphenylpropylamine | ||||
| A03AX58 | Alverine, combinations | ||||
| A03B | Belladonna and derivatives, plain | ||||
| A03BA | Belladonna alkaloids, tertiary amines | ||||
| A03BA01 | Atropine | ||||
| A03BA03 | Hyoscyamine | ||||
| A03BA04 | Belladonna total alkaloids | ||||
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | ||||
| A03BB01 | Butylscopolamine | ||||
| A03BB02 | Methylatropine | ||||
| A03BB03 | Methylscopolamine | ||||
| A03BB04 | Fentonium | ||||
| A03BB05 | Cimetropium bromide | ||||
| A03C | Antispasmodics in combination with psycholeptics | ||||
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics | ||||
| A03CA01 | Isopropamide and psycholeptics | ||||
| A03CA02 | Clidinium and psycholeptics | ||||
| A03CA03 | Oxyphencyclimine and psycholeptics | ||||
| A03CA04 | Otilonium bromide and psycholeptics | ||||
| A03CA05 | Glycopyrronium and psycholeptics | ||||
| A03CA06 | Bevonium and psycholeptics | ||||
| A03CA07 | Ambutonium and psycholeptics | ||||
| A03CA08 | Diphemanil and psycholeptics | ||||
| A03CA30 | Emepronium and psycholeptics | ||||
| A03CA34 | Propantheline and psycholeptics | ||||
| A03CB | Belladonna and derivatives in combination with psycholeptics | ||||
| A03CB01 | Methylscopolamine and psycholeptics | ||||
| A03CB02 | Belladonna total alkaloids and psycholeptics | ||||
| A03CB03 | Atropine and psycholeptics | ||||
| A03CB04 | Methylhomatropine and psycholeptics | ||||
| A03CB31 | Hyoscyamine and psycholeptics | ||||
| A03CC | Other antispasmodics in combination with psycholeptics | ||||
| empty | |||||
| A03D | Antispasmodics in combination with analgesics | ||||
| A03DA | Synthetic anticholinergic agents in combination with analgesics | ||||
| A03DA01 | Tropenzilone and analgesics | ||||
| A03DA02 | Pitofenone and analgesics | ||||
| A03DA03 | Bevonium and analgesics | ||||
| A03DA04 | Ciclonium and analgesics | ||||
| A03DA05 | Camylofin and analgesics | ||||
| A03DA06 | Trospium and analgesics | ||||
| A03DA07 | Tiemonium iodide and analgesics | ||||
| A03DB | Belladonna and derivatives in combination with analgesics | ||||
| A03DB04 | Butylscopolamine and analgesics | ||||
| A03DC | Other antispasmodics in combination with analgesics | ||||
| empty | |||||
| A03E | Antispasmodics and anticholinergics in combination with other drugs | ||||
| A03EA | Antispasmodics, psycholeptics and analgesics in combination | ||||
| empty | |||||
| A03ED | Antispasmodics in combination with other drugs | ||||
| empty | |||||
| A03F | Propulsives | ||||
| A03FA | Propulsives | ||||
| A03FA01 | Metoclopramide | ||||
| A03FA02 | Cisapride | ||||
| A03FA03 | Domperidone | ||||
| A03FA04 | Bromopride | ||||
| A03FA05 | Alizapride | ||||
| A03FA06 | Clebopride | ||||
| A04 | Antiemetics and antinauseants | ||||
| A04A | Antiemetics and antinauseants | ||||
| A04AA | Serotonin (5-HT3) antagonists | ||||
| A04AA01 | Ondansetron | ||||
| A04AA02 | Granisetron | ||||
| A04AA03 | Tropisetron | ||||
| A04AA04 | Dolasetron | ||||
| A04AA05 | Palonosetron | ||||
| A04AA55 | palonosetron, combinations | ||||
| A04AD | Other antiemetics | ||||
| A04AD01 | Scopolamine | ||||
| A04AD02 | Cerium oxalate | ||||
| A04AD04 | Chlorobutanol | ||||
| A04AD05 | Metopimazine | ||||
| A04AD10 | Dronabinol | ||||
| A04AD11 | Nabilone | ||||
| A04AD12 | Aprepitant | ||||
| A04AD13 | Casopitant | ||||
| A04AD51 | Scopolamine, combinations | ||||
| A04AD54 | Chlorobutanol, combinations | ||||
| A05 | Bile and liver therapy | ||||
| A05A | Bile therapy | ||||
| A05AA | Bile acids and derivatives | ||||
| A05AA01 | Chenodeoxycholic acid | ||||
| A05AA02 | Ursodeoxycholic acid | ||||
| A05AA03 | Cholic acid | ||||
| A05AA04 | obeticholic acid | ||||
| A05AA05 | ursodoxicoltaurine | ||||
| A05AA06 | norucholic acid | ||||
| A05AB | Preparations for biliary tract therapy | ||||
| A05AB01 | Nicotinyl methylamide | ||||
| A05AX | Other drugs for bile therapy | ||||
| A05AX01 | Piprozolin | ||||
| A05AX02 | Hymecromone | ||||
| A05AX03 | Cyclobutyrol | ||||
| A05AX04 | maralixibat chloride | ||||
| A05AX05 | odevixibat | ||||
| A05AX06 | elafibranor | ||||
| A05AX07 | seladelpar | ||||
| A05AX08 | linerixibat | ||||
| A05B | Liver therapy, lipotropics | ||||
| A05BA | Liver therapy | ||||
| A05BA01 | Arginine glutamate | ||||
| A05BA03 | Silymarin | ||||
| A05BA04 | Citiolone | ||||
| A05BA05 | Epomediol | ||||
| A05BA06 | Ornithine oxoglutarate | ||||
| A05BA07 | Tidiacic arginine | ||||
| A05BA08 | Glycyrrhizic acid (glycyrrhizin) | ||||
| A05BA09 | metadoxine | ||||
| A05BA10 | phospholipids | ||||
| A05BA11 | resmetirom | ||||
| A05C | Drugs for bile therapy and lipotropics in combination | ||||
| Empty | |||||
| A06 | Drugs for constipation | ||||
| A06A | Drugs for constipation | ||||
| A06AA | Softeners, emollients | ||||
| A06AA01 | Liquid paraffin | ||||
| A06AA02 | Docusate sodium | ||||
| A06AA51 | Liquid paraffin, combinations | ||||
| A06AB | Contact laxatives | ||||
| A06AB01 | Oxyphenisatine | ||||
| A06AB02 | Bisacodyl | ||||
| A06AB03 | Dantron | ||||
| A06AB04 | Phenolphthalein | ||||
| A06AB05 | Castor oil | ||||
| A06AB06 | Senna glycosides | ||||
| A06AB07 | Cascara | ||||
| A06AB08 | Sodium picosulfate | ||||
| A06AB09 | Bisoxatin | ||||
| A06AB20 | Contact laxatives in combination | ||||
| A06AB30 | Contact laxatives in combination with belladonna alkaloids | ||||
| A06AB52 | Bisacodyl, combinations | ||||
| A06AB53 | Dantron, combinations | ||||
| A06AB56 | Senna glycosides, combinations | ||||
| A06AB57 | Cascara, combinations | ||||
| A06AB58 | Sodium picosulfate, combinations | ||||
| A06AC | Bulk-forming laxatives | ||||
| A06AC01 | Ispaghula (psylla seeds) | ||||
| A06AC02 | Ethulose | ||||
| A06AC03 | Sterculia | ||||
| A06AC05 | Linseed | ||||
| A06AC06 | Methylcellulose | ||||
| A06AC07 | Triticum (wheat fibre) | ||||
| A06AC08 | Polycarbophil calcium | ||||
| A06AC51 | Ispaghula, combinations | ||||
| A06AC53 | Sterculia, combinations | ||||
| A06AC55 | Linseed, combinations | ||||
| A06AD | Osmotically acting laxatives | ||||
| A06AD01 | Magnesium carbonate | ||||
| A06AD02 | Magnesium oxide | ||||
| A06AD03 | Magnesium peroxide | ||||
| A06AD04 | Magnesium sulfate | ||||
| A06AD10 | Mineral salts in combination | ||||
| A06AD11 | Lactulose | ||||
| A06AD12 | Lactitol | ||||
| A06AD13 | Sodium sulfate | ||||
| A06AD14 | Pentaerithrityl | ||||
| A06AD15 | Macrogol | ||||
| A06AD16 | Mannitol | ||||
| A06AD17 | Sodium phosphate | ||||
| A06AD18 | Sorbitol | ||||
| A06AD19 | Magnesium citrate | ||||
| A06AD21 | Sodium tartrate | ||||
| A06AD61 | Lactulose, combinations | ||||
| A06AD65 | Macrogol, combinations | ||||
| A06AG | Enemas | ||||
| A06AG01 | Sodium phosphate | ||||
| A06AG02 | Bisacodyl | ||||
| A06AG03 | Dantron, including combinations | ||||
| A06AG04 | Glycerol | ||||
| A06AG06 | Oil | ||||
| A06AG07 | Sorbitol | ||||
| A06AG10 | Docusate sodium, including combinations | ||||
| A06AG11 | Laurilsulfate, including combinations | ||||
| A06AG20 | Combinations | ||||
| A06AH | Peripheral opioid receptor antagonists | ||||
| A06AH01 | Methylnaltrexone bromide | ||||
| A06AH02 | Alvimopan | ||||
| A06AH03 | naloxegol | ||||
| A06AH04 | naloxone | ||||
| A06AH05 | naldemedine | ||||
| A06AX | Other drugs for constipation | ||||
| A06AX01 | Glycerol | ||||
| A06AX02 | Carbon dioxide producing drugs | ||||
| A06AX03 | Lubiprostone | ||||
| A06AX04 | Linaclotide | ||||
| A06AX05 | Prucalopride | ||||
| A06AX06 | Tegaserod | ||||
| A06AX07 | plecanatide | ||||
| A06AX08 | tenapanor | ||||
| A06AX09 | elobixibat | ||||
| A07 | Antidiarrheals, intestinal anti-inflammatory/anti-infective agents | ||||
| A07A | Intestinal anti-infectives | ||||
| A07AA | Antibiotics | ||||
| A07AA01 | Neomycin | ||||
| A07AA02 | Nystatin | ||||
| A07AA03 | Natamycin | ||||
| A07AA04 | Streptomycin | ||||
| A07AA05 | Polymyxin B | ||||
| A07AA06 | Paromomycin | ||||
| A07AA07 | Amphotericin B | ||||
| A07AA08 | Kanamycin | ||||
| A07AA09 | Vancomycin | ||||
| A07AA10 | Colistin | ||||
| A07AA11 | Rifaximin | ||||
| A07AA12 | Fidaxomicin | ||||
| A07AA51 | Neomycin, combinations | ||||
| A07AA54 | Streptomycin, combinations | ||||
| A07AB | Sulfonamides | ||||
| A07AB02 | Phthalylsulfathiazole | ||||
| A07AB03 | Sulfaguanidine | ||||
| A07AB04 | Succinylsulfathiazole | ||||
| A07AC | Imidazole derivatives | ||||
| A07AC01 | Miconazole | ||||
| A07AX | Other intestinal anti-infectives | ||||
| A07AX01 | Broxyquinoline | ||||
| A07AX02 | Acetarsol | ||||
| A07AX03 | Nifuroxazide | ||||
| A07AX04 | Nifurzide | ||||
| A07B | Intestinal adsorbents | ||||
| A07BA | Charcoal preparations | ||||
| A07BA01 | Medicinal charcoal | ||||
| A07BA51 | Medicinal charcoal, combinations | ||||
| A07BB | Bismuth preparations | ||||
| empty | |||||
| A07BC | Other intestinal adsorbents | ||||
| A07BC01 | Pectin | ||||
| A07BC02 | Kaolin | ||||
| A07BC03 | Crospovidone | ||||
| A07BC04 | Attapulgite | ||||
| A07BC05 | Diosmectite | ||||
| A07BC30 | Combinations | ||||
| A07BC54 | Attapulgite, combinations | ||||
| A07C | Electrolytes with carbohydrates | ||||
| A07CA | Oral rehydration salt formulations | ||||
| human ATC classification. | |||||
| A07D | Antipropulsives | ||||
| A07DA | Antipropulsives | ||||
| A07DA01 | Diphenoxylate | ||||
| A07DA02 | Opium | ||||
| A07DA03 | Loperamide | ||||
| A07DA04 | Difenoxin | ||||
| A07DA05 | Loperamide oxide | ||||
| A07DA06 | eluxadoline | ||||
| A07DA52 | Morphine, combinations | ||||
| A07DA53 | Loperamide, combinations | ||||
| A07E | Intestinal anti-inflammatory agents | ||||
| A07EA | Corticosteroids acting locally | ||||
| A07EA01 | Prednisolone | ||||
| A07EA02 | Hydrocortisone | ||||
| A07EA03 | Prednisone | ||||
| A07EA04 | Betamethasone | ||||
| A07EA05 | Tixocortol | ||||
| A07EA06 | Budesonide | ||||
| A07EA07 | Beclometasone | ||||
| A07EB | Antiallergic agents, excluding corticosteroids | ||||
| A07EB01 | Cromoglicic acid | ||||
| A07EC | Aminosalicylic acid and similar agents | ||||
| A07EC01 | Sulfasalazine | ||||
| A07EC02 | Mesalazine | ||||
| A07EC03 | Olsalazine | ||||
| A07EC04 | Balsalazide | ||||
| A07F | Antidiarrheal micro-organisms | ||||
| A07FA | Antidiarrheal micro-organisms | ||||
| A07FA01 | Lactic acid producing organisms | ||||
| A07FA02 | Saccharomyces boulardii | ||||
| A07FA51 | Lactic acid producing organisms, combinations | ||||
| A07X | Other antidiarrheals | ||||
| A07XA | Other antidiarrheals | ||||
| A07XA01 | Albumin tannate | ||||
| A07XA02 | Ceratonia | ||||
| A07XA03 | Calcium compounds | ||||
| A07XA04 | Racecadotril | ||||
| A07XA51 | Albumin tannate, combinations | ||||
| A08 | Antiobesity preparations, excluding diet products | ||||
| A08A | Antiobesity preparations, excluding diet products | ||||
| A08AA | Centrally acting antiobesity products | ||||
| A08AA01 | Phentermine | ||||
| A08AA02 | Fenfluramine | ||||
| A08AA03 | Amfepramone | ||||
| A08AA04 | Dexfenfluramine | ||||
| A08AA05 | Mazindol | ||||
| A08AA06 | Etilamfetamine | ||||
| A08AA07 | Cathine | ||||
| A08AA08 | Clobenzorex | ||||
| A08AA09 | Mefenorex | ||||
| A08AA10 | Sibutramine | ||||
| A08AA11 | lorcaserin | ||||
| A08AA12 | setmelanotide | ||||
| A08AA51 | phentermine and topiramate | ||||
| A08AA56 | Ephedrine, combinations | ||||
| A08AA62 | bupropion and naltrexone | ||||
| A08AB | Peripherally acting antiobesity products | ||||
| A08AB01 | Orlistat | ||||
| A08AX | Other antiobesity drugs | ||||
| A08AX01 | Rimonabant | ||||
| A09 | Digestives,including enzymes | ||||
| A09A | Digestives, including enzymes | ||||
| A09AA | Enzyme preparations | ||||
| A09AA01 | Diastase | ||||
| A09AA02 | Multienzymes (lipase, protease, etc.) | ||||
| A09AA03 | Pepsin | ||||
| A09AA04 | Tilactase | ||||
| A09AB | Acid preparations | ||||
| A09AB01 | Glutamic acid hydrochloride | ||||
| A09AB02 | Betaine hydrochloride | ||||
| A09AB03 | Hydrochloric acid | ||||
| A09AB04 | Citric acid | ||||
| A09AC | Enzyme and acid preparations, combinations | ||||
| A09AC01 | Pepsin and acid preparations | ||||
| A09AC02 | Multienzymes and acid preparations | ||||
| A10 | Drugs used in diabetes | ||||
| A10A | Insulins and analogues | ||||
| A10AB | Insulins and analogues for injection, fast-acting | ||||
| A10AB01 | Insulin (human) | ||||
| A10AB02 | Insulin (beef) | ||||
| A10AB03 | Insulin (pork) | ||||
| A10AB04 | Insulin lispro | ||||
| A10AB05 | Insulin aspart | ||||
| A10AB06 | Insulin glulisine | ||||
| A10AB30 | Combinations | ||||
| A10AC | Insulins and analogues for injection, intermediate-acting | ||||
| A10AC01 | Insulin (human) | ||||
| A10AC02 | Insulin (beef) | ||||
| A10AC03 | Insulin (pork) | ||||
| A10AC04 | Insulin lispro | ||||
| A10AC30 | Combinations | ||||
| A10AD | Insulins and analogues for injection, intermediate-acting combined with fast-acting | ||||
| A10AD01 | Insulin (human) | ||||
| A10AD02 | Insulin (beef) | ||||
| A10AD03 | Insulin (pork) | ||||
| A10AD04 | Insulin lispro | ||||
| A10AD05 | Insulin aspart | ||||
| A10AD30 | Combinations | ||||
| A10AE | Insulins and analogues for injection, long-acting | ||||
| A10AE01 | Insulin (human) | ||||
| A10AE02 | Insulin (beef) | ||||
| A10AE03 | Insulin (pork) | ||||
| A10AE04 | Insulin glargine | ||||
| A10AE05 | Insulin detemir | ||||
| A10AE06 | insulin degludec | ||||
| A10AE07 | insulin icodec | ||||
| A10AE30 | Combinations | ||||
| A10AE54 | insulin glargine and lixisenatide | ||||
| A10AE56 | insulin degludec and liraglutide | ||||
| A10AE57 | insulin icodec and semaglutide | ||||
| A10AF | Insulins and analogues for inhalation | ||||
| A10AF01 | Insulin (human) | ||||
| A10B | Blood glucose lowering drugs, excluding insulins | ||||
| A10BA | Biguanides | ||||
| A10BA01 | Phenformin | ||||
| A10BA02 | Metformin | ||||
| A10BA03 | Buformin | ||||
| A10BB | Sulfonamides, urea derivatives | ||||
| A10BB01 | Glibenclamide | ||||
| A10BB02 | Chlorpropamide | ||||
| A10BB03 | Tolbutamide | ||||
| A10BB04 | Glibornuride | ||||
| A10BB05 | Tolazamide | ||||
| A10BB06 | Carbutamide | ||||
| A10BB07 | Glipizide | ||||
| A10BB08 | Gliquidone | ||||
| A10BB09 | Gliclazide | ||||
| A10BB10 | Metahexamide | ||||
| A10BB11 | Glisoxepide | ||||
| A10BB12 | Glimepiride | ||||
| A10BB31 | Acetohexamide | ||||
| A10BC | Sulfonamides (heterocyclic) | ||||
| A10BC01 | Glymidine | ||||
| A10BD | Combinations of oral blood glucose lowering drugs | ||||
| A10BD01 | Phenformin and sulfonamides | ||||
| A10BD02 | Metformin and sulfonamides | ||||
| A10BD03 | Metformin and rosiglitazone | ||||
| A10BD04 | Glimepiride and rosiglitazone | ||||
| A10BD05 | Metformin and pioglitazone | ||||
| A10BD06 | Glimepiride and pioglitazone | ||||
| A10BD07 | Metformin and sitagliptin | ||||
| A10BD08 | Metformin and vildagliptin | ||||
| A10BD09 | Pioglitazone and alogliptin | ||||
| A10BD10 | Metformin and saxagliptin | ||||
| A10BD11 | Metformin and linagliptin | ||||
| A10BD12 | Pioglitazone and sitagliptin | ||||
| A10BD13 | Metformin and alogliptin | ||||
| A10BD14 | metformin and repaglinide | ||||
| A10BD15 | metformin and dapagliflozin | ||||
| A10BD16 | metformin and canagliflozin | ||||
| A10BD17 | metformin and acarbose | ||||
| A10BD18 | metformin and gemigliptin | ||||
| A10BD19 | linagliptin and empagliflozin | ||||
| A10BD20 | metformin and empagliflozin | ||||
| A10BD21 | saxagliptin and dapagliflozin | ||||
| A10BD22 | metformin and evogliptin | ||||
| A10BD23 | metformin and ertugliflozin | ||||
| A10BD24 | sitagliptin and ertugliflozin | ||||
| A10BD25 | metformin, saxagliptin and dapagliflozin | ||||
| A10BD26 | metformin and lobeglitazone | ||||
| A10BD27 | metformin, linagliptin and empagliflozin | ||||
| A10BD28 | metformin and teneligliptin | ||||
| A10BD29 | sitagliptin and dapagliflozin | ||||
| A10BD30 | gemigliptin and dapagliflozin | ||||
| A10BD31 | metformin, sitagliptin and dapagliflozin | ||||
| A10BD32 | glimepiride and dapagliflozin | ||||
| A10BD33 | pioglitazone and dapagliflozin | ||||
| A10BD34 | metformin and enavogliflozin | ||||
| A10BF | Alpha glucosidase inhibitors | ||||
| A10BF01 | Acarbose | ||||
| A10BF02 | Miglitol | ||||
| A10BF03 | Voglibose | ||||
| A10BG | Thiazolidinediones | ||||
| A10BG01 | Troglitazone | ||||
| A10BG02 | Rosiglitazone | ||||
| A10BG03 | Pioglitazone | ||||
| A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors | ||||
| A10BH01 | Sitagliptin | ||||
| A10BH02 | Vildagliptin | ||||
| A10BH03 | Saxagliptin | ||||
| A10BH04 | Alogliptin | ||||
| A10BH05 | Linagliptin | ||||
| A10BH06 | gemigliptin | ||||
| A10BH07 | evogliptin | ||||
| A10BH08 | eneligliptin | ||||
| A10BH51 | Sitagliptin and simvastatin | ||||
| A10BH52 | gemigliptin and rosuvastatin | ||||
| A10BJ | Glucagon-like peptide-1 (GLP-1) analogues | ||||
| A10BJ01 | exenatide | ||||
| A10BJ02 | liraglutide | ||||
| A10BJ03 | lixisenatide | ||||
| A10BJ04 | albiglutide | ||||
| A10BJ05 | dulaglutide | ||||
| A10BJ06 | semaglutide | ||||
| A10BJ07 | beinaglutide | ||||
| A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors | ||||
| A10BK01 | Dapagliflozin | ||||
| A10BK02 | Canagliflozin | ||||
| A10BK03 | Empagliflozin | ||||
| A10BK04 | Ertugliflozin | ||||
| A10BK05 | Ipragliflozin | ||||
| A10BK06 | Sotagliflozin | ||||
| A10BK07 | Luseogliflozin | ||||
| A10BK08 | bexagliflozin | ||||
| A10BK09 | enavogliflozin | ||||
| A10BX | Other blood glucose lowering drugs, excluding insulins | ||||
| A10BX01 | Guar gum | ||||
| A10BX02 | Repaglinide | ||||
| A10BX03 | Nateglinide | ||||
| A10BX04 | Exenatide (New ATC code A10BJ01) | ||||
| A10BX05 | Pramlintide | ||||
| A10BX06 | Benfluorex | ||||
| A10BX07 | Liraglutide (New ATC code A10BJ02) | ||||
| A10BX08 | Mitiglinide | ||||
| A10BX09 | Dapagliflozin (New ATC code A10BK01) | ||||
| A10BX10 | lixisenatide (New ATC code A10BJ03) | ||||
| A10BX11 | canagliflozin (New ATC code A10BK02) | ||||
| A10BX12 | empagliflozin (New ATC code A10BK03) | ||||
| A10BX13 | albiglutide (New ATC code A10BJ04) | ||||
| A10BX14 | dulaglutide (New ATC code A10BJ05) | ||||
| A10BX15 | imeglimin | ||||
| A10BX16 | tirzepatide | ||||
| A10BX17 | carfloglitazar | ||||
| A10BX18 | dorzagliatin | ||||
| A10X | Other drugs used in diabetes | ||||
| A10XA | Aldose reductase inhibitors | ||||
| A10XA01 | Tolrestat | ||||
| A10XX | Other drugs used in diabetes | ||||
| A10XX01 | teplizumab | ||||
| A10XX02 | donislecel | ||||
| A11 | Vitamins | ||||
| A11A | Multivitamins, combinations | ||||
| A11AA | Multivitamins with minerals | ||||
| A11AA01 | Multivitamins and iron | ||||
| A11AA02 | Multivitamins and calcium | ||||
| A11AA03 | Multivitamins and other minerals, including combinations | ||||
| A11AA04 | Multivitamins and trace elements | ||||
| A11AB | Multivitamins, other combinations | ||||
| empty | |||||
| A11B | Multivitamins, plain | ||||
| A11BA | Multivitamins, plain | ||||
| empty | |||||
| A11C | Vitamin A and D, including combinations of the two | ||||
| A11CA | Vitamin A, plain | ||||
| A11CA01 | Retinol (vitamin A) | ||||
| A11CA02 | Betacarotene | ||||
| A11CB | Vitamin A and D in combination | ||||
| empty | |||||
| A11CC | Vitamin D and analogues | ||||
| A11CC01 | Ergocalciferol | ||||
| A11CC02 | Dihydrotachysterol | ||||
| A11CC03 | Alfacalcidol | ||||
| A11CC04 | Calcitriol | ||||
| A11CC05 | Colecalciferol | ||||
| A11CC06 | Calcifediol | ||||
| A11CC07 | paricalcitol (New ATC code H05BX02) | ||||
| A11CC20 | Combinations | ||||
| A11D | Vitamin B1, plain and in combination with vitamin B6 and B12 | ||||
| A11DA | Vitamin B1, plain | ||||
| A11DA01 | Thiamine (vitamin B1) | ||||
| A11DA02 | Sulbutiamine | ||||
| A11DA03 | Benfotiamine | ||||
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 | ||||
| empty | |||||
| A11E | Vitamin B-complex, including combinations | ||||
| A11EA | Vitamin B-complex, plain | ||||
| empty | |||||
| A11EB | Vitamin B-complex with vitamin C | ||||
| empty | |||||
| A11EC | Vitamin B-complex with minerals | ||||
| empty | |||||
| A11ED | Vitamin B-complex with anabolic steroids | ||||
| empty | |||||
| A11EX | Vitamin B-complex, other combinations | ||||
| empty | |||||
| A11G | Ascorbic acid (vitamin C), including combinations | ||||
| A11GA | Ascorbic acid (vitamin C), plain | ||||
| A11GA01 | Ascorbic acid (vitamin C) | ||||
| A11GB | Ascorbic acid (vitamin C), combinations | ||||
| A11GB01 | Ascorbic acid (vitamin C) and calcium | ||||
| A11H | Other plain vitamin preparations | ||||
| A11HA | Other plain vitamin preparations | ||||
| A11HA01 | Nicotinamide | ||||
| A11HA02 | Pyridoxine (vitamin B6) | ||||
| A11HA03 | Tocopherol (vitamin E) | ||||
| A11HA04 | Riboflavin (vitamin B2) | ||||
| A11HA05 | Biotin | ||||
| A11HA06 | Pyridoxal phosphate | ||||
| A11HA07 | Inositol | ||||
| A11HA08 | Tocofersolan | ||||
| A11HA30 | Dexpanthenol | ||||
| A11HA31 | Calcium pantothenate | ||||
| A11HA32 | Pantethine | ||||
| A11J | Other vitamin products, combinations | ||||
| A11JA | Combinations of vitamins | ||||
| empty | |||||
| A11JB | Vitamins with minerals | ||||
| empty | |||||
| A11JC | Vitamins, other combinations | ||||
| empty | |||||
| A12 | Mineral supplements | ||||
| A12A | Calcium | ||||
| A12AA | Calcium | ||||
| A12AA01 | Calcium phosphate | ||||
| A12AA02 | Calcium glubionate | ||||
| A12AA03 | Calcium gluconate | ||||
| A12AA04 | Calcium carbonate | ||||
| A12AA05 | Calcium lactate | ||||
| A12AA06 | Calcium lactate gluconate | ||||
| A12AA07 | Calcium chloride | ||||
| A12AA08 | Calcium glycerylphosphate | ||||
| A12AA09 | Calcium citrate lysine complex | ||||
| A12AA10 | Calcium glucoheptonate | ||||
| A12AA11 | Calcium pangamate | ||||
| A12AA12 | Calcium acetate anhydrous (New ATC code V03AE07) | ||||
| A12AA20 | Calcium (different salts in combination) | ||||
| A12AA30 | Calcium laevulate | ||||
| A12AX | Calcium, combinations with vitamin D and/or other drugs | ||||
| empty | |||||
| A12B | Potassium | ||||
| A12BA | Potassium | ||||
| A12BA01 | Potassium chloride | ||||
| A12BA02 | Potassium citrate | ||||
| A12BA03 | Potassium hydrogentartrate | ||||
| A12BA04 | Potassium hydrogencarbonate | ||||
| A12BA05 | Potassium gluconate | ||||
| A12BA30 | Combinations | ||||
| A12BA51 | Potassium chloride, combinations | ||||
| A12C | Other mineral supplements | ||||
| A12CA | Sodium | ||||
| A12CA01 | Sodium chloride | ||||
| A12CA02 | Sodium sulfate | ||||
| A12CB | Zinc | ||||
| A12CB01 | Zinc sulfate | ||||
| A12CB02 | Zinc gluconate | ||||
| A12CB03 | Zinc protein complex | ||||
| A12CB04 | zinc orotate | ||||
| A12CC | Magnesium | ||||
| A12CC01 | Magnesium chloride | ||||
| A12CC02 | Magnesium sulfate | ||||
| A12CC03 | Magnesium gluconate | ||||
| A12CC04 | Magnesium citrate | ||||
| A12CC05 | Magnesium aspartate | ||||
| A12CC06 | Magnesium lactate | ||||
| A12CC07 | Magnesium levulinate | ||||
| A12CC08 | Magnesium pidolate | ||||
| A12CC09 | Magnesium orotate | ||||
| A12CC10 | Magnesium oxide | ||||
| A12CC30 | Magnesium (different salts in combination) | ||||
| A12CD | Fluoride | ||||
| A12CD01 | Sodium fluoride | ||||
| A12CD02 | Sodium monofluorophosphate | ||||
| A12CD51 | Fluoride, combinations | ||||
| A12CE | Selenium | ||||
| A12CE01 | Sodium selenate | ||||
| A12CE02 | Sodium selenite | ||||
| A12CX | Other mineral products | ||||
| empty | |||||
| A13 | Tonics | ||||
| A13A | Tonics | ||||
| empty | |||||
| A14 | Anabolic agents for systemic use | ||||
| A14A | Anabolic steroids | ||||
| A14AA | Androstan derivatives | ||||
| A14AA01 | Androstanolone | ||||
| A14AA02 | Stanozolol | ||||
| A14AA03 | Metandienone | ||||
| A14AA04 | Metenolone | ||||
| A14AA05 | Oxymetholone | ||||
| A14AA06 | Quinbolone | ||||
| A14AA07 | Prasterone | ||||
| A14AA08 | Oxandrolone | ||||
| A14AA09 | Norethandrolone | ||||
| A14AB | Estren derivatives | ||||
| A14AB01 | Nandrolone | ||||
| A14AB02 | Ethylestrenol | ||||
| A14AB03 | Oxabolone cipionate | ||||
| A14B | Other anabolic agents | ||||
| empty | |||||
| A15 | Appetite stimulants | ||||
| empty | |||||
| A16 | Other alimentary tract and metabolism products | ||||
| A16A | Other alimentary tract and metabolism products | ||||
| A16AA | Amino acids and derivatives | ||||
| A16AA01 | Levocarnitine | ||||
| A16AA02 | Ademetionine | ||||
| A16AA03 | Levoglutamide | ||||
| A16AA04 | Mercaptamine | ||||
| A16AA05 | Carglumic acid | ||||
| A16AA06 | Betaine | ||||
| A16AB | Enzymes | ||||
| A16AB01 | Alglucerase | ||||
| A16AB02 | Imiglucerase | ||||
| A16AB03 | Agalsidase alfa | ||||
| A16AB04 | Agalsidase beta | ||||
| A16AB05 | Laronidase | ||||
| A16AB06 | Sacrosidase | ||||
| A16AB07 | Alglucosidase alfa | ||||
| A16AB08 | Galsulfase | ||||
| A16AB09 | Idursulfase | ||||
| A16AB10 | Velaglucerase alfa | ||||
| A16AB11 | Taliglucerase alfa | ||||
| A16AB12 | elosulfase alfa | ||||
| A16AB13 | asfotase alfa | ||||
| A16AB14 | sebelipase alfa | ||||
| A16AB15 | velmanase alfa | ||||
| A16AB16 | idursulfase beta | ||||
| A16AB17 | cerliponase alfa | ||||
| A16AB18 | vestronidase alfa | ||||
| A16AB19 | pegvaliase | ||||
| A16AB20 | pegunigalsidase alfa | ||||
| A16AB21 | atidarsagene autotemcel | ||||
| A16AB22 | avalglucosidase alfa | ||||
| A16AB23 | cipaglucosidase alfa | ||||
| A16AB24 | pegzilarginase | ||||
| A16AB25 | olipudase alfa | ||||
| A16AB26 | eladocagene exuparvovec | ||||
| A16AB27 | pabinafusp alfa | ||||
| A16AB28 | verenafusp alfa | ||||
| A16AB29 | rebisufligene etisparvovec | ||||
| A16AX | Various alimentary tract and metabolism products | ||||
| A16AX01 | Thioctic acid | ||||
| A16AX02 | Anethole trithione | ||||
| A16AX03 | Sodium phenylbutyrate | ||||
| A16AX04 | Nitisinone | ||||
| A16AX05 | Zinc acetate | ||||
| A16AX06 | Miglustat | ||||
| A16AX07 | Sapropterin | ||||
| A16AX08 | Teduglutide | ||||
| A16AX09 | Glycerol phenylbutyrate | ||||
| A16AX10 | eliglustat | ||||
| A16AX11 | sodium benzoate | ||||
| A16AX12 | trientine | ||||
| A16AX13 | uridine triacetate | ||||
| A16AX14 | migalastat | ||||
| A16AX15 | telotristat | ||||
| A16AX16 | givosiran | ||||
| A16AX17 | triheptanoin | ||||
| A16AX18 | lumasiran | ||||
| A16AX19 | fosdenopterin | ||||
| A16AX20 | lonafarnib | ||||
| A16AX21 | elivaldogene autotemcel | ||||
| A16AX22 | tiomolibdic acid | ||||
| A16AX23 | leriglitazone | ||||
| A16AX24 | govorestat | ||||
| A16AX25 | nedosiran | ||||
| A16AX26 | glepaglutide | ||||
| A16AX27 | apraglutide | ||||
| A16AX28 | sepiapterin | ||||
| A16AX29 | doxecitine and doxribtimine | ||||
| A16AX30 | sodium benzoate and sodium phenylacetate | ||||
| âB | Blood and blood forming organs | ||||
| B01 | Antithrombotic agents | ||||
| B01A | Antithrombotic agents | ||||
| B01AA | Vitamin K antagonists | ||||
| B01AA01 | Dicoumarol | ||||
| B01AA02 | Phenindione | ||||
| B01AA03 | Warfarin | ||||
| B01AA04 | Phenprocoumon | ||||
| B01AA07 | Acenocoumarol | ||||
| B01AA08 | Ethyl biscoumacetate | ||||
| B01AA09 | Clorindione | ||||
| B01AA10 | Diphenadione | ||||
| B01AA11 | Tioclomarol | ||||
| B01AA12 | Fluindione | ||||
| B01AB | Heparin group | ||||
| B01AB01 | Heparin | ||||
| B01AB02 | Antithrombin III | ||||
| B01AB04 | Dalteparin | ||||
| B01AB05 | Enoxaparin | ||||
| B01AB06 | Nadroparin | ||||
| B01AB07 | Parnaparin | ||||
| B01AB08 | Reviparin | ||||
| B01AB09 | Danaparoid | ||||
| B01AB10 | Tinzaparin | ||||
| B01AB11 | Sulodexide | ||||
| B01AB12 | Bemiparin | ||||
| B01AB51 | Heparin, combinations | ||||
| B01AC | Platelet aggregation inhibitors excluding heparin | ||||
| B01AC01 | Ditazole | ||||
| B01AC02 | Cloricromen | ||||
| B01AC03 | Picotamide | ||||
| B01AC04 | Clopidogrel | ||||
| B01AC05 | Ticlopidine | ||||
| B01AC06 | Acetylsalicylic acid | ||||
| B01AC07 | Dipyridamole | ||||
| B01AC08 | Carbasalate calcium | ||||
| B01AC09 | Epoprostenol | ||||
| B01AC10 | Indobufen | ||||
| B01AC11 | Iloprost | ||||
| B01AC13 | Abciximab | ||||
| B01AC14 | anagrelide (New ATC code L01XX35) | ||||
| B01AC15 | Aloxiprin | ||||
| B01AC16 | Eptifibatide | ||||
| B01AC17 | Tirofiban | ||||
| B01AC18 | Triflusal | ||||
| B01AC19 | Beraprost | ||||
| B01AC21 | Treprostinil | ||||
| B01AC22 | Prasugrel | ||||
| B01AC23 | Cilostazol | ||||
| B01AC24 | Ticagrelor | ||||
| B01AC30 | Combinations | ||||
| B01AC56 | Acetylsalicylic acid and esomeprazole | ||||
| B01AD | Enzymes | ||||
| B01AD01 | Streptokinase | ||||
| B01AD02 | Alteplase | ||||
| B01AD03 | Anistreplase | ||||
| B01AD04 | Urokinase | ||||
| B01AD05 | Fibrinolysin | ||||
| B01AD06 | Brinase | ||||
| B01AD07 | Reteplase | ||||
| B01AD08 | Saruplase | ||||
| B01AD09 | Ancrod | ||||
| B01AD10 | Drotrecogin alfa (activated) | ||||
| B01AD11 | Tenecteplase | ||||
| B01AD12 | Protein C | ||||
| B01AD13 | apadamtase alfa and cinaxadamtase alfa | ||||
| B01AE | Direct thrombin inhibitors | ||||
| B01AE01 | Desirudin | ||||
| B01AE02 | Lepirudin | ||||
| B01AE03 | Argatroban | ||||
| B01AE04 | Melagatran | ||||
| B01AE05 | Ximelagatran | ||||
| B01AE06 | Bivalirudin | ||||
| B01AE07 | Dabigatran etexilate | ||||
| B01AF | Direct factor Xa inhibitors | ||||
| B01AF01 | Rivaroxaban | ||||
| B01AF02 | Apixaban | ||||
| B01AF03 | edoxaban | ||||
| B01AF04 | betrixaban | ||||
| B01AX | Other antithrombotic agents | ||||
| B01AX01 | Defibrotide | ||||
| B01AX04 | Dermatan sulfate | ||||
| B01AX05 | Fondaparinux | ||||
| B01AX06 | rivaroxaban (New ATC code B01AF01) | ||||
| B01AX07 | caplacizumab | ||||
| B02 | Antihemorrhagics | ||||
| B02A | Antifibrinolytics | ||||
| B02AA | Amino acids | ||||
| B02AA01 | Aminocaproic acid | ||||
| B02AA02 | Tranexamic acid | ||||
| B02AA03 | Aminomethylbenzoic acid | ||||
| B02AB | Proteinase inhibitors | ||||
| B02AB01 | Aprotinin | ||||
| B02AB02 | Alfa1 antitrypsin | ||||
| B02AB03 | c1-inhibitor, plasma derived (New ATC code B06AC01) | ||||
| B02AB04 | Camostat | ||||
| B02B | Vitamin K and other hemostatics | ||||
| B02BA | Vitamin K | ||||
| B02BA01 | Phytomenadione | ||||
| B02BA02 | Menadione | ||||
| B02BB | Fibrinogen | ||||
| B02BB01 | Human fibrinogen | ||||
| B02BC | Local hemostatics | ||||
| B02BC01 | Absorbable gelatin sponge | ||||
| B02BC02 | Oxidized cellulose | ||||
| B02BC03 | Tetragalacturonic acid hydroxymethylester | ||||
| B02BC05 | Adrenalone | ||||
| B02BC06 | Thrombin | ||||
| B02BC07 | Collagen | ||||
| B02BC08 | Calcium alginate | ||||
| B02BC09 | Epinephrine | ||||
| B02BC10 | Fibrinogen, human (New ATC code B02BC30) | ||||
| B02BC30 | Combinations | ||||
| B02BD | Blood coagulation factors | ||||
| B02BD01 | Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate) | ||||
| B02BD02 | Coagulation factor VIII | ||||
| B02BD03 | Factor VIII inhibitor bypassing activity | ||||
| B02BD04 | Coagulation factor IX | ||||
| B02BD05 | Coagulation factor VII | ||||
| B02BD06 | Von Willebrand factor and coagulation factor VIII in combination | ||||
| B02BD07 | Coagulation factor XIII | ||||
| B02BD08 | Eptacog alfa (activated) | ||||
| B02BD09 | Nonacog alfa (New ATC code B02BD04) | ||||
| B02BD10 | von Willebrand factor | ||||
| B02BD11 | Catridecacog | ||||
| B02BD12 | Trenonacog alfa (New ATC code B02BD04) | ||||
| B02BD13 | coagulation factor X | ||||
| B02BD14 | susoctocog alfa | ||||
| B02BD15 | valoctocogene roxaparvovec | ||||
| B02BD16 | etranacogene dezaparvovec | ||||
| B02BD17 | fidanacogene elaparvovec | ||||
| B02BD18 | arvenacogene sanparvovec | ||||
| B02BD30 | Thrombin | ||||
| B02BX | Other systemic hemostatics | ||||
| B02BX01 | Etamsylate | ||||
| B02BX02 | Carbazochrome | ||||
| B02BX03 | Batroxobin | ||||
| B02BX04 | Romiplostim | ||||
| B02BX05 | Eltrombopag | ||||
| B02BX06 | emicizumab | ||||
| B02BX07 | lusutrombopag | ||||
| B02BX08 | avatrombopag | ||||
| B02BX09 | fostamatinib | ||||
| B02BX10 | concizumab | ||||
| B02BX11 | marstacimab | ||||
| B02BX12 | fitusiran | ||||
| B03 | Antianemic preparations | ||||
| B03A | Iron preparations | ||||
| B03AA | Iron bivalent, oral preparations | ||||
| B03AA01 | Ferrous glycine sulfate | ||||
| B03AA02 | Ferrous fumarate | ||||
| B03AA03 | Ferrous gluconate | ||||
| B03AA04 | Ferrous carbonate | ||||
| B03AA05 | Ferrous chloride | ||||
| B03AA06 | Ferrous succinate | ||||
| B03AA07 | Ferrous sulfate | ||||
| B03AA08 | Ferrous tartrate | ||||
| B03AA09 | Ferrous aspartate | ||||
| B03AA10 | Ferrous ascorbate | ||||
| B03AA11 | Ferrous iodine | ||||
| B03AB | Iron trivalent, oral preparations | ||||
| B03AB01 | Ferric sodium citrate | ||||
| B03AB02 | Saccharated iron oxide | ||||
| B03AB03 | Sodium feredetate | ||||
| B03AB04 | Ferric hydroxide | ||||
| B03AB05 | Ferric oxide polymaltose complexes | ||||
| B03AB06 | Ferric citrate (New ATC code V03AE08) | ||||
| B03AB07 | Chondroitin sulfate-iron complex | ||||
| B03AB08 | Ferric acetyl transferrin | ||||
| B03AB09 | Ferric proteinsuccinylate | ||||
| B03AC | Iron trivalent, parenteral preparations | ||||
| B03AC01 | Ferric oxide polymaltose complexes | ||||
| B03AC02 | Saccharated iron oxide - deleted | ||||
| B03AC03 | Iron-sorbitol-citric acid complex - Deleted | ||||
| B03AC05 | Ferric sorbitol gluconic acid complex - deleted | ||||
| B03AC06 | Ferric oxide dextran complexes - deleted | ||||
| B03AC07 | Ferric sodium gluconate complex - deleted | ||||
| B03AD | Iron in combination with folic acid | ||||
| B03AD01 | Ferrous amino acid complex | ||||
| B03AD02 | Ferrous fumarate | ||||
| B03AD03 | Ferrous sulfate | ||||
| B03AD04 | Ferric oxide polymaltose complexes | ||||
| B03AE | Iron in other combinations | ||||
| B03AE01 | Iron, vitamin B12 and folic acid | ||||
| B03AE02 | Iron, multivitamins and folic acid | ||||
| B03AE03 | Iron and multivitamins | ||||
| B03AE04 | Iron, multivitamins and minerals | ||||
| B03AE10 | Various combinations | ||||
| B03B | Vitamin B12 and folic acid | ||||
| B03BA | Vitamin B12 (cyanocobalamin and analogues) | ||||
| B03BA01 | Cyanocobalamin | ||||
| B03BA02 | Cyanocobalamin tannin complex | ||||
| B03BA03 | Hydroxocobalamin | ||||
| B03BA04 | Cobamamide | ||||
| B03BA05 | Mecobalamin | ||||
| B03BA51 | Cyanocobalamin, combinations | ||||
| B03BA53 | Hydroxocobalamin, combinations | ||||
| B03BB | Folic acid and derivatives | ||||
| B03BB01 | Folic acid | ||||
| B03BB51 | Folic acid, combinations | ||||
| B03X | Other antianemic preparations | ||||
| B03XA | Other antianemic preparations | ||||
| B03XA01 | Erythropoietin | ||||
| B03XA02 | Darbepoetin alfa | ||||
| B03XA03 | Methoxy polyethylene glycol-epoetin beta | ||||
| B03XA04 | Peginesatide | ||||
| B03XA05 | roxadustat | ||||
| B03XA06 | luspatercept | ||||
| B03XA07 | daprodustat | ||||
| B03XA08 | vadadustat | ||||
| B03XA09 | molidustat | ||||
| B03XA10 | efepoetin alfa | ||||
| B05 | Blood substitutes and perfusion solutions | ||||
| B05A | Blood and related products | ||||
| B05AA | Blood substitutes and plasma protein fractions | ||||
| B05AA01 | Serum albumin | ||||
| B05AA02 | Other plasma protein fractions | ||||
| B05AA03 | Fluorocarbon blood substitutes | ||||
| B05AA05 | Dextran | ||||
| B05AA06 | Gelatin agents | ||||
| B05AA07 | Hydroxyethylstarch | ||||
| B05AA08 | Hemoglobin crosfumaril | ||||
| B05AA09 | Hemoglobin raffimer | ||||
| B05AA10 | Hemoglobin glutamer (bovine) | ||||
| B05AX | Other blood products | ||||
| B05AX01 | Erythrocytes | ||||
| B05AX02 | Thrombocytes | ||||
| B05AX03 | Blood plasma | ||||
| B05AX04 | Stem cells from umbilical cord blood | ||||
| B05B | I.v. solutions | ||||
| B05BA | Solutions for parenteral nutrition | ||||
| B05BA01 | Amino acids | ||||
| B05BA02 | Fat emulsions | ||||
| B05BA03 | Carbohydrates | ||||
| B05BA04 | Protein hydrolysates | ||||
| B05BA10 | Combinations | ||||
| B05BB | Solutions affecting the electrolyte balance | ||||
| B05BB01 | Electrolytes | ||||
| B05BB02 | Electrolytes with carbohydrates | ||||
| B05BB03 | Trometamol | ||||
| B05BB04 | Electrolytes in combination with other drugs | ||||
| B05BC | Solutions producing osmotic diuresis | ||||
| B05BC01 | Mannitol | ||||
| B05BC02 | Carbamide | ||||
| B05C | Irrigating solutions | ||||
| B05CA | Antiinfectives | ||||
| B05CA01 | Cetylpyridinium | ||||
| B05CA02 | Chlorhexidine | ||||
| B05CA03 | Nitrofural | ||||
| B05CA04 | Sulfamethizole | ||||
| B05CA05 | Taurolidine | ||||
| B05CA06 | Mandelic acid | ||||
| B05CA07 | Noxytiolin | ||||
| B05CA08 | Ethacridine lactate | ||||
| B05CA09 | Neomycin | ||||
| B05CA10 | Combinations | ||||
| B05CB | Salt solutions | ||||
| B05CB01 | Sodium chloride | ||||
| B05CB02 | Sodium citrate | ||||
| B05CB03 | Magnesium citrate | ||||
| B05CB04 | Sodium bicarbonate | ||||
| B05CB10 | Combinations | ||||
| B05CX | Other irrigating solutions | ||||
| B05CX01 | Glucose | ||||
| B05CX02 | Sorbitol | ||||
| B05CX03 | Glycine | ||||
| B05CX04 | Mannitol | ||||
| B05CX10 | Combinations | ||||
| B05D | Peritoneal dialytics | ||||
| B05DA | Isotonic solutions | ||||
| empty | |||||
| B05DB | Hypertonic solutions | ||||
| empty | |||||
| B05X | I.v. solution additives | ||||
| B05XA | Electrolyte solutions | ||||
| B05XA01 | Potassium chloride | ||||
| B05XA02 | Sodium bicarbonate | ||||
| B05XA03 | Sodium chloride | ||||
| B05XA04 | Ammonium chloride | ||||
| B05XA05 | Magnesium sulfate | ||||
| B05XA06 | Potassium phosphate, including combinations with other potassium salts | ||||
| B05XA07 | Calcium chloride | ||||
| B05XA08 | Sodium acetate | ||||
| B05XA09 | Sodium phosphate | ||||
| B05XA10 | Magnesium phosphate | ||||
| B05XA11 | Magnesium chloride | ||||
| B05XA12 | Zinc chloride | ||||
| B05XA13 | Hydrochloric acid | ||||
| B05XA14 | Sodium glycerophosphate | ||||
| B05XA15 | Potassium lactate | ||||
| B05XA16 | Cardioplegia solutions | ||||
| B05XA17 | Potassium acetate | ||||
| B05XA30 | Combinations of electrolytes | ||||
| B05XA31 | Electrolytes in combination with other drugs | ||||
| B05XB | Amino acids | ||||
| B05XB01 | Arginine hydrochloride | ||||
| B05XB02 | Alanyl glutamine | ||||
| B05XB03 | Lysine | ||||
| B05XC | Vitamins | ||||
| empty | |||||
| B05XX | Other i.v. solution additives | ||||
| B05XX02 | Trometamol | ||||
| B05Z | Hemodialytics and hemofiltrates | ||||
| B05ZA | Hemodialytics, concentrates | ||||
| empty | |||||
| B05ZB | Hemofiltrates | ||||
| empty | |||||
| B06 | Other hematological agents | ||||
| B06A | Other hematological agents | ||||
| B06AA | Enzymes | ||||
| B06AA02 | Fibrinolysin and desoxyribonuclease | ||||
| B06AA03 | Hyaluronidase | ||||
| B06AA04 | Chymotrypsin | ||||
| B06AA07 | Trypsin | ||||
| B06AA10 | Desoxyribonuclease | ||||
| B06AA11 | Bromelain (New ATC code D03BA03) | ||||
| B06AA55 | Streptokinase, combinations | ||||
| B06AB | Other hematological products | ||||
| B06AB01 | Hematin | ||||
| B06AC | Drugs used in hereditary angioedema | ||||
| B06AC01 | C1-inhibitor, plasma derived | ||||
| B06AC02 | Icatibant | ||||
| B06AC03 | Ecallantide | ||||
| B06AC04 | Conestat alfa | ||||
| B06AC05 | lanadelumab | ||||
| B06AC06 | berotralstat | ||||
| B06AC07 | garadacimab | ||||
| B06AC08 | sebetralstat | ||||
| B06AC09 | donidalorsen | ||||
| B06AX | Other hematological agents | ||||
| B06AX01 | crizanlizumab | ||||
| B06AX02 | betibeglogene autotemcel | ||||
| B06AX03 | voxelotor | ||||
| B06AX04 | mitapivat | ||||
| B06AX05 | exagamglogene autotemcel | ||||
| B06AX06 | lovotibeglogene autotemcel | ||||
| B06AX07 | mozafancogene autotemcel | ||||
| âC | Cardiovascular system | ||||
| C01 | Cardiac therapy | ||||
| C01A | Cardiac glycosides | ||||
| C01AA | Digitalis glycosides | ||||
| C01AA01 | Acetyldigitoxin | ||||
| C01AA02 | Acetyldigoxin | ||||
| C01AA03 | Digitalis leaves | ||||
| C01AA04 | Digitoxin | ||||
| C01AA05 | Digoxin | ||||
| C01AA06 | Lanatoside C | ||||
| C01AA07 | Deslanoside | ||||
| C01AA08 | Metildigoxin | ||||
| C01AA09 | Gitoformate | ||||
| C01AA52 | Acetyldigoxin, combinations | ||||
| C01AB | Scilla glycosides | ||||
| C01AB01 | Proscillaridin | ||||
| C01AB51 | Proscillaridin, combinations | ||||
| C01AC | Strophantus glycosides | ||||
| C01AC01 | G-strophanthin | ||||
| C01AC03 | Cymarin | ||||
| C01AX | Other cardiac glycosides | ||||
| C01AX02 | Peruvoside | ||||
| C01B | Antiarrhythmics, class I and III | ||||
| C01BA | Antiarrhythmics, class Ia | ||||
| C01BA01 | Quinidine | ||||
| C01BA02 | Procainamide | ||||
| C01BA03 | Disopyramide | ||||
| C01BA04 | Sparteine | ||||
| C01BA05 | Ajmaline | ||||
| C01BA08 | Prajmaline | ||||
| C01BA12 | Lorajmine | ||||
| C01BA51 | Quinidine, combinations excluding psycholeptics | ||||
| C01BA71 | Quinidine, combinations with psycholeptics | ||||
| C01BB | Antiarrhythmics, class Ib | ||||
| C01BB01 | Lidocaine | ||||
| C01BB02 | Mexiletine | ||||
| C01BB03 | Tocainide | ||||
| C01BB04 | Aprindine | ||||
| C01BC | Antiarrhythmics, class Ic | ||||
| C01BC03 | Propafenone | ||||
| C01BC04 | Flecainide | ||||
| C01BC07 | Lorcainide | ||||
| C01BC08 | Encainide | ||||
| C01BC09 | Ethacizine | ||||
| C01BD | Antiarrhythmics, class III | ||||
| C01BD01 | Amiodarone | ||||
| C01BD02 | Bretylium tosilate | ||||
| C01BD03 | Bunaftine | ||||
| C01BD04 | Dofetilide | ||||
| C01BD05 | Ibutilide | ||||
| C01BD06 | Tedisamil | ||||
| C01BD07 | Dronedarone | ||||
| C01BG | Other antiarrhythmics, class I and III | ||||
| C01BG01 | Moracizine | ||||
| C01BG07 | Cibenzoline | ||||
| C01BG11 | Vernakalant | ||||
| C01C | Cardiac stimulants excluding cardiac glycosides | ||||
| C01CA | Adrenergic and dopaminergic agents | ||||
| C01CA01 | Etilefrine | ||||
| C01CA02 | Isoprenaline | ||||
| C01CA03 | Norepinephrine | ||||
| C01CA04 | Dopamine | ||||
| C01CA05 | Norfenefrine | ||||
| C01CA06 | Phenylephrine | ||||
| C01CA07 | Dobutamine | ||||
| C01CA08 | Oxedrine | ||||
| C01CA09 | Metaraminol | ||||
| C01CA10 | Methoxamine | ||||
| C01CA11 | Mephentermine | ||||
| C01CA12 | Dimetofrine | ||||
| C01CA13 | Prenalterol | ||||
| C01CA14 | Dopexamine | ||||
| C01CA15 | Gepefrine | ||||
| C01CA16 | Ibopamine | ||||
| C01CA17 | Midodrine | ||||
| C01CA18 | Octopamine | ||||
| C01CA19 | Fenoldopam | ||||
| C01CA21 | Cafedrine | ||||
| C01CA22 | Arbutamine | ||||
| C01CA23 | Theodrenaline | ||||
| C01CA24 | Epinephrine | ||||
| C01CA25 | Amezinium metilsulfate | ||||
| C01CA26 | Ephedrine | ||||
| C01CA27 | droxidopa | ||||
| C01CA30 | Combinations | ||||
| C01CA51 | Etilefrine, combinations | ||||
| C01CE | Phosphodiesterase inhibitors | ||||
| C01CE01 | Amrinone | ||||
| C01CE02 | Milrinone | ||||
| C01CE03 | Enoximone | ||||
| C01CE04 | Bucladesine | ||||
| C01CX | Other cardiac stimulants | ||||
| C01CX06 | Angiotensinamide | ||||
| C01CX07 | Xamoterol | ||||
| C01CX08 | Levosimendan | ||||
| C01D | Vasodilators used in cardiac diseases | ||||
| C01DA | Organic nitrates | ||||
| C01DA02 | Glyceryl trinitrate | ||||
| C01DA04 | Methylpropylpropanediol dinitrate | ||||
| C01DA05 | Pentaerithrityl tetranitrate | ||||
| C01DA07 | Propatylnitrate | ||||
| C01DA08 | Isosorbide dinitrate | ||||
| C01DA09 | Trolnitrate | ||||
| C01DA13 | Eritrityl tetranitrate | ||||
| C01DA14 | Isosorbide mononitrate | ||||
| C01DA20 | Organic nitrates in combination | ||||
| C01DA38 | Tenitramine | ||||
| C01DA52 | Glyceryl trinitrate, combinations | ||||
| C01DA54 | Methylpropylpropanediol dinitrate, combinations | ||||
| C01DA55 | Pentaerithrityl tetranitrate, combinations | ||||
| C01DA57 | Propatylnitrate, combinations | ||||
| C01DA58 | Isosorbide dinitrate, combinations | ||||
| C01DA59 | Trolnitrate, combinations | ||||
| C01DA63 | Eritrityl tetranitrate, combinations | ||||
| C01DA70 | Organic nitrates in combination with psycholeptics | ||||
| C01DB | Quinolone vasodilators | ||||
| C01DB01 | Flosequinan | ||||
| C01DX | Other vasodilators used in cardiac diseases | ||||
| C01DX01 | Itramin tosilate | ||||
| C01DX02 | Prenylamine | ||||
| C01DX03 | Oxyfedrine | ||||
| C01DX04 | Benziodarone | ||||
| C01DX05 | Carbocromen | ||||
| C01DX06 | Hexobendine | ||||
| C01DX07 | Etafenone | ||||
| C01DX08 | Heptaminol | ||||
| C01DX09 | Imolamine | ||||
| C01DX10 | Dilazep | ||||
| C01DX11 | Trapidil | ||||
| C01DX12 | Molsidomine | ||||
| C01DX13 | Efloxate | ||||
| C01DX14 | Cinepazet | ||||
| C01DX15 | Cloridarol | ||||
| C01DX16 | Nicorandil | ||||
| C01DX18 | Linsidomine | ||||
| C01DX19 | Nesiritide | ||||
| C01DX51 | Itramin tosilate, combinations | ||||
| C01DX52 | Prenylamine, combinations | ||||
| C01DX53 | Oxyfedrine, combinations | ||||
| C01DX54 | Benziodarone, combinations | ||||
| C01E | Other cardiac preparations | ||||
| C01EA | Prostaglandins | ||||
| C01EA01 | Alprostadil | ||||
| C01EB | Other cardiac preparations | ||||
| C01EB02 | Camphora | ||||
| C01EB03 | Indometacin | ||||
| C01EB04 | Crataegus glycosides | ||||
| C01EB05 | Creatinolfosfate | ||||
| C01EB06 | Fosfocreatine | ||||
| C01EB07 | Fructose 1,6-diphosphate | ||||
| C01EB09 | Ubidecarenone | ||||
| C01EB10 | Adenosine | ||||
| C01EB11 | Tiracizine | ||||
| C01EB12 | tedisamil (New ATC code C01BD06) | ||||
| C01EB13 | Acadesine | ||||
| C01EB15 | Trimetazidine | ||||
| C01EB16 | Ibuprofen | ||||
| C01EB17 | Ivabradine | ||||
| C01EB18 | Ranolazine | ||||
| C01EB19 | icatibant (New ATC code B06AC02) | ||||
| C01EB21 | Regadenoson | ||||
| C01EB22 | meldonium | ||||
| C01EB23 | tiazotic acid | ||||
| C01EB24 | mavacamten | ||||
| C01EB25 | acoramidis | ||||
| C01EX | Other cardiac combination products | ||||
| empty | |||||
| C02 | Antihypertensives | ||||
| C02A | Antiadrenergic agents, centrally acting | ||||
| C02AA | Rauvolfia alkaloids | ||||
| C02AA01 | Rescinnamine | ||||
| C02AA02 | Reserpine | ||||
| C02AA03 | Combinations of rauwolfia alkaloids | ||||
| C02AA04 | Rauwolfia alkaloids, whole root | ||||
| C02AA05 | Deserpidine | ||||
| C02AA06 | Methoserpidine | ||||
| C02AA07 | Bietaserpine | ||||
| C02AA52 | Reserpine, combinations | ||||
| C02AA53 | Combinations of rauwolfia alkoloids, combinations | ||||
| C02AA57 | Bietaserpine, combinations | ||||
| C02AB | Methyldopa | ||||
| C02AB01 | Methyldopa (levorotatory) | ||||
| C02AB02 | Methyldopa (racemic) | ||||
| C02AC | Imidazoline receptor agonists | ||||
| C02AC01 | Clonidine | ||||
| C02AC02 | Guanfacine | ||||
| C02AC04 | Tolonidine | ||||
| C02AC05 | Moxonidine | ||||
| C02AC06 | Rilmenidine | ||||
| C02B | Antiadrenergic agents, ganglion-blocking | ||||
| C02BA | Sulfonium derivatives | ||||
| C02BA01 | Trimetaphan | ||||
| C02BB | Secondary and tertiary amines | ||||
| C02BB01 | Mecamylamine | ||||
| C02BC | Bisquaternary ammonium compounds | ||||
| empty | |||||
| C02C | Antiadrenergic agents, peripherally acting | ||||
| C02CA | Alpha-adrenoreceptor antagonists | ||||
| C02CA01 | Prazosin | ||||
| C02CA02 | Indoramin | ||||
| C02CA03 | Trimazosin | ||||
| C02CA04 | Doxazosin | ||||
| C02CA06 | Urapidil | ||||
| C02CC | Guanidine derivatives | ||||
| C02CC01 | Betanidine | ||||
| C02CC02 | Guanethidine | ||||
| C02CC03 | Guanoxan | ||||
| C02CC04 | Debrisoquine | ||||
| C02CC05 | Guanoclor | ||||
| C02CC06 | Guanazodine | ||||
| C02CC07 | Guanoxabenz | ||||
| C02D | Arteriolar smooth muscle, agents acting on | ||||
| C02DA | Thiazide derivatives | ||||
| C02DA01 | Diazoxide | ||||
| C02DB | Hydrazinophthalazine derivatives | ||||
| C02DB01 | Dihydralazine | ||||
| C02DB02 | Hydralazine | ||||
| C02DB03 | Endralazine | ||||
| C02DB04 | Cadralazine | ||||
| C02DC | Pyrimidine derivatives | ||||
| C02DC01 | Minoxidil | ||||
| C02DD | Nitroferricyanide derivatives | ||||
| C02DD01 | Nitroprusside | ||||
| C02DG | Guanidine derivatives | ||||
| C02DG01 | Pinacidil | ||||
| C02K | Other antihypertensives | ||||
| C02KA | Alkaloids, excluding rauwolfia | ||||
| C02KA01 | Veratrum | ||||
| C02KB | Tyrosine hydroxylase inhibitors | ||||
| C02KB01 | Metirosine | ||||
| C02KC | MAO inhibitors | ||||
| C02KC01 | Pargyline | ||||
| C02KD | Serotonin antagonists | ||||
| C02KD01 | Ketanserin | ||||
| C02KN | Other antihypertensives | ||||
| C02KN01 | aprocitentan | ||||
| C02KN02 | baxdrostat | ||||
| C02KX | Antihypertensives for pulmonary arterial hypertension | ||||
| C02KX01 | Bosentan | ||||
| C02KX02 | Ambrisentan | ||||
| C02KX03 | Sitaxentan | ||||
| C02KX04 | macitentan | ||||
| C02KX05 | riociguat | ||||
| C02KX06 | sotatercept | ||||
| C02KX52 | ambrisentan and tadalafil | ||||
| C02KX54 | macitentan and tadalafil | ||||
| C02L | Antihypertensives and diuretics in combination | ||||
| C02LA | Rauwolfia alkaloids and diuretics in combination | ||||
| C02LA01 | Reserpine and diuretics | ||||
| C02LA02 | Rescinnamine and diuretics | ||||
| C02LA03 | Deserpidine and diuretics | ||||
| C02LA04 | Methoserpidine and diuretics | ||||
| C02LA07 | Bietaserpine and diuretics | ||||
| C02LA08 | Rauwolfia alkaloids, whole root and diuretics | ||||
| C02LA09 | Syrosingopine and diuretics | ||||
| C02LA50 | Combinations of rauwolfia alkaloids and diuretics including other combinations | ||||
| C02LA51 | Reserpine and diuretics, combinations with other drugs | ||||
| C02LA52 | Rescinnamine and diuretics, combinations with other drugs | ||||
| C02LA71 | Reserpine and diuretics, combinations with psycholeptics | ||||
| C02LB | Methyldopa and diuretics in combination | ||||
| C02LB01 | Methyldopa (levorotatory) and diuretics | ||||
| C02LC | Imidazoline receptor agonists in combination with diuretics | ||||
| C02LC01 | Clonidine and diuretics | ||||
| C02LC05 | Moxonidine and diuretics | ||||
| C02LC51 | Clonidine and diuretics, combinations with other drugs | ||||
| C02LE | Alpha-adrenoreceptor antagonists and diuretics | ||||
| C02LE01 | Prazosin and diuretics | ||||
| C02LF | Guanidine derivatives and diuretics | ||||
| C02LF01 | Guanethidine and diuretics | ||||
| C02LG | Hydrazinophthalazine derivatives and diuretics | ||||
| C02LG01 | Dihydralazine and diuretics | ||||
| C02LG02 | Hydralazine and diuretics | ||||
| C02LG03 | Picodralazine and diuretics | ||||
| C02LG51 | Dihydralazine and diuretics, combinations with other drugs | ||||
| C02LG73 | Picodralazine and diuretics, combinations with psycholeptics | ||||
| C02LK | Alkaloids, excluding rauwolfia, in combination with diuretics | ||||
| C02LK01 | Veratrum and diuretics | ||||
| C02LL | MAO inhibitors and diuretics | ||||
| C02LL01 | Pargyline and diuretics | ||||
| C02LN | Serotonin antagonists and diuretics | ||||
| empty | |||||
| C02LX | Other antihypertensives and diuretics | ||||
| C02LX01 | Pinacidil and diuretics | ||||
| C02N | Combinations of antihypertensives in ATC-group C02 | ||||
| empty | |||||
| C03 | Diuretics | ||||
| C03A | Low-ceiling diuretics, thiazides | ||||
| C03AA | Thiazides, plain | ||||
| C03AA01 | Bendroflumethiazide | ||||
| C03AA02 | Hydroflumethiazide | ||||
| C03AA03 | Hydrochlorothiazide | ||||
| C03AA04 | Chlorothiazide | ||||
| C03AA05 | Polythiazide | ||||
| C03AA06 | Trichlormethiazide | ||||
| C03AA07 | Cyclopenthiazide | ||||
| C03AA08 | Methyclothiazide | ||||
| C03AA09 | Cyclothiazide | ||||
| C03AA13 | Mebutizide | ||||
| C03AB | Thiazides and potassium in combination | ||||
| C03AB01 | Bendroflumethiazide and potassium | ||||
| C03AB02 | Hydroflumethiazide and potassium | ||||
| C03AB03 | Hydrochlorothiazide and potassium | ||||
| C03AB04 | Chlorothiazide and potassium | ||||
| C03AB05 | Polythiazide and potassium | ||||
| C03AB06 | Trichlormethiazide and potassium | ||||
| C03AB07 | Cyclopenthiazide and potassium | ||||
| C03AB08 | Methyclothiazide and potassium | ||||
| C03AB09 | Cyclothiazide and potassium | ||||
| C03AH | Thiazides, combinations with psycholeptics and/or analgesics | ||||
| C03AH01 | Chlorothiazide, combinations | ||||
| C03AH02 | Hydroflumethiazide, combinations | ||||
| C03AX | Thiazides, combinations with other drugs | ||||
| C03AX01 | Hydrochlorothiazide, combinations | ||||
| C03B | Low-ceiling diuretics, excluding thiazides | ||||
| C03BA | Sulfonamides, plain | ||||
| C03BA02 | Quinethazone | ||||
| C03BA03 | Clopamide | ||||
| C03BA04 | Chlortalidone | ||||
| C03BA05 | Mefruside | ||||
| C03BA07 | Clofenamide | ||||
| C03BA08 | Metolazone | ||||
| C03BA09 | Meticrane | ||||
| C03BA10 | Xipamide | ||||
| C03BA11 | Indapamide | ||||
| C03BA12 | Clorexolone | ||||
| C03BA13 | Fenquizone | ||||
| C03BA82 | Clorexolone, combinations with psycholeptics | ||||
| C03BB | Sulfonamides and potassium in combination | ||||
| C03BB02 | Quinethazone and potassium | ||||
| C03BB03 | Clopamide and potassium | ||||
| C03BB04 | Chlortalidone and potassium | ||||
| C03BB05 | Mefruside and potassium | ||||
| C03BB07 | Clofenamide and potassium | ||||
| C03BC | Mercurial diuretics | ||||
| C03BC01 | Mersalyl | ||||
| C03BD | Xanthine derivatives | ||||
| C03BD01 | Theobromine | ||||
| C03BK | Sulfonamides, combinations with other drugs | ||||
| empty | |||||
| C03BX | Other low-ceiling diuretics | ||||
| C03BX03 | Cicletanine | ||||
| C03C | High-ceiling diuretics | ||||
| C03CA | Sulfonamides, plain | ||||
| C03CA01 | Furosemide | ||||
| C03CA02 | Bumetanide | ||||
| C03CA03 | Piretanide | ||||
| C03CA04 | Torasemide | ||||
| C03CB | Sulfonamides and potassium in combination | ||||
| C03CB01 | Furosemide and potassium | ||||
| C03CB02 | Bumetanide and potassium | ||||
| C03CC | Aryloxyacetic acid derivatives | ||||
| C03CC01 | Etacrynic acid | ||||
| C03CC02 | Tienilic acid | ||||
| C03CD | Pyrazolone derivatives | ||||
| C03CD01 | Muzolimine | ||||
| C03CX | Other high-ceiling diuretics | ||||
| C03CX01 | Etozolin | ||||
| C03D | Potassium-sparing agents | ||||
| C03DA | Aldosterone antagonists | ||||
| C03DA01 | Spironolactone | ||||
| C03DA02 | Potassium canrenoate | ||||
| C03DA03 | Canrenone | ||||
| C03DA04 | Eplerenone | ||||
| C03DA05 | finerenone | ||||
| C03DA54 | eplerenone and dapagliflozin | ||||
| C03DB | Other potassium-sparing agents | ||||
| C03DB01 | Amiloride | ||||
| C03DB02 | Triamterene | ||||
| C03E | Diuretics and potassium-sparing agents in combination | ||||
| C03EA | Low-ceiling diuretics and potassium-sparing agents | ||||
| C03EA01 | Hydrochlorothiazide and potassium-sparing agents | ||||
| C03EA02 | Trichlormethiazide and potassium-sparing agents | ||||
| C03EA03 | Epitizide and potassium-sparing agents | ||||
| C03EA04 | Altizide and potassium-sparing agents | ||||
| C03EA05 | Mebutizide and potassium-sparing agents | ||||
| C03EA06 | Chlortalidone and potassium-sparing agents | ||||
| C03EA07 | Cyclopenthiazide and potassium-sparing agents | ||||
| C03EA12 | Metolazone and potassium-sparing agents | ||||
| C03EA13 | Bendroflumethiazide and potassium-sparing agents | ||||
| C03EA14 | Butizide and potassium-sparing agents | ||||
| C03EB | High-ceiling diuretics and potassium-sparing agents | ||||
| C03EB01 | Furosemide and potassium-sparing agents | ||||
| C03EB02 | Bumetanide and potassium-sparing agents | ||||
| C03EB03 | torasemide and potassium-sparing agents | ||||
| C03X | Other diuretics | ||||
| C03XA | Vasopressin antagonists | ||||
| C03XA01 | Tolvaptan | ||||
| C03XA02 | Conivaptan | ||||
| C04 | Peripheral vasodilators | ||||
| C04A | Peripheral vasodilators | ||||
| C04AA | 2-amino-1-phenylethanol derivatives | ||||
| C04AA01 | Isoxsuprine | ||||
| C04AA02 | Buphenine | ||||
| C04AA31 | Bamethan | ||||
| C04AB | Imidazoline derivatives | ||||
| C04AB01 | Phentolamine | ||||
| C04AB02 | Tolazoline | ||||
| C04AC | Nicotinic acid and derivatives | ||||
| C04AC01 | Nicotinic acid | ||||
| C04AC02 | Nicotinyl alcohol (pyridylcarbinol) | ||||
| C04AC03 | Inositol nicotinate | ||||
| C04AC07 | Ciclonicate | ||||
| C04AD | Purine derivatives | ||||
| C04AD01 | Pentifylline | ||||
| C04AD02 | Xantinol nicotinate | ||||
| C04AD03 | Pentoxifylline | ||||
| C04AD04 | Etofylline nicotinate | ||||
| C04AE | Ergot alkaloids | ||||
| C04AE01 | Ergoloid mesylates | ||||
| C04AE02 | Nicergoline | ||||
| C04AE04 | Dihydroergocristine | ||||
| C04AE51 | Ergoloid mesylates, combinations | ||||
| C04AE54 | Dihydroergocristine, combinations | ||||
| C04AF | Enzymes | ||||
| C04AF01 | Kallidinogenase | ||||
| C04AX | Other peripheral vasodilators | ||||
| C04AX01 | Cyclandelate | ||||
| C04AX02 | Phenoxybenzamine | ||||
| C04AX07 | Vincamine | ||||
| C04AX10 | Moxisylyte | ||||
| C04AX11 | Bencyclane | ||||
| C04AX13 | piribedil (New ATC code N04BC08) | ||||
| C04AX17 | Vinburnine | ||||
| C04AX19 | Sulcotidil | ||||
| C04AX20 | Buflomedil | ||||
| C04AX21 | Naftidrofuryl | ||||
| C04AX23 | Butalamine | ||||
| C04AX24 | Visnadine | ||||
| C04AX26 | Cetiedil | ||||
| C04AX27 | Cinepazide | ||||
| C04AX28 | Ifenprodil | ||||
| C04AX30 | Azapetine | ||||
| C04AX32 | Fasudil | ||||
| C05 | Vasoprotectives | ||||
| C05A | Agents for treatment of hemorrhoids and anal fissures for topical use | ||||
| C05AA | Corticosteroids | ||||
| C05AA01 | Hydrocortisone | ||||
| C05AA04 | Prednisolone | ||||
| C05AA05 | Betamethasone | ||||
| C05AA06 | Fluorometholone | ||||
| C05AA08 | Fluocortolone | ||||
| C05AA09 | Dexamethasone | ||||
| C05AA10 | Fluocinolone acetonide | ||||
| C05AA11 | Fluocinonide | ||||
| C05AA12 | Triamcinolone | ||||
| C05AB | Antibiotics | ||||
| empty | |||||
| C05AD | Local anesthetics | ||||
| C05AD01 | Lidocaine | ||||
| C05AD02 | Tetracaine | ||||
| C05AD03 | Benzocaine | ||||
| C05AD04 | Cinchocaine | ||||
| C05AD05 | Procaine | ||||
| C05AD06 | Oxetacaine | ||||
| C05AD07 | Pramocaine | ||||
| C05AE | Muscle relaxants | ||||
| C05AE01 | Glyceryl trinitrate | ||||
| C05AE02 | Isosorbide dinitrate | ||||
| C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | ||||
| C05AX01 | Aluminium preparations | ||||
| C05AX02 | Bismuth preparations, combinations | ||||
| C05AX03 | Other preparations, combinations | ||||
| C05AX04 | Zinc preparations | ||||
| C05AX05 | Tribenoside | ||||
| C05B | Antivaricose therapy | ||||
| C05BA | Heparins or heparinoids for topical use | ||||
| C05BA01 | Organo-heparinoid | ||||
| C05BA02 | Sodium apolate | ||||
| C05BA03 | Heparin | ||||
| C05BA04 | Pentosan polysulfate sodium | ||||
| C05BA51 | Heparinoid, combinations | ||||
| C05BA53 | Heparin, combinations | ||||
| C05BB | Sclerosing agents for local injection | ||||
| C05BB01 | Monoethanolamine oleate | ||||
| C05BB02 | Polidocanol | ||||
| C05BB03 | Invert sugar | ||||
| C05BB04 | Sodium tetradecyl sulfate | ||||
| C05BB05 | Phenol | ||||
| C05BB56 | Glucose, combinations | ||||
| C05BX | Other sclerosing agents | ||||
| C05BX01 | Calcium dobesilate | ||||
| C05BX51 | Calcium dobesilate, combinations | ||||
| C05C | Capillary stabilising agents | ||||
| C05CA | Bioflavonoids | ||||
| C05CA01 | Rutoside | ||||
| C05CA02 | Monoxerutin | ||||
| C05CA03 | Diosmin | ||||
| C05CA04 | Troxerutin | ||||
| C05CA05 | Hidrosmin | ||||
| C05CA51 | Rutoside, combinations | ||||
| C05CA53 | Diosmin, combinations | ||||
| C05CA54 | Troxerutin, combinations | ||||
| C05CX | Other capillary stabilising agents | ||||
| C05CX01 | Tribenoside | ||||
| C05CX02 | Naftazone | ||||
| C05CX03 | Hippocastani semen | ||||
| C07 | Beta blocking agents | ||||
| C07A | Beta blocking agents | ||||
| C07AA | Beta blocking agents, non-selective | ||||
| C07AA01 | Alprenolol | ||||
| C07AA02 | Oxprenolol | ||||
| C07AA03 | Pindolol | ||||
| C07AA05 | Propranolol | ||||
| C07AA06 | Timolol | ||||
| C07AA07 | Sotalol | ||||
| C07AA12 | Nadolol | ||||
| C07AA14 | Mepindolol | ||||
| C07AA15 | Carteolol | ||||
| C07AA16 | Tertatolol | ||||
| C07AA17 | Bopindolol | ||||
| C07AA19 | Bupranolol | ||||
| C07AA23 | Penbutolol | ||||
| C07AA27 | Cloranolol | ||||
| C07AA57 | Sotalol, combinations (New ATC code C07FX02) | ||||
| C07AB | Beta blocking agents, selective | ||||
| C07AB01 | Practolol | ||||
| C07AB02 | Metoprolol | ||||
| C07AB03 | Atenolol | ||||
| C07AB04 | Acebutolol | ||||
| C07AB05 | Betaxolol | ||||
| C07AB06 | Bevantolol | ||||
| C07AB07 | Bisoprolol | ||||
| C07AB08 | Celiprolol | ||||
| C07AB09 | Esmolol | ||||
| C07AB10 | Epanolol | ||||
| C07AB11 | S-atenolol | ||||
| C07AB12 | Nebivolol | ||||
| C07AB13 | Talinolol | ||||
| C07AB52 | Metoprolol, combinations (New ATC code C07FX03) | ||||
| C07AB57 | Bisoprolol, combinations (New ATC code C07FX04) | ||||
| C07AG | Alpha and beta blocking agents | ||||
| C07AG01 | Labetalol | ||||
| C07AG02 | Carvedilol | ||||
| C07B | Beta blocking agents and thiazides | ||||
| C07BA | Beta blocking agents, non-selective, and thiazides | ||||
| C07BA02 | Oxprenolol and thiazides | ||||
| C07BA05 | Propranolol and thiazides | ||||
| C07BA06 | Timolol and thiazides | ||||
| C07BA07 | Sotalol and thiazides | ||||
| C07BA12 | Nadolol and thiazides | ||||
| C07BA68 | Metipranolol and thiazides, combinations | ||||
| C07BB | Beta blocking agents, selective, and thiazides | ||||
| C07BB02 | Metoprolol and thiazides | ||||
| C07BB03 | Atenolol and thiazides | ||||
| C07BB04 | Acebutolol and thiazides | ||||
| C07BB06 | Bevantolol and thiazides | ||||
| C07BB07 | Bisoprolol and thiazides | ||||
| C07BB12 | Nebivolol and thiazides | ||||
| C07BB52 | Metoprolol and thiazides, combinations | ||||
| C07BG | Alpha and beta blocking agents and thiazides | ||||
| C07BG01 | Labetalol and thiazides | ||||
| C07C | Beta blocking agents and other diuretics | ||||
| C07CA | Beta blocking agents, non-selective, and other diuretics | ||||
| C07CA02 | Oxprenolol and other diuretics | ||||
| C07CA03 | Pindolol and other diuretics | ||||
| C07CA17 | Bopindolol and other diuretics | ||||
| C07CA23 | Penbutolol and other diuretics | ||||
| C07CB | Beta blocking agents, selective, and other diuretics | ||||
| C07CB02 | Metoprolol and other diuretics | ||||
| C07CB03 | Atenolol and other diuretics | ||||
| C07CB53 | Atenolol and other diuretics, combinations | ||||
| C07CG | Alpha and beta blocking agents and other diuretics | ||||
| C07CG01 | Labetalol and other diuretics | ||||
| C07D | Beta blocking agents, thiazides and other diuretics | ||||
| C07DA | Beta blocking agents, non-selective, thiazides and other diuretics | ||||
| C07DA06 | Timolol, thiazides and other diuretics | ||||
| C07DB | Beta blocking agents, selective, thiazides and other diuretics | ||||
| C07DB01 | Atenolol, thiazides and other diuretics | ||||
| C07E | Beta blocking agents and vasodilators | ||||
| C07EA | Beta blocking agents, non-selective, and vasodilators | ||||
| empty | |||||
| C07EB | Beta blocking agents, selective, and vasodilators | ||||
| empty | |||||
| C07F | Beta blocking agents and other antihypertensives | ||||
| C07FA | Beta blocking agents, non-selective, and other antihypertensives | ||||
| C07FA05 | Propranolol and other antihypertensives (New ATC code C07FX01) | ||||
| C07FB | Beta blocking agents and calcium channel blockers | ||||
| C07FB02 | metoprolol and felodipine (New ATC code C07FB13) | ||||
| C07FB03 | atenolol and nifedipine | ||||
| C07FB07 | bisoprolol and amlodipine | ||||
| C07FB12 | nebivolol and amlodipine | ||||
| C07FB13 | metoprolol and amlodipine | ||||
| C07FX | Beta blocking agents, other combinations | ||||
| C07FX01 | propranolol and other combinations | ||||
| C07FX02 | sotalol and acetylsalicylic acid | ||||
| C07FX03 | metoprolol and acetylsalicylic acid | ||||
| C07FX04 | bisoprolol and acetylsalicylic acid | ||||
| C07FX05 | metoprolol and ivabradine | ||||
| C07FX06 | carvedilol and ivabradine | ||||
| C08 | Calcium channel blockers | ||||
| C08C | Selective calcium channel blockers with mainly vascular effects | ||||
| C08CA | Dihydropyridine derivatives | ||||
| C08CA01 | Amlodipine | ||||
| C08CA02 | Felodipine | ||||
| C08CA03 | Isradipine | ||||
| C08CA04 | Nicardipine | ||||
| C08CA05 | Nifedipine | ||||
| C08CA06 | Nimodipine | ||||
| C08CA07 | Nisoldipine | ||||
| C08CA08 | Nitrendipine | ||||
| C08CA09 | Lacidipine | ||||
| C08CA10 | Nilvadipine | ||||
| C08CA11 | Manidipine | ||||
| C08CA12 | Barnidipine | ||||
| C08CA13 | Lercanidipine | ||||
| C08CA14 | Cilnidipine | ||||
| C08CA15 | Benidipine | ||||
| C08CA16 | Clevidipine | ||||
| C08CA17 | levamlodipine | ||||
| C08CA51 | amlodipine and celecoxib | ||||
| C08CA55 | Nifedipine, combinations | ||||
| C08CX | Other selective calcium channel blockers with mainly vascular effects | ||||
| C08CX01 | Mibefradil | ||||
| C08D | Selective calcium channel blockers with direct cardiac effects | ||||
| C08DA | Phenylalkylamine derivatives | ||||
| C08DA01 | Verapamil | ||||
| C08DA02 | Gallopamil | ||||
| C08DA03 | etripamil | ||||
| C08DA51 | Verapamil, combinations | ||||
| C08DB | Benzothiazepine derivatives | ||||
| C08DB01 | Diltiazem | ||||
| C08E | Non-selective calcium channel blockers | ||||
| C08EA | Phenylalkylamine derivatives | ||||
| C08EA01 | Fendiline | ||||
| C08EA02 | Bepridil | ||||
| C08EX | Other non-selective calcium channel blockers | ||||
| C08EX01 | Lidoflazine | ||||
| C08EX02 | Perhexiline | ||||
| C08G | Calcium channel blockers and diuretics | ||||
| C08GA | Calcium channel blockers and diuretics | ||||
| C08GA01 | Nifedipine and diuretics | ||||
| C09 | Agents acting on the renin-angiotensin system | ||||
| C09A | ACE inhibitors, plain | ||||
| C09AA | ACE inhibitors, plain | ||||
| C09AA01 | Captopril | ||||
| C09AA02 | Enalapril | ||||
| C09AA03 | Lisinopril | ||||
| C09AA04 | Perindopril | ||||
| C09AA05 | Ramipril | ||||
| C09AA06 | Quinaprl | ||||
| C09AA07 | Benazepril | ||||
| C09AA08 | Cilazapril | ||||
| C09AA09 | Fosinopril | ||||
| C09AA10 | Trandolapril | ||||
| C09AA11 | Spirapril | ||||
| C09AA12 | Delapril | ||||
| C09AA13 | Moexipril | ||||
| C09AA14 | Temocapril | ||||
| C09AA15 | Zofenopril | ||||
| C09AA16 | Imidapril | ||||
| C09B | ACE inhibitors, combinations | ||||
| C09BA | ACE inhibitors and diuretics | ||||
| C09BA01 | Captopril and diuretics | ||||
| C09BA02 | Enalapril and diuretics | ||||
| C09BA03 | Lisinopril and diuretics | ||||
| C09BA04 | Perindopril and diuretics | ||||
| C09BA05 | Ramipril and diuretics | ||||
| C09BA06 | Quinapril and diuretics | ||||
| C09BA07 | Benazepril and diuretics | ||||
| C09BA08 | Cilazapril and diuretics | ||||
| C09BA09 | Fosinopril and diuretics | ||||
| C09BA12 | Delapril and diuretics | ||||
| C09BA13 | Moexipril and diuretics | ||||
| C09BA15 | Zofenopril and diuretics | ||||
| C09BB | ACE inhibitors and calcium channel blockers | ||||
| C09BB02 | Enalapril and lercanidipine | ||||
| C09BB03 | Lisinopril and amlodipine | ||||
| C09BB04 | Perindopril and amlodipine | ||||
| C09BB05 | Ramipril and felodipine | ||||
| C09BB06 | Enalapril and nitrendipine | ||||
| C09BB07 | Ramipril and amlodipine | ||||
| C09BB10 | Trandolapril and verapamil | ||||
| C09BB12 | Delapril and manidipine | ||||
| C09BB13 | benazepril and amlodipine | ||||
| C09BB14 | zofenopril and amlodipine | ||||
| C09C | Angiotensin II antagonists, plain | ||||
| C09CA | Angiotensin II antagonists, plain | ||||
| C09CA01 | Losartan | ||||
| C09CA02 | Eprosartan | ||||
| C09CA03 | Valsartan | ||||
| C09CA04 | Irbesartan | ||||
| C09CA05 | Tasosartan | ||||
| C09CA06 | Candesartan | ||||
| C09CA07 | Telmisartan | ||||
| C09CA08 | Olmesartan medoxomil | ||||
| C09CA09 | Azilsartan medoxomil | ||||
| C09D | Angiotensin II antagonists, combinations | ||||
| C09DA | Angiotensin II antagonists and diuretics | ||||
| C09DA01 | Losartan and diuretics | ||||
| C09DA02 | Eprosartan and diuretics | ||||
| C09DA03 | Valsartan and diuretics | ||||
| C09DA04 | Irbesartan and diuretics | ||||
| C09DA06 | Candesartan and diuretics | ||||
| C09DA07 | Telmisartan and diuretics | ||||
| C09DA08 | Olmesartan medoxomil and diuretics | ||||
| C09DB | Angiotensin II antagonists and calcium channel blockers | ||||
| C09DB01 | Valsartan and amlodipine | ||||
| C09DB02 | Olmesartan medoxomil and amlodipine | ||||
| C09DB04 | Telmisartan and amlodipine | ||||
| C09DB05 | Irbesartan and amlodipine | ||||
| C09DB06 | Losartan and amlodipine | ||||
| C09DX | Angiotensin II antagonists, other combinations | ||||
| C09DX01 | Valsartan, amlodipine and hydrochlorothiazide | ||||
| C09DX02 | Valsartan and aliskiren | ||||
| C09DX03 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide | ||||
| C09DX04 | valsartan and sacubitril | ||||
| C09DX05 | valsartan and nebivolol | ||||
| C09DX06 | candesartan, amlodipine and hydrochlorothiazide | ||||
| C09DX07 | irbesartan, amlodipine and hydrochlorothiazide | ||||
| C09DX08 | telmisartan, amlodipine and hydrochlorothiazide | ||||
| C09DX09 | candesartan, amlodipine and indapamide | ||||
| C09X | Other agents acting on the renin-angiotensin system | ||||
| C09XA | Renin-inhibitors | ||||
| C09XA01 | Remikiren | ||||
| C09XA02 | Aliskiren | ||||
| C09XA52 | Aliskiren and hydrochlorothiazide | ||||
| C09XA53 | Aliskiren and amlodipine | ||||
| C09XA54 | Aliskiren, amlodipine and hydrochlorothiazide | ||||
| C09XX | Other agents acting on the renin-angiotensin system | ||||
| C09XX01 | sparsentan | ||||
| C10 | Lipid modifying agents | ||||
| C10A | Lipid modifying agents, plain | ||||
| C10AA | HMG CoA reductase inhibitors | ||||
| C10AA01 | Simvastatin | ||||
| C10AA02 | Lovastatin | ||||
| C10AA03 | Pravastatin | ||||
| C10AA04 | Fluvastatin | ||||
| C10AA05 | Atorvastatin | ||||
| C10AA06 | Cerivastatin | ||||
| C10AA07 | Rosuvastatin | ||||
| C10AA08 | Pitavastatin | ||||
| C10AA51 | simvastatin, combinations (New ATC code C10BX01) | ||||
| C10AA52 | lovastatin, combinations (New ATC code C10BA01) | ||||
| C10AA53 | pravastatin, combinations (New ATC code C10BX02) | ||||
| C10AA55 | atorvastatin, combinations (New ATC code C10BX03) | ||||
| C10AB | Fibrates | ||||
| C10AB01 | Clofibrate | ||||
| C10AB02 | Bezafibrate | ||||
| C10AB03 | Aluminium clofibrate | ||||
| C10AB04 | Gemfibrozil | ||||
| C10AB05 | Fenofibrate | ||||
| C10AB06 | Simfibrate | ||||
| C10AB07 | Ronifibrate | ||||
| C10AB08 | Ciprofibrate | ||||
| C10AB09 | Etofibrate | ||||
| C10AB10 | Clofibride | ||||
| C10AB11 | Choline fenofibrate | ||||
| C10AC | Bile acid sequestrants | ||||
| C10AC01 | Colestyramine | ||||
| C10AC02 | Colestipol | ||||
| C10AC03 | Colextran | ||||
| C10AC04 | Colesevelam | ||||
| C10AD | Nicotinic acid and derivatives | ||||
| C10AD01 | Niceritrol | ||||
| C10AD02 | Nicotinic acid | ||||
| C10AD03 | Nicofuranose | ||||
| C10AD04 | Aluminium nicotinate | ||||
| C10AD05 | Nicotinyl alcohol (pyridylcarbinol) | ||||
| C10AD06 | Acipimox | ||||
| C10AD52 | Nicotinic acid, combinations | ||||
| C10AX | Other lipid modifying agents | ||||
| C10AX01 | Dextrothyroxine | ||||
| C10AX02 | Probucol | ||||
| C10AX03 | Tiadenol | ||||
| C10AX04 | benfluorex (New ATC code A10BX06) | ||||
| C10AX05 | Meglutol | ||||
| C10AX06 | Omega-3-triglycerides | ||||
| C10AX07 | Magnesium pyridoxal 5-phosphate glutamate | ||||
| C10AX08 | Policosanol | ||||
| C10AX09 | Ezetimibe | ||||
| C10AX10 | Alipogene tiparvovec | ||||
| C10AX11 | Mipomersen | ||||
| C10AX12 | Lomitapide | ||||
| C10AX13 | evolocumab | ||||
| C10AX14 | alirocumab | ||||
| C10AX15 | bempedoic acid | ||||
| C10AX16 | inclisiran | ||||
| C10AX17 | evinacumab | ||||
| C10AX18 | volanesorsen | ||||
| C10AX19 | lerodalcibep | ||||
| C10B | Lipid modifying agents, combinations | ||||
| C10BA | Combinations of various lipid modifying agents | ||||
| C10BA01 | Lovastatin and nicotinic acid | ||||
| C10BA02 | Simvastatin and ezetimibe | ||||
| C10BA03 | Pravastatin and fenofibrate | ||||
| C10BA04 | Simvastatin and fenofibrate | ||||
| C10BA05 | Atorvastatin and ezetimibe | ||||
| C10BA06 | rosuvastatin and ezetimibe | ||||
| C10BA07 | rosuvastatin and omega-3 fatty acids | ||||
| C10BA08 | atorvastatin and omega-3 fatty acids | ||||
| C10BA09 | rosuvastatin and fenofibrate | ||||
| C10BA10 | bempedoic acid and ezetimibe | ||||
| C10BA11 | pravastatin and ezetimibe | ||||
| C10BA12 | pravastatin, ezetimibe and fenofibrate | ||||
| C10BA13 | pitavastatin and ezetimibe | ||||
| C10BA14 | pitavastatin and fenofibrate | ||||
| C10BA15 | rosuvastatin, ezetimibe and fenofibrate | ||||
| C10BA16 | atorvastatin and fenofibrate | ||||
| C10BX | Lipid modifying agents in combination with other drugs | ||||
| C10BX01 | Simvastatin and acetylsalicylic acid | ||||
| C10BX02 | Pravastatin and acetylsalicylic acid | ||||
| C10BX03 | Atorvastatin and amlodipine | ||||
| C10BX04 | Simvastatin, acetylsalicylic acid and ramipril | ||||
| C10BX05 | rosuvastatin and acetylsalicylic acid | ||||
| C10BX06 | atorvastatin, acetylsalicylic acid and ramipril | ||||
| C10BX07 | rosuvastatin, amlodipine and lisinopril | ||||
| C10BX08 | atorvastatin and acetylsalicylic acid | ||||
| C10BX09 | rosuvastatin and amlodipine | ||||
| C10BX10 | rosuvastatin and valsartan | ||||
| C10BX11 | atorvastatin, amlodipine and perindopril | ||||
| C10BX12 | atorvastatin, acetylsalicylic acid and perindopril | ||||
| C10BX13 | rosuvastatin, perindopril and indapamide | ||||
| C10BX14 | rosuvastatin, amlodipine and perindopril | ||||
| C10BX15 | atorvastatin and perindopril | ||||
| C10BX16 | rosuvastatin and fimasartan | ||||
| C10BX17 | rosuvastatin and ramipril | ||||
| C10BX18 | atorvastatin, amlodipine and ramipril | ||||
| C10BX19 | atorvastatin, amlodipine and candesartan | ||||
| C10BX20 | rosuvastatin and telmisartan | ||||
| C10BX21 | rosuvastatin and perindopril | ||||
| C10BX22 | rosuvastatin and nebivolol | ||||
| C10BX23 | rosuvastatin, amlodipine and ramipril | ||||
| C10BX24 | rosuvastatin, amlodipine and telmisartan | ||||
| âD | Dermatologicals | ||||
| D01 | Antifungals for dermatological use | ||||
| D01A | Antifungals for topical use | ||||
| D01AA | Antibiotics | ||||
| D01AA01 | Nystatin | ||||
| D01AA02 | Natamycin | ||||
| D01AA03 | Hachimycin | ||||
| D01AA04 | Pecilocin | ||||
| D01AA06 | Mepartricin | ||||
| D01AA07 | Pyrrolnitrin | ||||
| D01AA08 | Griseofulvin | ||||
| D01AA20 | Combinations | ||||
| D01AC | Imidazole and triazole derivatives | ||||
| D01AC01 | Clotrimazole | ||||
| D01AC02 | Miconazole | ||||
| D01AC03 | Econazole | ||||
| D01AC04 | Clomidazole | ||||
| D01AC05 | Isoconazole | ||||
| D01AC06 | Tiabendazole | ||||
| D01AC07 | Tioconazole | ||||
| D01AC08 | Ketoconazole | ||||
| D01AC09 | Sulconazole | ||||
| D01AC10 | Bifonazole | ||||
| D01AC11 | Oxiconazole | ||||
| D01AC12 | Fenticonazole | ||||
| D01AC13 | Omoconazole | ||||
| D01AC14 | Sertaconazole | ||||
| D01AC15 | Fluconazole | ||||
| D01AC16 | Flutrimazole | ||||
| D01AC17 | Eberconazole | ||||
| D01AC20 | Combinations | ||||
| D01AC52 | Miconazole, combinations | ||||
| D01AC60 | Bifonazole, combinations | ||||
| D01AE | Other antifungals for topical use | ||||
| D01AE01 | Bromochlorosalicylanilide | ||||
| D01AE02 | Methylrosaniline | ||||
| D01AE03 | Tribromometacresol | ||||
| D01AE04 | Undecylenic acid | ||||
| D01AE05 | Polynoxylin | ||||
| D01AE06 | 2-(4-chlorphenoxy)-ethanol | ||||
| D01AE07 | Chlorphenesin | ||||
| D01AE08 | Ticlatone | ||||
| D01AE09 | Sulbentine | ||||
| D01AE10 | Ethyl hydroxybenzoate | ||||
| D01AE11 | Haloprogin | ||||
| D01AE12 | Salicylic acid | ||||
| D01AE13 | Selenium sulfide | ||||
| D01AE14 | Ciclopirox | ||||
| D01AE15 | Terbinafine | ||||
| D01AE16 | Amorolfine | ||||
| D01AE17 | Dimazole | ||||
| D01AE18 | Tolnaftate | ||||
| D01AE19 | Tolciclate | ||||
| D01AE20 | Combinations | ||||
| D01AE21 | Flucytosine | ||||
| D01AE22 | Naftifine | ||||
| D01AE23 | Butenafine | ||||
| D01AE54 | Undecylenic acid, combinations | ||||
| D01B | Antifungals for systemic use | ||||
| D01BA | Antifungals for systemic use | ||||
| D01BA01 | Griseofulvin | ||||
| D01BA02 | Terbinafine | ||||
| D02 | Emollients and protectives | ||||
| D02A | Emollients and protectives | ||||
| D02AA | Silicone products | ||||
| empty | |||||
| D02AB | Zinc products | ||||
| empty | |||||
| D02AC | Soft paraffin and fat products | ||||
| empty | |||||
| D02AD | Liquid plasters | ||||
| empty | |||||
| D02AE | Carbamide products | ||||
| D02AE01 | Carbamide | ||||
| D02AE51 | Carbamide, combinations | ||||
| D02AF | Salicylic acid preparations | ||||
| empty | |||||
| D02AX | Other emollients and protectives | ||||
| empty | |||||
| D02B | Protectives against UV-radiation | ||||
| D02BA | Protectives against UV-radiation for topical use | ||||
| D02BA01 | Aminobenzoic acid | ||||
| D02BA02 | Octinoxate | ||||
| D02BB | Protectives against UV-radiation for systemic use | ||||
| D02BB01 | Betacarotene | ||||
| D03 | Preparations for treatment of wounds and ulcers | ||||
| D03A | Cicatrizants | ||||
| D03AA | Cod-liver oil ointments | ||||
| empty | |||||
| D03AX | Other cicatrizants | ||||
| D03AX01 | Cadexomer iodine | ||||
| D03AX02 | Dextranomer | ||||
| D03AX03 | Dexpanthenol | ||||
| D03AX04 | Calcium pantothenate | ||||
| D03AX05 | Hyaluronic acid | ||||
| D03AX06 | Becaplermin | ||||
| D03AX07 | glyceryl trinitrate (New ATC code C05AE01) | ||||
| D03AX08 | isosorbide dinitrate (New ATC code C05AE02) | ||||
| D03AX09 | Crilanomer | ||||
| D03AX10 | Enoxolone | ||||
| D03AX11 | Sodium chlorite (tetrachlorodecaoxide) | ||||
| D03AX12 | trolamine | ||||
| D03AX13 | Betulae cortex | ||||
| D03AX14 | Centella asiatica herba | ||||
| D03AX15 | trafermin | ||||
| D03AX16 | beremagene geperpavec | ||||
| D03AX17 | diperoxochloric acid | ||||
| D03B | Enzymes | ||||
| D03BA | Proteolytic enzymes | ||||
| D03BA01 | Trypsin | ||||
| D03BA02 | Clostridiopeptidase | ||||
| D03BA03 | bromelains | ||||
| D03BA52 | Clostridiopeptidase, combinations | ||||
| D04 | Antipruritics, including antihistamines, anesthetics, etc | ||||
| D04A | Antipruritics, including antihistamines, anesthetics, etc. | ||||
| D04AA | Antihistamines for topical use | ||||
| D04AA01 | Thonzylamine | ||||
| D04AA02 | Mepyramine | ||||
| D04AA03 | Thenalidine | ||||
| D04AA04 | Tripelennamine | ||||
| D04AA09 | Chloropyramine | ||||
| D04AA10 | Promethazine | ||||
| D04AA12 | Tolpropamine | ||||
| D04AA13 | Dimetindene | ||||
| D04AA14 | Clemastine | ||||
| D04AA15 | Bamipine | ||||
| D04AA22 | Isothipendyl | ||||
| D04AA32 | Diphenhydramine | ||||
| D04AA33 | Diphenhydramine methylbromide | ||||
| D04AA34 | Chlorphenoxamine | ||||
| D04AB | Anesthetics for topical use | ||||
| D04AB01 | Lidocaine | ||||
| D04AB02 | Cinchocaine | ||||
| D04AB03 | Oxybuprocaine | ||||
| D04AB04 | Benzocaine | ||||
| D04AB05 | Quinisocaine | ||||
| D04AB06 | Tetracaine | ||||
| D04AB07 | Pramocaine | ||||
| D04AX | Other antipruritics | ||||
| empty | |||||
| D05 | Antipsoriatics | ||||
| D05A | Antipsoriatics for topical use | ||||
| D05AA | Tars | ||||
| empty | |||||
| D05AC | Antracen derivatives | ||||
| D05AC01 | Dithranol | ||||
| D05AC51 | Dithranol, combinations | ||||
| D05AD | Psoralens for topical use | ||||
| D05AD01 | Trioxysalen | ||||
| D05AD02 | Methoxsalen | ||||
| D05AX | Other antipsoriatics for topical use | ||||
| D05AX01 | Fumaric acid | ||||
| D05AX02 | Calcipotriol | ||||
| D05AX03 | Calcitriol | ||||
| D05AX04 | Tacalcitol | ||||
| D05AX05 | Tazarotene | ||||
| D05AX52 | Calcipotriol, combinations | ||||
| D05B | Antipsoriatics for systemic use | ||||
| D05BA | Psoralens for systemic use | ||||
| D05BA01 | Trioxysalen | ||||
| D05BA02 | Methoxsalen | ||||
| D05BA03 | Bergapten | ||||
| D05BB | Retinoids for treatment of psoriasis | ||||
| D05BB01 | Etretinate | ||||
| D05BB02 | Acitretin | ||||
| D05BX | Other antipsoriatics for systemic use | ||||
| D05BX51 | Fumaric acid derivatives, combinations | ||||
| D06 | Antibiotics and chemotherapeutics for dermatological use | ||||
| D06A | Antibiotics for topical use | ||||
| D06AA | Tetracycline and derivatives | ||||
| D06AA01 | Demeclocycline | ||||
| D06AA02 | Chlortetracycline | ||||
| D06AA03 | Oxytetracycline | ||||
| D06AA04 | Tetracycline | ||||
| D06AX | Other antibiotics for topical use | ||||
| D06AX01 | Fusidic acid | ||||
| D06AX02 | Chloramphenicol | ||||
| D06AX04 | Neomycin | ||||
| D06AX05 | Bacitracin | ||||
| D06AX07 | Gentamicin | ||||
| D06AX08 | Tyrothricin | ||||
| D06AX09 | Mupirocin | ||||
| D06AX10 | Virginiamycin | ||||
| D06AX11 | Rifaximin | ||||
| D06AX12 | Amikacin | ||||
| D06AX13 | Retapamulin | ||||
| D06B | Chemotherapeutics for topical use | ||||
| D06BA | Sulfonamides | ||||
| D06BA01 | Silver sulfadiazine | ||||
| D06BA02 | Sulfathiazole | ||||
| D06BA03 | Mafenide | ||||
| D06BA04 | Sulfamethizole | ||||
| D06BA05 | Sulfanilamide | ||||
| D06BA06 | Sulfamerazine | ||||
| D06BB | Antivirals | ||||
| D06BB01 | Idoxuridine | ||||
| D06BB02 | Tromantadine | ||||
| D06BB03 | Aciclovir | ||||
| D06BB04 | Podophyllotoxin | ||||
| D06BB05 | Inosine | ||||
| D06BB06 | Penciclovir | ||||
| D06BB07 | Lysozyme | ||||
| D06BB08 | Ibacitabine | ||||
| D06BB09 | Edoxudine | ||||
| D06BB10 | Imiquimod | ||||
| D06BB11 | Docosanol | ||||
| D06BB12 | Sinecatechins | ||||
| D06BB13 | berdazimer sodium | ||||
| D06BB53 | Aciclovir, combinations | ||||
| D06BX | Other chemotherapeutics | ||||
| D06BX01 | Metronidazole | ||||
| D06BX02 | Ingenol mebutate | ||||
| D06BX03 | tirbanibulin | ||||
| D06C | Antibiotics and chemotherapeutics, combinations | ||||
| empty | |||||
| D07 | Corticosteroids, dermatological preparations | ||||
| D07A | Corticosteroids, plain | ||||
| D07AA | Corticosteroids, weak (group I) | ||||
| D07AA01 | Methylprednisolone | ||||
| D07AA02 | Hydrocortisone | ||||
| D07AA03 | Prednisolone | ||||
| D07AB | Corticosteroids, moderately potent (group II) | ||||
| D07AB01 | Clobetasone | ||||
| D07AB02 | Hydrocortisone butyrate | ||||
| D07AB03 | Flumetasone | ||||
| D07AB04 | Fluocortin | ||||
| D07AB05 | Fluperolone | ||||
| D07AB06 | Fluorometholone | ||||
| D07AB07 | Fluprednidene | ||||
| D07AB08 | Desonide | ||||
| D07AB09 | Triamcinolone | ||||
| D07AB10 | Alclometasone | ||||
| D07AB11 | Hydrocortisone buteprate | ||||
| D07AB19 | Dexamethasone | ||||
| D07AB21 | Clocortolone | ||||
| D07AB30 | Combinations of corticosteroids | ||||
| D07AC | Corticosteroids, potent (group III) | ||||
| D07AC01 | Betamethasone | ||||
| D07AC02 | Fluclorolone | ||||
| D07AC03 | Desoximetasone | ||||
| D07AC04 | Fluocinolone acetonide | ||||
| D07AC05 | Fluocortolone | ||||
| D07AC06 | Diflucortolone | ||||
| D07AC07 | Fludroxycortide | ||||
| D07AC08 | Fluocinonide | ||||
| D07AC09 | Budesonide | ||||
| D07AC10 | Diflorasone | ||||
| D07AC11 | Amcinonide | ||||
| D07AC12 | Halometasone | ||||
| D07AC13 | Mometasone | ||||
| D07AC14 | Methylprednisolone aceponate | ||||
| D07AC15 | Beclometasone | ||||
| D07AC16 | Hydrocortisone aceponate | ||||
| D07AC17 | Fluticasone | ||||
| D07AC18 | Prednicarbate | ||||
| D07AC19 | Difluprednate | ||||
| D07AC21 | Ulobetasol | ||||
| D07AD | Corticosteroids, very potent (group IV) | ||||
| D07AD01 | Clobetasol | ||||
| D07AD02 | Halcinonide | ||||
| D07B | Corticosteroids, combinations with antiseptics | ||||
| D07BA | Corticosteroids, weak, combinations with antiseptics | ||||
| D07BA01 | Prednisolone and antiseptics | ||||
| D07BA04 | Hydrocortisone and antiseptics | ||||
| D07BB | Corticosteroids, moderately potent, combinations with antiseptics | ||||
| D07BB01 | Flumetasone and antiseptics | ||||
| D07BB02 | Desonide and antiseptics | ||||
| D07BB03 | Triamcinolone and antiseptics | ||||
| D07BB04 | Hydrocortisone butyrate and antiseptics | ||||
| D07BC | Corticosteroids, potent, combinations with antiseptics | ||||
| D07BC01 | Betamethasone and antiseptics | ||||
| D07BC02 | Fluocinolone acetonide and antiseptics | ||||
| D07BC03 | Fluocortolone and antiseptics | ||||
| D07BC04 | Diflucortolone and antiseptics | ||||
| D07BD | Corticosteroids, very potent, combinations with antiseptics | ||||
| empty | |||||
| D07C | Corticosteroids, combinations with antibiotics | ||||
| D07CA | Corticosteroids, weak, combinations with antibiotics | ||||
| D07CA01 | Hydrocortisone and antibiotics | ||||
| D07CA02 | Methylprednisolone and antibiotics | ||||
| D07CA03 | Prednisolone and antibiotics | ||||
| D07CB | Corticosteroids, moderately potent, combinations with antibiotics | ||||
| D07CB01 | Triamcinolone and antibiotics | ||||
| D07CB02 | Fluprednidene and antibiotics | ||||
| D07CB03 | Fluorometholone and antibiotics | ||||
| D07CB04 | Dexamethasone and antibiotics | ||||
| D07CB05 | Flumetasone and antibiotics | ||||
| D07CC | Corticosteroids, potent, combinations with antibiotics | ||||
| D07CC01 | Betamethasone and antibiotics | ||||
| D07CC02 | Fluocinolone acetonide and antibiotics | ||||
| D07CC03 | Fludroxycortide and antibiotics | ||||
| D07CC04 | Beclometasone and antibiotics | ||||
| D07CC05 | Fluocinonide and antibiotics | ||||
| D07CC06 | Fluocortolone and antibiotics | ||||
| D07CD | Corticosteroids, very potent, combinations with antibiotics | ||||
| D07CD01 | Clobetasol and antibiotics | ||||
| D07X | Corticosteroids, other combinations | ||||
| D07XA | Corticosteroids, weak, other combinations | ||||
| D07XA01 | Hydrocortisone | ||||
| D07XA02 | Prednisolone | ||||
| D07XB | Corticosteroids, moderately potent, other combinations | ||||
| D07XB01 | Flumetasone | ||||
| D07XB02 | Triamcinolone | ||||
| D07XB03 | Fluprednidene | ||||
| D07XB04 | Fluorometholone | ||||
| D07XB05 | Dexamethasone | ||||
| D07XB30 | Combinations of corticosteroids | ||||
| D07XC | Corticosteroids, potent, other combinations | ||||
| D07XC01 | Betamethasone | ||||
| D07XC02 | Desoximetasone | ||||
| D07XC03 | Mometasone | ||||
| D07XC04 | Diflucortolone | ||||
| D07XD | Corticosteroids, very potent, other combinations | ||||
| empty | |||||
| D08 | Antiseptics and disinfectants | ||||
| D08A | Antiseptics and disinfectants | ||||
| D08AA | Acridine derivatives | ||||
| D08AA01 | Ethacridine lactate | ||||
| D08AA02 | Aminoacridine | ||||
| D08AA03 | Euflavine | ||||
| D08AB | Aluminium agents | ||||
| empty | |||||
| D08AC | Biguanides and amidines | ||||
| D08AC01 | Dibrompropamidine | ||||
| D08AC02 | Chlorhexidine | ||||
| D08AC03 | Propamidine | ||||
| D08AC04 | Hexamidine | ||||
| D08AC05 | Polihexanide | ||||
| D08AC52 | Chlorhexidine, combinations | ||||
| D08AD | Boric acid products | ||||
| empty | |||||
| D08AE | Phenol and derivatives | ||||
| D08AE01 | Hexachlorophene | ||||
| D08AE02 | Policresulen | ||||
| D08AE03 | Phenol | ||||
| D08AE04 | Triclosan | ||||
| D08AE05 | Chloroxylenol | ||||
| D08AE06 | Biphenylol | ||||
| D08AF | Nitrofuran derivatives | ||||
| D08AF01 | Nitrofural | ||||
| D08AG | Iodine products | ||||
| D08AG01 | Iodine/octylphenoxypolyglycolether | ||||
| D08AG02 | Povidone-iodine | ||||
| D08AG03 | Iodine | ||||
| D08AG04 | Diiodohydroxypropane | ||||
| D08AH | Quinoline derivatives | ||||
| D08AH01 | Dequalinium | ||||
| D08AH02 | Chlorquinaldol | ||||
| D08AH03 | Oxyquinoline | ||||
| D08AH30 | Clioquinol | ||||
| D08AJ | Quaternary ammonium compounds | ||||
| D08AJ01 | Benzalkonium | ||||
| D08AJ02 | Cetrimonium | ||||
| D08AJ03 | Cetylpyridinium | ||||
| D08AJ04 | Cetrimide | ||||
| D08AJ05 | Benzoxonium chloride | ||||
| D08AJ06 | Didecyldimethylammonium chloride | ||||
| D08AJ08 | Benzethonium chloride | ||||
| D08AJ57 | Octenidine, combinations | ||||
| D08AJ58 | Benzethonium chloride, combinations | ||||
| D08AJ59 | Dodeclonium bromide, combinations | ||||
| D08AK | Mercurial products | ||||
| D08AK01 | Mercuric amidochloride | ||||
| D08AK02 | Phenylmercuric borate | ||||
| D08AK03 | Mercuric chloride | ||||
| D08AK04 | Mercurochrome | ||||
| D08AK05 | Mercury, metallic | ||||
| D08AK06 | Thiomersal | ||||
| D08AK30 | Mercuric iodide | ||||
| D08AL | Silver compounds | ||||
| D08AL01 | Silver nitrate | ||||
| D08AL30 | Silver | ||||
| D08AX | Other antiseptics and disinfectants | ||||
| D08AX01 | Hydrogen peroxide | ||||
| D08AX02 | Eosin | ||||
| D08AX03 | Propanol | ||||
| D08AX04 | Tosylchloramide sodium | ||||
| D08AX05 | Isopropanol | ||||
| D08AX06 | Potassium permanganate | ||||
| D08AX07 | Sodium hypochlorite | ||||
| D08AX08 | Ethanol | ||||
| D08AX53 | Propanol, combinations | ||||
| D09 | Medicated dressings | ||||
| D09A | Medicated dressings | ||||
| D09AA | Medicated dressings with antiinfectives | ||||
| D09AA01 | Framycetin | ||||
| D09AA02 | Fusidic acid | ||||
| D09AA03 | Nitrofural | ||||
| D09AA04 | Phenylmercuric nitrate | ||||
| D09AA05 | Benzododecinium | ||||
| D09AA06 | Triclosan | ||||
| D09AA07 | Cetylpyridinium | ||||
| D09AA08 | Aluminium chlorohydrate | ||||
| D09AA09 | Povidone-iodine | ||||
| D09AA10 | Clioquinol | ||||
| D09AA11 | Benzalkonium | ||||
| D09AA12 | Chlorhexidine | ||||
| D09AA13 | Iodoform | ||||
| D09AB | Zinc bandages | ||||
| D09AB01 | Zinc bandage without supplements | ||||
| D09AB02 | Zinc bandage with supplements | ||||
| D09AX | Soft paraffin dressings | ||||
| empty | |||||
| D10 | Anti-acne preparations | ||||
| D10A | Anti-acne preparations for topical use | ||||
| D10AA | Corticosteroids, combinations for treatment of acne | ||||
| D10AA01 | Fluorometholone | ||||
| D10AA02 | Methylprednisolone | ||||
| D10AA03 | Dexamethasone | ||||
| D10AB | Preparations containing sulfur | ||||
| D10AB01 | Bithionol | ||||
| D10AB02 | Sulfur | ||||
| D10AB03 | Tioxolone | ||||
| D10AB05 | Mesulfen | ||||
| D10AD | Retinoids for topical use in acne | ||||
| D10AD01 | Tretinoin | ||||
| D10AD02 | Retinol | ||||
| D10AD03 | Adapalene | ||||
| D10AD04 | Isotretinoin | ||||
| D10AD05 | Motretinide | ||||
| D10AD06 | trifarotene | ||||
| D10AD51 | Tretinoin, combinations | ||||
| D10AD53 | Adapalene, combinations | ||||
| D10AD54 | Isotretinoin, combinations | ||||
| D10AE | Peroxides | ||||
| D10AE01 | Benzoyl peroxide | ||||
| D10AE51 | Benzoyl peroxide, combinations | ||||
| D10AF | Anti-infectives for treatment of acne | ||||
| D10AF01 | Clindamycin | ||||
| D10AF02 | Erythromycin | ||||
| D10AF03 | Chloramphenicol | ||||
| D10AF04 | Meclocycline | ||||
| D10AF51 | Clindamycin, combinations | ||||
| D10AF52 | Erythromycin, combinations | ||||
| D10AX | Other anti-acne preparations for topical use | ||||
| D10AX01 | Aluminium chloride | ||||
| D10AX02 | Resorcinol | ||||
| D10AX03 | Azelaic acid | ||||
| D10AX04 | Aluminium oxide | ||||
| D10AX05 | Dapsone | ||||
| D10AX30 | Various combinations | ||||
| D10B | Anti-acne preparations for systemic use | ||||
| D10BA | Retinoids for treatment of acne | ||||
| D10BA01 | Isotretinoin | ||||
| D10BX | Other anti-acne preparations for systemic use | ||||
| D10BX01 | Ichtasol | ||||
| D11 | Other dermatological preparations | ||||
| D11A | Other dermatological preparations | ||||
| D11AA | Antihidrotics | ||||
| D11AA01 | glycopyrronium | ||||
| D11AA02 | sofpironium bromide | ||||
| D11AC | Medicated shampoos | ||||
| D11AC01 | Cetrimide | ||||
| D11AC02 | Cadmium compounds | ||||
| D11AC03 | Selenium compounds | ||||
| D11AC06 | Povidone-iodine | ||||
| D11AC08 | Sulfur compounds | ||||
| D11AC09 | Xenysalate | ||||
| D11AC30 | Others | ||||
| D11AE | Androgens for topical use | ||||
| D11AE01 | Metandienone | ||||
| D11AF | Wart and anti-corn preparations | ||||
| empty | |||||
| D11AH | Agents for dermatitis, excluding corticosteroids | ||||
| D11AH01 | Tacrolimus | ||||
| D11AH02 | Pimecrolimus | ||||
| D11AH03 | Cromoglicic acid | ||||
| D11AH04 | Alitretinoin | ||||
| D11AH05 | Dupilumab | ||||
| D11AH06 | Crisaborole | ||||
| D11AH07 | Tralokinumab | ||||
| D11AH08 | abrocitinib | ||||
| D11AH09 | ruxolitinib | ||||
| D11AH10 | lebrikizumab | ||||
| D11AH11 | delgocitinib | ||||
| D11AH12 | nemolizumab | ||||
| D11AX | Other dermatologicals | ||||
| D11AX01 | Minoxidil | ||||
| D11AX02 | Gamolenic acid | ||||
| D11AX03 | Calcium gluconate | ||||
| D11AX04 | Lithium succinate | ||||
| D11AX05 | Magnesium sulfate | ||||
| D11AX06 | Mequinol | ||||
| D11AX08 | Tiratricol | ||||
| D11AX09 | Oxaceprol | ||||
| D11AX10 | Finasteride | ||||
| D11AX11 | Hydroquinone | ||||
| D11AX12 | Pyrithione zinc | ||||
| D11AX13 | Monobenzone | ||||
| D11AX14 | Tacrolimus (New ATC code D11AH01) | ||||
| D11AX15 | Pimecrolimus (New ATC code D11AH02) | ||||
| D11AX16 | Eflornithine | ||||
| D11AX17 | cromoglicic acid (New ATC code D11AH03) | ||||
| D11AX18 | Diclofenac | ||||
| D11AX19 | alitretinoin (New ATC code D11AH04) | ||||
| D11AX52 | Gamolenic acid, combinations | ||||
| D11AX57 | Collagen, combinations | ||||
| âG | Genito-urinary system and sex hormones | ||||
| G01 | Gynecological antiinfectives and antiseptics | ||||
| G01A | Antiinfectives and antiseptics, excluding combinations with corticosteroids | ||||
| G01AA | Antibiotics | ||||
| G01AA01 | Nystatin | ||||
| G01AA02 | Natamycin | ||||
| G01AA03 | Amphotericin B | ||||
| G01AA04 | Candicidin | ||||
| G01AA05 | Chloramphenicol | ||||
| G01AA06 | Hachimycin | ||||
| G01AA07 | Oxytetracycline | ||||
| G01AA08 | Carfecillin | ||||
| G01AA09 | Mepartricin | ||||
| G01AA10 | Clindamycin | ||||
| G01AA11 | Pentamycin | ||||
| G01AA51 | Nystatin, combinations | ||||
| G01AB | Arsenic compounds | ||||
| G01AB01 | Acetarsol | ||||
| G01AC | Quinoline derivatives | ||||
| G01AC01 | Diiodohydroxyquinoline | ||||
| G01AC02 | Clioquinol | ||||
| G01AC03 | Chlorquinaldol | ||||
| G01AC05 | Dequalinium | ||||
| G01AC06 | Broxyquinoline | ||||
| G01AC30 | Oxyquinoline | ||||
| G01AD | Organic acids | ||||
| G01AD01 | Lactic acid | ||||
| G01AD02 | Acetic acid | ||||
| G01AD03 | Ascorbic acid | ||||
| G01AE | Sulfonamides | ||||
| G01AE01 | Sulfatolamide | ||||
| G01AE10 | Combinations of sulfonamides | ||||
| G01AF | Imidazole derivatives | ||||
| G01AF01 | Metronidazole | ||||
| G01AF02 | Clotrimazole | ||||
| G01AF04 | Miconazole | ||||
| G01AF05 | Econazole | ||||
| G01AF06 | Ornidazole | ||||
| G01AF07 | Isoconazole | ||||
| G01AF08 | Tioconazole | ||||
| G01AF11 | Ketoconazole | ||||
| G01AF12 | Fenticonazole | ||||
| G01AF13 | Azanidazole | ||||
| G01AF14 | Propenidazole | ||||
| G01AF15 | Butoconazole | ||||
| G01AF16 | Omoconazole | ||||
| G01AF17 | Oxiconazole | ||||
| G01AF18 | Flutrimazole | ||||
| G01AF20 | Combinations of imidazole derivatives | ||||
| G01AG | Triazole derivatives | ||||
| G01AG02 | Terconazole | ||||
| G01AX | Other anti-infectives and antiseptics | ||||
| G01AX01 | Clodantoin | ||||
| G01AX02 | Inosine | ||||
| G01AX03 | Policresulen | ||||
| G01AX05 | Nifuratel | ||||
| G01AX06 | Furazolidone | ||||
| G01AX09 | Methylrosaniline | ||||
| G01AX11 | Povidone-iodine | ||||
| G01AX12 | Ciclopirox | ||||
| G01AX13 | Protiofate | ||||
| G01AX14 | Lactobacillus fermentum | ||||
| G01AX15 | Copper usnate | ||||
| G01AX66 | Octenidine, combinations | ||||
| G01B | Antiinfectives/antiseptics in combination with corticosteroids | ||||
| G01BA | Antibiotics and corticosteroids | ||||
| empty | |||||
| G01BC | Quinoline derivatives and corticosteroids | ||||
| empty | |||||
| G01BD | Antiseptics and corticosteroids | ||||
| empty | |||||
| G01BE | Sulfonamides and corticosteroids | ||||
| empty | |||||
| G01BF | Imidazole derivatives and corticosteroids | ||||
| empty | |||||
| G02 | Other gynecologicals | ||||
| G02A | Oxytocics | ||||
| G02AB | Ergot alkaloids | ||||
| G02AB01 | Methylergometrine | ||||
| G02AB02 | Ergot alkaloids | ||||
| G02AB03 | Ergometrine | ||||
| G02AC | Ergot alkaloids and oxytocin including analogues, in combination | ||||
| G02AC01 | Methylergometrine and oxytocin | ||||
| G02AD | Prostaglandins | ||||
| G02AD01 | Dinoprost | ||||
| G02AD02 | Dinoprostone | ||||
| G02AD03 | Gemeprost | ||||
| G02AD04 | Carboprost | ||||
| G02AD05 | Sulprostone | ||||
| G02AD06 | Misoprostol | ||||
| G02AX | Other oxytocics | ||||
| empty | |||||
| G02B | Contraceptives for topical use | ||||
| G02BA | Intrauterine contraceptives | ||||
| G02BA01 | Plastic IUD | ||||
| G02BA02 | Plastic IUD with copper | ||||
| G02BA03 | Plastic IUD with progestogen | ||||
| G02BB | Intravaginal contraceptives | ||||
| G02BB01 | Vaginal ring with progestogen and estrogen | ||||
| G02C | Other gynecologicals | ||||
| G02CA | Sympathomimetics, labour repressants | ||||
| G02CA01 | Ritodrine | ||||
| G02CA02 | Buphenine | ||||
| G02CA03 | Fenoterol | ||||
| G02CB | Prolactin inhibitors | ||||
| G02CB01 | Bromocriptine | ||||
| G02CB02 | Lisuride | ||||
| G02CB03 | Cabergoline | ||||
| G02CB04 | Quinagolide | ||||
| G02CB05 | Metergoline | ||||
| G02CB06 | Terguride | ||||
| G02CC | Anti-inflammatory products for vaginal administration | ||||
| G02CC01 | Ibuprofen | ||||
| G02CC02 | Naproxen | ||||
| G02CC03 | Benzydamine | ||||
| G02CC04 | Flunoxaprofen | ||||
| G02CX | Other gynecologicals | ||||
| G02CX01 | Atosiban | ||||
| G02CX02 | flibanserin | ||||
| G02CX03 | Agni casti fructus | ||||
| G02CX04 | Cimicifugae rhizoma | ||||
| G02CX05 | bremelanotide | ||||
| G02CX06 | fezolinetant | ||||
| G02CX07 | elinzanetant | ||||
| G03 | Sex hormones and modulators of the genital system | ||||
| G03A | Hormonal contraceptives for systemic use | ||||
| G03AA | Progestogens and estrogens, fixed combinations | ||||
| G03AA01 | Etynodiol and ethinylestradiol | ||||
| G03AA02 | Quingestanol and ethinylestradiol | ||||
| G03AA03 | Lynestrenol and ethinylestradiol | ||||
| G03AA04 | Megestrol and ethinylestradiol | ||||
| G03AA05 | Norethisterone and ethinylestradiol | ||||
| G03AA06 | Norgestrel and ethinylestradiol | ||||
| G03AA07 | Levonorgestrel and ethinylestradiol | ||||
| G03AA08 | Medroxyprogesterone and ethinylestradiol | ||||
| G03AA09 | Desogestrel and ethinylestradiol | ||||
| G03AA10 | Gestodene and ethinylestradiol | ||||
| G03AA11 | Norgestimate and ethinylestradiol | ||||
| G03AA12 | Drospirenone and ethinylestradiol | ||||
| G03AA13 | Norelgestromin and ethinylestradiol | ||||
| G03AA14 | Nomegestrol and estradiol | ||||
| G03AA15 | Chlormadinone and ethinylestradiol | ||||
| G03AA16 | dienogest and ethinylestradiol | ||||
| G03AA17 | medroxyprogesterone and estradiol | ||||
| G03AA18 | drospirenone and estetrol | ||||
| G03AB | Progestogens and estrogens, sequential preparations | ||||
| G03AB01 | Megestrol and ethinylestradiol | ||||
| G03AB02 | Lynestrenol and ethinylestradiol | ||||
| G03AB03 | Levonorgestrel and ethinylestradiol | ||||
| G03AB04 | Norethisterone and ethinylestradiol | ||||
| G03AB05 | Desogestrel and ethinylestradiol | ||||
| G03AB06 | Gestodene and ethinylestradiol | ||||
| G03AB07 | Chlormadinone and ethinylestradiol | ||||
| G03AB08 | Dienogest and estradiol | ||||
| G03AC | Progestogens | ||||
| G03AC01 | Norethisterone | ||||
| G03AC02 | Lynestrenol | ||||
| G03AC03 | Levonorgestrel | ||||
| G03AC04 | Quingestanol | ||||
| G03AC05 | Megestrol | ||||
| G03AC06 | Medroxyprogesterone | ||||
| G03AC07 | Norgestrienone | ||||
| G03AC08 | Etonogestrel | ||||
| G03AC09 | Desogestrel | ||||
| G03AC10 | drospirenone | ||||
| G03AD | Emergency contraceptives | ||||
| G03AD01 | Levonorgestrel | ||||
| G03AD02 | Ulipristal | ||||
| G03B | Androgens | ||||
| G03BA | 3-oxoandrosten-(4) derivatives | ||||
| G03BA01 | Fluoxymesterone | ||||
| G03BA02 | Methyltestosterone | ||||
| G03BA03 | Testosterone | ||||
| G03BB | 5-androstanon-(3) derivatives | ||||
| G03BB01 | Mesterolone | ||||
| G03BB02 | Androstanolone | ||||
| G03C | Estrogens | ||||
| G03CA | Natural and semisynthetic estrogens, plain | ||||
| G03CA01 | Ethinylestradiol | ||||
| G03CA03 | Estradiol | ||||
| G03CA04 | Estriol | ||||
| G03CA06 | Chlorotrianisene | ||||
| G03CA07 | Estrone | ||||
| G03CA09 | Promestriene | ||||
| G03CA10 | estetrol | ||||
| G03CA53 | Estradiol, combinations | ||||
| G03CA57 | Conjugated estrogens | ||||
| G03CB | Synthetic estrogens, plain | ||||
| G03CB01 | Dienestrol | ||||
| G03CB02 | Diethylstilbestrol | ||||
| G03CB03 | Methallenestril | ||||
| G03CB04 | Moxestrol | ||||
| G03CC | Estrogens, combinations with other drugs | ||||
| G03CC02 | Dienestrol | ||||
| G03CC03 | Methallenestril | ||||
| G03CC04 | Estrone | ||||
| G03CC05 | Diethylstilbestrol | ||||
| G03CC06 | Estriol | ||||
| G03CX | Other estrogens | ||||
| G03CX01 | Tibolone | ||||
| G03D | Progestogens | ||||
| G03DA | Pregnen-(4) derivatives | ||||
| G03DA01 | Gestonorone | ||||
| G03DA02 | Medroxyprogesterone | ||||
| G03DA03 | Hydroxyprogesterone | ||||
| G03DA04 | Progesterone | ||||
| G03DB | Pregnadien derivatives | ||||
| G03DB01 | Dydrogesterone | ||||
| G03DB02 | Megestrol | ||||
| G03DB03 | Medrogestone | ||||
| G03DB04 | Nomegestrol | ||||
| G03DB05 | Demegestone | ||||
| G03DB06 | Chlormadinone | ||||
| G03DB07 | Promegestone | ||||
| G03DB08 | Dienogest | ||||
| G03DC | Estren derivatives | ||||
| G03DC01 | Allylestrenol | ||||
| G03DC02 | Norethisterone | ||||
| G03DC03 | Lynestrenol | ||||
| G03DC04 | Ethisterone | ||||
| G03DC05 | Tibolone (New ATC code G03CX01) | ||||
| G03DC06 | Etynodiol | ||||
| G03DC31 | Methylestrenolone | ||||
| G03E | Androgens and female sex hormones in combination | ||||
| G03EA | Androgens and estrogens | ||||
| G03EA01 | Methyltestosterone and estrogen | ||||
| G03EA02 | Testosterone and estrogen | ||||
| G03EA03 | Prasterone and estrogen | ||||
| G03EB | Androgen, progestogen and estrogen in combination | ||||
| empty | |||||
| G03EK | Androgens and female sex hormones in combination with other drugs | ||||
| G03EK01 | Methyltestosterone | ||||
| G03F | Progestogens and estrogens in combination | ||||
| G03FA | Progestogens and estrogens, fixed combinations | ||||
| G03FA01 | Norethisterone and estrogen | ||||
| G03FA02 | Hydroxyprogesterone and estrogen | ||||
| G03FA03 | Ethisterone and estrogen | ||||
| G03FA04 | Progesterone and estrogen | ||||
| G03FA05 | Methylnortestosterone and estrogen | ||||
| G03FA06 | Etynodiol and estrogen | ||||
| G03FA07 | Lynestrenol and estrogen | ||||
| G03FA08 | Megestrol and estrogen | ||||
| G03FA09 | Noretynodrel and estrogen | ||||
| G03FA10 | Norgestrel and estrogen | ||||
| G03FA11 | Levonorgestrel and estrogen | ||||
| G03FA12 | Medroxyprogesterone and estrogen | ||||
| G03FA13 | Norgestimate and estrogen | ||||
| G03FA14 | Dydrogesterone and estrogen | ||||
| G03FA15 | Dienogest and estrogen | ||||
| G03FA16 | Trimegestone and estrogen | ||||
| G03FA17 | Drospirenone and estrogen | ||||
| G03FB | Progestogens and estrogens, sequential preparations | ||||
| G03FB01 | Norgestrel and estrogen | ||||
| G03FB02 | Lynestrenol and estrogen | ||||
| G03FB03 | Chlormadinone and estrogen | ||||
| G03FB04 | Megestrol and estrogen | ||||
| G03FB05 | Norethisterone and estrogen | ||||
| G03FB06 | Medroxyprogesterone and estrogen | ||||
| G03FB07 | Medrogestone and estrogen | ||||
| G03FB08 | Dydrogesterone and estrogen | ||||
| G03FB09 | Levonorgestrel and estrogen | ||||
| G03FB10 | Desogestrel and estrogen | ||||
| G03FB11 | Trimegestone and estrogen | ||||
| G03G | Gonadotropins and other ovulation stimulants | ||||
| G03GA | Gonadotropins | ||||
| G03GA01 | chorionic gonadotrophin | ||||
| G03GA02 | Human menopausal gonadotropin | ||||
| G03GA03 | Serum gonadotropin | ||||
| G03GA04 | Urofollitropin | ||||
| G03GA05 | Follitropin alfa | ||||
| G03GA06 | Follitropin beta | ||||
| G03GA07 | Lutropin alfa | ||||
| G03GA08 | Choriogonadotropin alfa | ||||
| G03GA09 | Corifollitropin alfa | ||||
| G03GA10 | follitropin delta | ||||
| G03GA30 | Combinations | ||||
| G03GB | Ovulation stimulants, synthetic | ||||
| G03GB01 | Cyclofenil | ||||
| G03GB02 | Clomifene | ||||
| G03GB03 | Epimestrol | ||||
| G03H | Antiandrogens | ||||
| G03HA | Antiandrogens, plain | ||||
| G03HA01 | Cyproterone | ||||
| G03HB | Antiandrogens and estrogens | ||||
| G03HB01 | Cyproterone and estrogen | ||||
| G03X | Other sex hormones and modulators of the genital system | ||||
| G03XA | Antigonadotropins and similar agents | ||||
| G03XA01 | Danazol | ||||
| G03XA02 | Gestrinone | ||||
| G03XB | Antiprogestogens | ||||
| G03XB01 | Mifepristone | ||||
| G03XC | Selective estrogen receptor modulators | ||||
| G03XC01 | Raloxifene | ||||
| G03XC02 | Bazedoxifene | ||||
| G03XC03 | Lasofoxifene | ||||
| G03XC04 | Ormeloxifene | ||||
| G04 | Urologicals | ||||
| G04B | Urologicals | ||||
| G04BA | Acidifiers | ||||
| G04BA01 | Ammonium chloride | ||||
| G04BA03 | Calcium chloride | ||||
| G04BC | Urinary concrement solvents | ||||
| empty | |||||
| G04BD | Drugs for urinary frequency and incontinence | ||||
| G04BD01 | Emepronium | ||||
| G04BD02 | Flavoxate | ||||
| G04BD03 | Meladrazine | ||||
| G04BD04 | Oxybutynin | ||||
| G04BD05 | Terodiline | ||||
| G04BD06 | Propiverine | ||||
| G04BD07 | Tolterodine | ||||
| G04BD08 | Solifenacin | ||||
| G04BD09 | Trospium | ||||
| G04BD10 | Darifenacin | ||||
| G04BD11 | Fesoterodine | ||||
| G04BD12 | Mirabegron | ||||
| G04BE | Drugs used in erectile dysfunction | ||||
| G04BE01 | Alprostadil | ||||
| G04BE02 | Papaverine | ||||
| G04BE03 | Sildenafil | ||||
| G04BE04 | Yohimbin | ||||
| G04BE05 | phentolamine (New ATC code V03AB36) | ||||
| G04BE06 | Moxisylyte | ||||
| G04BE07 | Apomorphine | ||||
| G04BE08 | Tadalafil | ||||
| G04BE09 | Vardenafil | ||||
| G04BE30 | Combinations | ||||
| G04BE52 | Papaverine, combinations | ||||
| G04BX | Other urologicals | ||||
| G04BX01 | Magnesium hydroxide | ||||
| G04BX03 | Acetohydroxamic acid | ||||
| G04BX06 | Phenazopyridine | ||||
| G04BX10 | Succinimide | ||||
| G04BX11 | Collagen | ||||
| G04BX12 | Phenyl salicylate | ||||
| G04BX13 | Dimethyl sulfoxide | ||||
| G04BX14 | Dapoxetine | ||||
| G04BX15 | Pentosan polysulfate sodium | ||||
| G04BX16 | tiopronin | ||||
| G04BX17 | sodium salicylate and methenamine | ||||
| G04C | Drugs used in benign prostatic hypertrophy | ||||
| G04CA | Alpha-adrenoreceptor antagonists | ||||
| G04CA01 | Alfuzosin | ||||
| G04CA02 | Tamsulosin | ||||
| G04CA03 | Terazosin | ||||
| G04CA04 | Silodosin | ||||
| G04CA51 | Alfuzosin and finasteride | ||||
| G04CA52 | Tamsulosin and dutasteride | ||||
| G04CA53 | Tamsulosin and solifenacin | ||||
| G04CB | Testosterone-5-alpha reductase inhibitors | ||||
| G04CB01 | Finasteride | ||||
| G04CB02 | Dutasteride | ||||
| G04CX | Other drugs used in benign prostatic hypertrophy | ||||
| G04CX01 | Prunus africanae cortex | ||||
| G04CX02 | Sabalis serrulatae fructus | ||||
| G04CX03 | Mepartricin | ||||
| G04CX04 | fexapotide | ||||
| âH | Systemic hormonal preparations, excluding sex hormones and insulins | ||||
| H01 | Pituitary and hypothalamic hormones and analogues | ||||
| H01A | Anterior pituitary lobe hormones and analogues | ||||
| H01AA | Adrenocorticotropic hormone | ||||
| H01AA01 | Corticotropin | ||||
| H01AA02 | Tetracosactide | ||||
| H01AB | Thyrotropin | ||||
| H01AB01 | Thyrotropin | ||||
| H01AC | Somatropin and somatropin agonists | ||||
| H01AC01 | Somatropin | ||||
| H01AC02 | Somatrem | ||||
| H01AC03 | Mecasermin | ||||
| H01AC04 | Sermorelin | ||||
| H01AC05 | Mecasermin rinfabate | ||||
| H01AC06 | Tesamorelin | ||||
| H01AC07 | somapacitan | ||||
| H01AC08 | somatrogon | ||||
| H01AC09 | lonapegsomatropin | ||||
| H01AX | Other anterior pituitary lobe hormones and analogues | ||||
| H01AX01 | Pegvisomant | ||||
| H01B | Posterior pituitary lobe hormones | ||||
| H01BA | Vasopressin and analogues | ||||
| H01BA01 | vasopressin (argipressin) | ||||
| H01BA02 | Desmopressin | ||||
| H01BA03 | Lypressin | ||||
| H01BA04 | Terlipressin | ||||
| H01BA05 | Ornipressin | ||||
| H01BA06 | Argipressin (Deleted) | ||||
| H01BB | Oxytocin and analogues | ||||
| H01BB01 | Demoxytocin | ||||
| H01BB02 | Oxytocin | ||||
| H01BB03 | Carbetocin | ||||
| H01C | Hypothalamic hormones | ||||
| H01CA | Gonadotropin-releasing hormones | ||||
| H01CA01 | Gonadorelin | ||||
| H01CA02 | Nafarelin | ||||
| H01CA03 | histrelin (New ATC code L02AE05) | ||||
| H01CB | Somatostatin and analogues | ||||
| H01CB01 | Somatostatin | ||||
| H01CB02 | Octreotide | ||||
| H01CB03 | Lanreotide | ||||
| H01CB04 | Vapreotide | ||||
| H01CB05 | Pasireotide | ||||
| H01CB06 | paltusotine | ||||
| H01CC | Anti-gonadotropin-releasing hormones | ||||
| H01CC01 | Ganirelix | ||||
| H01CC02 | Cetrorelix | ||||
| H01CC03 | elagolix | ||||
| H01CC04 | linzagolix | ||||
| H01CC53 | elagolix, estradiol and norethisterone | ||||
| H01CC54 | relugolix, estradiol and norethisterone | ||||
| H02 | Corticosteroids for systemic use | ||||
| H02A | Corticosteroids for systemic use, plain | ||||
| H02AA | Mineralocorticoids | ||||
| H02AA01 | Aldosterone | ||||
| H02AA02 | Fludrocortisone | ||||
| H02AA03 | Desoxycortone | ||||
| H02AB | Glucocorticoids | ||||
| H02AB01 | Betamethasone | ||||
| H02AB02 | Dexamethasone | ||||
| H02AB03 | Fluocortolone | ||||
| H02AB04 | Methylprednisolone | ||||
| H02AB05 | Paramethasone | ||||
| H02AB06 | Prednisolone | ||||
| H02AB07 | Prednisone | ||||
| H02AB08 | Triamcinolone | ||||
| H02AB09 | Hydrocortisone | ||||
| H02AB10 | Cortisone | ||||
| H02AB11 | Prednylidene | ||||
| H02AB12 | Rimexolone | ||||
| H02AB13 | Deflazacort | ||||
| H02AB14 | Cloprednol | ||||
| H02AB15 | Meprednisone | ||||
| H02AB17 | Cortivazol | ||||
| H02AB18 | vamorolone | ||||
| H02B | Corticosteroids for systemic use, combinations | ||||
| H02BX | Corticosteroids for systemic use, combinations | ||||
| H02BX01 | Methylprednisolone, combinations | ||||
| H02C | Antiadrenal preparations | ||||
| H02CA | Anticorticosteroids | ||||
| H02CA01 | Trilostane | ||||
| H02CA02 | osilodrostat | ||||
| H02CA03 | ketoconazole | ||||
| H02CA04 | levoketoconazole | ||||
| H03 | Thyroid therapy | ||||
| H03A | Thyroid preparations | ||||
| H03AA | Thyroid hormones | ||||
| H03AA01 | Levothyroxine sodium | ||||
| H03AA02 | Liothyronine sodium | ||||
| H03AA03 | Combinations of levothyroxine and liothyronine | ||||
| H03AA04 | Tiratricol | ||||
| H03AA05 | Thyroid gland preparations | ||||
| H03B | Antithyroid preparations | ||||
| H03BA | Thiouracils | ||||
| H03BA01 | Methylthiouracil | ||||
| H03BA02 | Propylthiouracil | ||||
| H03BA03 | Benzylthiouracil | ||||
| H03BB | Sulphur-containing imidazole derivatives | ||||
| H03BB01 | Carbimazole | ||||
| H03BB02 | Thiamazole | ||||
| H03BB52 | Thiamazole, combinations | ||||
| H03BC | Perchlorates | ||||
| H03BC01 | Potassium perchlorate | ||||
| H03BX | Other antithyroid preparations | ||||
| H03BX01 | Diiodotyrosine | ||||
| H03BX02 | Dibromotyrosine | ||||
| H03C | Iodine therapy | ||||
| H03CA | Iodine therapy | ||||
| empty | |||||
| H04 | Pancreatic hormones | ||||
| H04A | Glycogenolytic hormones | ||||
| H04AA | Glycogenolytic hormones | ||||
| H04AA01 | Glucagon | ||||
| H05 | Calcium homeostasis | ||||
| H05A | Parathyroid hormones and analogues | ||||
| H05AA | Parathyroid hormones and analogues | ||||
| H05AA01 | Parathyroid gland extract | ||||
| H05AA02 | Teriparatide | ||||
| H05AA03 | Parathyroid hormone | ||||
| H05AA04 | abaloparatide | ||||
| H05AA05 | palopegteriparatide | ||||
| H05B | Anti-parathyroid agents | ||||
| H05BA | Calcitonin preparations | ||||
| H05BA01 | Calcitonin (salmon synthetic) | ||||
| H05BA02 | Calcitonin (pork natural) | ||||
| H05BA03 | Calcitonin (human synthetic) | ||||
| H05BA04 | Elcatonin | ||||
| H05BX | Other anti-parathyroid agents | ||||
| H05BX01 | Cinacalcet | ||||
| H05BX02 | Paricalcitol | ||||
| H05BX03 | Doxercalciferol | ||||
| âJ | Antiinfectives for systemic use | ||||
| J01 | Antibacterials for systemic use | ||||
| J01A | Tetracyclines | ||||
| J01AA | Tetracyclines | ||||
| J01AA01 | Demeclocycline | ||||
| J01AA02 | Doxycycline | ||||
| J01AA03 | Chlortetracycline | ||||
| J01AA04 | Lymecycline | ||||
| J01AA05 | Metacycline | ||||
| J01AA06 | Oxytetracycline | ||||
| J01AA07 | Tetracycline | ||||
| J01AA08 | Minocycline | ||||
| J01AA09 | Rolitetracycline | ||||
| J01AA10 | Penimepicycline | ||||
| J01AA11 | Clomocycline | ||||
| J01AA12 | Tigecycline | ||||
| J01AA20 | Combinations of tetracyclines | ||||
| J01AA56 | Oxytetracycline, combinations | ||||
| J01B | Amphenicols | ||||
| J01BA | Amphenicols | ||||
| J01BA01 | Chloramphenicol | ||||
| J01BA02 | Thiamphenicol | ||||
| J01BA52 | Thiamphenicol, combinations | ||||
| J01C | Beta-lactam antibacterials, penicillins | ||||
| J01CA | Penicillins with extended spectrum | ||||
| J01CA01 | Ampicillin | ||||
| J01CA02 | Pivampicillin | ||||
| J01CA03 | Carbenicillin | ||||
| J01CA04 | Amoxicillin | ||||
| J01CA05 | Carindacillin | ||||
| J01CA06 | Bacampicillin | ||||
| J01CA07 | Epicillin | ||||
| J01CA08 | Pivmecillinam | ||||
| J01CA09 | Azlocillin | ||||
| J01CA10 | Mezlocillin | ||||
| J01CA11 | Mecillinam | ||||
| J01CA12 | Piperacillin | ||||
| J01CA13 | Ticarcillin | ||||
| J01CA14 | Metampicillin | ||||
| J01CA15 | Talampicillin | ||||
| J01CA16 | Sulbenicillin | ||||
| J01CA17 | Temocillin | ||||
| J01CA18 | Hetacillin | ||||
| J01CA19 | Aspoxicillin | ||||
| J01CA20 | Combinations | ||||
| J01CA51 | Ampicillin, combinations | ||||
| J01CE | Beta-lactamase-sensitive penicillins | ||||
| J01CE01 | Benzylpenicillin | ||||
| J01CE02 | Phenoxymethylpenicillin | ||||
| J01CE03 | Propicillin | ||||
| J01CE04 | Azidocillin | ||||
| J01CE05 | Pheneticillin | ||||
| J01CE06 | Penamecillin | ||||
| J01CE07 | Clometocillin | ||||
| J01CE08 | Benzathine benzylpenicillin | ||||
| J01CE09 | Procaine benzylpenicillin | ||||
| J01CE10 | Benzathine phenoxymethylpenicillin | ||||
| J01CE30 | Combinations | ||||
| J01CF | Beta-lactamase-resistant penicillins | ||||
| J01CF01 | Dicloxacillin | ||||
| J01CF02 | Cloxacillin | ||||
| J01CF03 | Methicillin | ||||
| J01CF04 | Oxacillin | ||||
| J01CF05 | Flucloxacillin | ||||
| J01CF06 | Nafcillin | ||||
| J01CG | Beta-lactamase inhibitors | ||||
| J01CG01 | Sulbactam | ||||
| J01CG02 | Tazobactam | ||||
| J01CG30 | sulbactam and durlobactam | ||||
| J01CR | Combinations of penicillins, including beta-lactamase inhibitors | ||||
| J01CR01 | Ampicillin and enzyme inhibitor | ||||
| J01CR02 | Amoxicillin and enzyme inhibitor | ||||
| J01CR03 | Ticarcillin and enzyme inhibitor | ||||
| J01CR04 | Sultamicillin | ||||
| J01CR05 | Piperacillin and enzyme inhibitor | ||||
| J01CR50 | Combinations of penicillins | ||||
| J01D | Other beta-lactam antibacterials | ||||
| J01DA | new ATC 4th levels, J01DB-J01DE | ||||
| J01DA01 | cefalexin New ATC code J01DB01 | ||||
| J01DA02 | cefaloridine New ATC code J01DB02 | ||||
| J01DA03 | cefalotin New ATC code J01DB03 | ||||
| J01DA04 | cefazolin New ATC code J01DB04 | ||||
| J01DA05 | cefoxitin New ATC code J01DC01 | ||||
| J01DA06 | cefuroxime New ATC code J01DC02 | ||||
| J01DA07 | cefamandole New ATC code J01DC03 | ||||
| J01DA08 | cefaclor New ATC code J01DC04 | ||||
| J01DA09 | cefadroxil New ATC code J01DB05 | ||||
| J01DA10 | cefotaxime New ATC code J01DD01 | ||||
| J01DA11 | ceftazidime New ATC code J01DD02 | ||||
| J01DA12 | cefsulodin New ATC code J01DD03 | ||||
| J01DA13 | ceftriaxone New ATC code J01DD04 | ||||
| J01DA14 | cefotetan New ATC code J01DC05 | ||||
| J01DA15 | cefazedone New ATC code J01DB06 | ||||
| J01DA16 | cefmenoxime New ATC code J01DD05 | ||||
| J01DA17 | cefonicid New ATC code J01DC06 | ||||
| J01DA18 | latamoxef New ATC code J01DD06 | ||||
| J01DA19 | cefotiam New ATC code J01DC07 | ||||
| J01DA21 | cefatrizine New ATC code J01DB07 | ||||
| J01DA22 | ceftizoxime New ATC code J01DD07 | ||||
| J01DA23 | cefixime New ATC code J01DD08 | ||||
| J01DA24 | cefepime New ATC code J01DE01 | ||||
| J01DA25 | cefodizime New ATC code J01DD09 | ||||
| J01DA26 | cefetamet New ATC code J01DD10 | ||||
| J01DA27 | cefpiramide New ATC code J01DD11 | ||||
| J01DA30 | cefapirin New ATC code J01DB08 | ||||
| J01DA31 | cefradine New ATC code J01DB09 | ||||
| J01DA32 | cefoperazone New ATC code J01DD12 | ||||
| J01DA33 | cefpodoxime New ATC code J01DD13 | ||||
| J01DA34 | cefacetrile New ATC code J01DB10 | ||||
| J01DA35 | cefroxadine New ATC code J01DB11 | ||||
| J01DA36 | ceftezole New ATC code J01DB12 | ||||
| J01DA37 | cefpirome New ATC code J01DE02 | ||||
| J01DA38 | loracarbef New ATC code J01DC08 | ||||
| J01DA39 | ceftibuten New ATC code J01DD14 | ||||
| J01DA40 | cefmetazole New ATC code J01DC09 | ||||
| J01DA41 | cefprozil New ATC code J01DC10 | ||||
| J01DA42 | cefdinir New ATC code J01DD15 | ||||
| J01DA63 | ceftriaxone, combinations New ATC code J01DD54 | ||||
| J01DB | First-generation cephalosporins | ||||
| J01DB01 | Cefalexin | ||||
| J01DB02 | Cefaloridine | ||||
| J01DB03 | Cefalotin | ||||
| J01DB04 | Cefazolin | ||||
| J01DB05 | Cefadroxil | ||||
| J01DB06 | Cefazedone | ||||
| J01DB07 | Cefatrizine | ||||
| J01DB08 | Cefapirin | ||||
| J01DB09 | Cefradine | ||||
| J01DB10 | Cefacetrile | ||||
| J01DB11 | Cefroxadine | ||||
| J01DB12 | Ceftezole | ||||
| J01DC | Second-generation cephalosporins | ||||
| J01DC01 | Cefoxitin | ||||
| J01DC02 | Cefuroxime | ||||
| J01DC03 | Cefamandole | ||||
| J01DC04 | Cefaclor | ||||
| J01DC05 | Cefotetan | ||||
| J01DC06 | Cefonicide | ||||
| J01DC07 | Cefotiam | ||||
| J01DC08 | Loracarbef | ||||
| J01DC09 | Cefmetazole | ||||
| J01DC10 | Cefprozil | ||||
| J01DC11 | Ceforanide | ||||
| J01DC12 | Cefminox | ||||
| J01DC13 | Cefbuperazone | ||||
| J01DC14 | Flomoxef | ||||
| J01DD | Third-generation cephalosporins | ||||
| J01DD01 | Cefotaxime | ||||
| J01DD02 | Ceftazidime | ||||
| J01DD03 | Cefsulodin | ||||
| J01DD04 | Ceftriaxone | ||||
| J01DD05 | Cefmenoxime | ||||
| J01DD06 | Latamoxef | ||||
| J01DD07 | Ceftizoxime | ||||
| J01DD08 | Cefixime | ||||
| J01DD09 | Cefodizime | ||||
| J01DD10 | Cefetamet | ||||
| J01DD11 | Cefpiramide | ||||
| J01DD12 | Cefoperazone | ||||
| J01DD13 | Cefpodoxime | ||||
| J01DD14 | Ceftibuten | ||||
| J01DD15 | Cefdinir | ||||
| J01DD16 | Cefditoren | ||||
| J01DD17 | Cefcapene | ||||
| J01DD18 | cefteram | ||||
| J01DD51 | cefotaxime and beta-lactamase inhibitor | ||||
| J01DD52 | ceftazidime and beta-lactamase inhibitor | ||||
| J01DD54 | Ceftriaxone, combinations (New ATC code J01DD63) | ||||
| J01DD62 | Cefoperazone, combinations | ||||
| J01DD63 | ceftriaxone and beta-lactamase inhibitor | ||||
| J01DD64 | cefpodoxime and beta-lactamase inhibitor | ||||
| J01DE | Fourth-generation cephalosporins | ||||
| J01DE01 | Cefepime | ||||
| J01DE02 | Cefpirome | ||||
| J01DE03 | Cefozopran | ||||
| J01DF | Monobactams | ||||
| J01DF01 | Aztreonam | ||||
| J01DF02 | Carumonam | ||||
| J01DF51 | aztreonam and beta-lactamase inhibitor | ||||
| J01DH | Carbapenems | ||||
| J01DH02 | Meropenem | ||||
| J01DH03 | Ertapenem | ||||
| J01DH04 | Doripenem | ||||
| J01DH05 | Biapenem | ||||
| J01DH06 | tebipenem pivoxil | ||||
| J01DH51 | Imipenem and enzyme inhibitor | ||||
| J01DH52 | meropenem and vaborbactam | ||||
| J01DH55 | Panipenem and betamipron | ||||
| J01DH56 | imipenem, cilastatin and relebactam | ||||
| J01DI | Other cephalosporins and penems | ||||
| J01DI01 | Ceftobiprole medocaril | ||||
| J01DI02 | Ceftaroline fosamil | ||||
| J01DI03 | Faropenem | ||||
| J01DI04 | cefiderocol | ||||
| J01DI54 | ceftolozane and beta-lactamase inhibitor | ||||
| J01DI55 | sulopenem and probenecid | ||||
| J01E | Sulfonamides and trimethoprim | ||||
| J01EA | Trimethoprim and derivatives | ||||
| J01EA01 | Trimethoprim | ||||
| J01EA02 | Brodimoprim | ||||
| J01EA03 | Iclaprim | ||||
| J01EB | Short-acting sulfonamides | ||||
| J01EB01 | Sulfaisodimidine | ||||
| J01EB02 | Sulfamethizole | ||||
| J01EB03 | Sulfadimidine | ||||
| J01EB04 | Sulfapyridine | ||||
| J01EB05 | Sulfafurazole | ||||
| J01EB06 | Sulfanilamide | ||||
| J01EB07 | Sulfathiazole | ||||
| J01EB08 | Sulfathiourea | ||||
| J01EB20 | Combinations | ||||
| J01EC | Intermediate-acting sulfonamides | ||||
| J01EC01 | Sulfamethoxazole | ||||
| J01EC02 | Sulfadiazine | ||||
| J01EC03 | Sulfamoxole | ||||
| J01EC20 | Combinations | ||||
| J01ED | Long-acting sulfonamides | ||||
| J01ED01 | Sulfadimethoxine | ||||
| J01ED02 | Sulfalene | ||||
| J01ED03 | Sulfametomidine | ||||
| J01ED04 | Sulfametoxydiazine | ||||
| J01ED05 | Sulfamethoxypyridazine | ||||
| J01ED06 | Sulfaperin | ||||
| J01ED07 | Sulfamerazine | ||||
| J01ED08 | Sulfaphenazole | ||||
| J01ED09 | Sulfamazon | ||||
| J01ED20 | Combinations | ||||
| J01EE | Combinations of sulfonamides and trimethoprim, including derivatives | ||||
| J01EE01 | Sulfamethoxazole and trimethoprim | ||||
| J01EE02 | Sulfadiazine and trimethoprim | ||||
| J01EE03 | Sulfametrole and trimethoprim | ||||
| J01EE04 | Sulfamoxole and trimethoprim | ||||
| J01EE05 | Sulfadimidine and trimethoprim | ||||
| J01EE06 | Sulfadiazine and tetroxoprim | ||||
| J01EE07 | Sulfamerazine and trimethoprim | ||||
| J01F | Macrolides, lincosamides and streptogramins | ||||
| J01FA | Macrolides | ||||
| J01FA01 | Erythromycin | ||||
| J01FA02 | Spiramycin | ||||
| J01FA03 | Midecamycin | ||||
| J01FA05 | Oleandomycin | ||||
| J01FA06 | Roxithromycin | ||||
| J01FA07 | Josamycin | ||||
| J01FA08 | Troleandomycin | ||||
| J01FA09 | Clarithromycin | ||||
| J01FA10 | Azithromycin | ||||
| J01FA11 | Miocamycin | ||||
| J01FA12 | Rokitamycin | ||||
| J01FA13 | Dirithromycin | ||||
| J01FA14 | Flurithromycin | ||||
| J01FA15 | Telithromycin | ||||
| J01FA16 | solithromycin | ||||
| J01FA17 | Telithromycin | ||||
| J01FF | nafithromycin | ||||
| J01FF01 | Clindamycin | ||||
| J01FF02 | Lincomycin | ||||
| J01FG | Streptogramins | ||||
| J01FG01 | Pristinamycin | ||||
| J01FG02 | Quinupristin/dalfopristin | ||||
| J01G | Aminoglycoside antibacterials | ||||
| J01GA | Streptomycins | ||||
| J01GA01 | Streptomycin | ||||
| J01GA02 | Streptoduocin | ||||
| J01GB | Other aminoglycosides | ||||
| J01GB01 | Tobramycin | ||||
| J01GB03 | Gentamicin | ||||
| J01GB04 | Kanamycin | ||||
| J01GB05 | Neomycin | ||||
| J01GB06 | Amikacin | ||||
| J01GB07 | Netilmicin | ||||
| J01GB08 | Sisomicin | ||||
| J01GB09 | Dibekacin | ||||
| J01GB10 | Ribostamycin | ||||
| J01GB11 | Isepamicin | ||||
| J01GB12 | Arbekacin | ||||
| J01GB13 | Bekanamycin | ||||
| J01M | Quinolone antibacterials | ||||
| J01MA | Fluoroquinolones | ||||
| J01MA01 | Ofloxacin | ||||
| J01MA02 | Ciprofloxacin | ||||
| J01MA03 | Pefloxacin | ||||
| J01MA04 | Enoxacin | ||||
| J01MA05 | Temafloxacin | ||||
| J01MA06 | Norfloxacin | ||||
| J01MA07 | Lomefloxacin | ||||
| J01MA08 | Fleroxacin | ||||
| J01MA09 | Sparfloxacin | ||||
| J01MA10 | Rufloxacin | ||||
| J01MA11 | Grepafloxacin | ||||
| J01MA12 | Levofloxacin | ||||
| J01MA13 | Trovafloxacin | ||||
| J01MA14 | Moxifloxacin | ||||
| J01MA15 | Gemifloxacin | ||||
| J01MA16 | Gatifloxacin | ||||
| J01MA17 | Prulifloxacin | ||||
| J01MA18 | Pazufloxacin | ||||
| J01MA19 | Garenoxacin | ||||
| J01MA21 | Sitafloxacin | ||||
| J01MB | Other quinolones | ||||
| J01MB01 | Rosoxacin | ||||
| J01MB02 | Nalidixic acid | ||||
| J01MB03 | Piromidic acid | ||||
| J01MB04 | Pipemidic acid | ||||
| J01MB05 | Oxolinic acid | ||||
| J01MB06 | Cinoxacin | ||||
| J01MB07 | Flumequine | ||||
| J01R | Combinations of antibacterials | ||||
| J01RA | Combinations of antbacterials | ||||
| J01RA01 | Penicillins, combinations with other antibacterials | ||||
| J01RA02 | Sulfonamides, combinations with other antibacterials (excluding trimethoprim) | ||||
| J01RA03 | cefuroxime and metronidazole | ||||
| J01RA04 | spiramycin and metronidazole | ||||
| J01RA05 | levofloxacin and ornidazole | ||||
| J01RA06 | cefepime and amikacin | ||||
| J01RA07 | azithromycin, fluconazole and secnidazole | ||||
| J01RA08 | tetracycline and oleandomycin | ||||
| J01RA09 | ofloxacin and ornidazole | ||||
| J01RA10 | ciprofloxacin and metronidazole | ||||
| J01RA11 | ciprofloxacin and tinidazole | ||||
| J01RA12 | ciprofloxacin and ornidazole | ||||
| J01RA13 | norfloxacin and tinidazole | ||||
| J01RA14 | norfloxacin and metronidazole | ||||
| J01RA15 | cefixime and ornidazole | ||||
| J01RA16 | cefixime and azithromycin | ||||
| J01RA17 | ofloxacin and nitazoxanide | ||||
| J01RA18 | ofloxacin and tinidazole | ||||
| J01RA19 | tetracycline and nystatin | ||||
| J01X | Other antibacterials | ||||
| J01XA | Glycopeptide antibacterials | ||||
| J01XA01 | Vancomycin | ||||
| J01XA02 | Teicoplanin | ||||
| J01XA03 | Telavancin | ||||
| J01XA04 | Dalbavancin | ||||
| J01XA05 | Oritavancin | ||||
| J01XB | Polymyxins | ||||
| J01XB01 | Colistin | ||||
| J01XB02 | Polymyxin B | ||||
| J01XC | Steroid antibacterials | ||||
| J01XC01 | Fusidic acid | ||||
| J01XD | Imidazole derivatives | ||||
| J01XD01 | Metronidazole | ||||
| J01XD02 | Tinidazole | ||||
| J01XD03 | Ornidazole | ||||
| J01XE | Nitrofuran derivatives | ||||
| J01XE01 | Nitrofurantoin | ||||
| J01XE02 | Nifurtoinol | ||||
| J01XE03 | furazidin | ||||
| J01XE51 | nitrofurantoin, combinations | ||||
| J01XX | Other antibacterials | ||||
| J01XX01 | Fosfomycin | ||||
| J01XX02 | Xibornol | ||||
| J01XX03 | Clofoctol | ||||
| J01XX04 | Spectinomycin | ||||
| J01XX05 | Methenamine | ||||
| J01XX06 | Mandelic acid | ||||
| J01XX07 | Nitroxoline | ||||
| J01XX08 | Linezolid | ||||
| J01XX09 | Daptomycin | ||||
| J01XX10 | Bacitracin | ||||
| J01XX11 | tedizolid | ||||
| J01XX12 | lefamulin | ||||
| J01XX13 | gepotidacin | ||||
| J02 | Antimycotics for systemic use | ||||
| J02A | Antimycotics for systemic use | ||||
| J02AA | Antibiotics | ||||
| J02AA01 | Amphotericin B | ||||
| J02AA02 | Hachimycin | ||||
| J02AB | Imidazole derivatives | ||||
| J02AB01 | Miconazole | ||||
| J02AB02 | Ketoconazole | ||||
| J02AC | Triazole derivatives | ||||
| J02AC01 | Fluconazole | ||||
| J02AC02 | Itraconazole | ||||
| J02AC03 | Voriconazole | ||||
| J02AC04 | Posaconazole | ||||
| J02AX | Other antimycotics for systemic use | ||||
| J02AX01 | Flucytosine | ||||
| J02AX04 | Caspofungin | ||||
| J02AX05 | Micafungin | ||||
| J02AX06 | Anidulafungin | ||||
| J04 | Antimycobacterials | ||||
| J04A | Drugs for treatment of tuberculosis | ||||
| J04AA | Aminosalicylic acid and derivatives | ||||
| J04AA01 | Aminosalicylic acid | ||||
| J04AA02 | Sodium aminosalicylate | ||||
| J04AA03 | Calcium aminosalicylate | ||||
| J04AB | Antibiotics | ||||
| J04AB01 | Cycloserine | ||||
| J04AB02 | Rifampicin | ||||
| J04AB03 | Rifamycin | ||||
| J04AB04 | Rifabutin | ||||
| J04AB05 | Rifapentin | ||||
| J04AB30 | Capreomycin | ||||
| J04AC | Hydrazides | ||||
| J04AC01 | Isoniazid | ||||
| J04AC02 | ftivazide | ||||
| J04AC51 | Isoniazid, combinations | ||||
| J04AD | Thiocarbamide derivatives | ||||
| J04AD01 | Protionamide | ||||
| J04AD02 | Tiocarlide | ||||
| J04AD03 | Ethionamide | ||||
| J04AK | Other drugs for treatment of tuberculosis | ||||
| J04AK01 | Pyrazinamide | ||||
| J04AK02 | Ethambutol | ||||
| J04AK03 | Terizidone | ||||
| J04AK04 | Morinamide | ||||
| J04AM | Combinations of drugs for treatment of tuberculosis | ||||
| J04AM01 | Streptomycin and isoniazid | ||||
| J04AM02 | Rifampicin and isoniazid | ||||
| J04AM03 | Ethambutol and isoniazid | ||||
| J04AM04 | Thioacetazone and isoniazid | ||||
| J04AM05 | Rifampicin, pyrazinamide and isoniazid | ||||
| J04AM06 | Rifampicin, pyrazinamide, ethambutol and isoniazid | ||||
| J04AM07 | rifampicin, ethambutol and isoniazid | ||||
| J04AM08 | isoniazid, sulfamethoxazole and trimethoprim | ||||
| J04AM09 | pyrazinamide, ethambutol, isoniazid and lomefloxacin | ||||
| J04AM10 | pyrazinamide, ethambutol, protionamide and lomefloxacin | ||||
| J04AM11 | rifabutin, pyrazinamide and protionamide | ||||
| J04AM12 | rifampicin, pyrazinamide, isoniazid and levofloxacin | ||||
| J04B | Drugs for treatment of lepra | ||||
| J04BA | Drugs for treatment of lepra | ||||
| J04BA01 | Clofazimine | ||||
| J04BA02 | Dapsone | ||||
| J04BA03 | Aldesulfone sodium | ||||
| J05 | Antivirals for systemic use | ||||
| J05A | Direct acting antiviral drugs | ||||
| J05AA | Thiosemicarbazones | ||||
| J05AA01 | Metisazone | ||||
| J05AB | Nucleosides and nucleotides excluding reverse transcriptase inhibitors | ||||
| J05AB01 | Aciclovir | ||||
| J05AB02 | Idoxuridine | ||||
| J05AB03 | Vidarabine | ||||
| J05AB04 | Ribavirin (New ATC code J05AP01) | ||||
| J05AB06 | Ganciclovir | ||||
| J05AB09 | Famciclovir | ||||
| J05AB11 | Valaciclovir | ||||
| J05AB12 | Cidofovir | ||||
| J05AB13 | Penciclovir | ||||
| J05AB14 | Valganciclovir | ||||
| J05AB15 | Brivudine | ||||
| J05AB16 | remdesivir | ||||
| J05AB17 | brincidofovir | ||||
| J05AB54 | Ribavirin, combinations (New ATC code L03AB60) | ||||
| J05AC | Cyclic amines | ||||
| J05AC02 | Rimantadine | ||||
| J05AC03 | Tromantadine | ||||
| J05AD | Phosphonic acid derivatives | ||||
| J05AD01 | Foscarnet | ||||
| J05AD02 | Fosfonet | ||||
| J05AE | Protease inhibitors | ||||
| J05AE01 | Saquinavir | ||||
| J05AE02 | Indinavir | ||||
| J05AE03 | Ritonavir | ||||
| J05AE04 | Nelfinavir | ||||
| J05AE05 | Amprenavir | ||||
| J05AE06 | lopinavir and ritonavir (New ATC code J05AR10) | ||||
| J05AE07 | Fosamprenavir | ||||
| J05AE08 | Atazanavir | ||||
| J05AE09 | Tipranavir | ||||
| J05AE10 | Darunavir | ||||
| J05AE11 | Telaprevir (New ATC code J05AP02) | ||||
| J05AE12 | Boceprevir (New ATC code J05AP03) | ||||
| J05AE13 | faldaprevir (New ATC code J05AP04) | ||||
| J05AE14 | simeprevir (New ATC code J05AP05) | ||||
| J05AE15 | asunaprevir (New ATC code J05AP06) | ||||
| J05AE16 | ensitrelvir | ||||
| J05AE30 | nirmatrelvir and ritonavir | ||||
| J05AF | Nucleoside and nucleotide reverse transcriptase inhibitors | ||||
| J05AF01 | Zidovudine | ||||
| J05AF02 | Didanosine | ||||
| J05AF03 | Zalcitabine | ||||
| J05AF04 | Stavudine | ||||
| J05AF05 | Lamivudine | ||||
| J05AF06 | Abacavir | ||||
| J05AF07 | Tenofovir disoproxil | ||||
| J05AF08 | Adefovir dipivoxil | ||||
| J05AF09 | Emtricitabine | ||||
| J05AF10 | Entecavir | ||||
| J05AF11 | Telbivudine | ||||
| J05AF12 | Clevudine | ||||
| J05AF13 | tenofovir alafenamide | ||||
| J05AG | Non-nucleoside reverse transcriptase inhibitors | ||||
| J05AG01 | Nevirapine | ||||
| J05AG02 | Delavirdine | ||||
| J05AG03 | Efavirenz | ||||
| J05AG04 | Etravirine | ||||
| J05AG05 | Rilpivirine | ||||
| J05AG06 | doravirine | ||||
| J05AG07 | elsulfavirine | ||||
| J05AH | Neuraminidase inhibitors | ||||
| J05AH01 | Zanamivir | ||||
| J05AH02 | Oseltamivir | ||||
| J05AJ | Integrase inhibitors | ||||
| J05AJ01 | raltegravir | ||||
| J05AJ02 | elvitegravir | ||||
| J05AJ03 | dolutegravir | ||||
| J05AJ04 | cabotegravir | ||||
| J05AP | Antivirals for treatment of HCV infections | ||||
| J05AP01 | ribavirin | ||||
| J05AP02 | telaprevir | ||||
| J05AP03 | boceprevir | ||||
| J05AP04 | faldaprevir | ||||
| J05AP05 | simeprevir | ||||
| J05AP06 | asunaprevir | ||||
| J05AP07 | daclatasvir | ||||
| J05AP08 | sofosbuvir | ||||
| J05AP09 | dasabuvir | ||||
| J05AP10 | elbasvir | ||||
| J05AP11 | grazoprevir | ||||
| J05AP12 | coblopasvir | ||||
| J05AP13 | ravidasvir | ||||
| J05AP14 | narlaprevir | ||||
| J05AP51 | sofosbuvir and ledipasvir | ||||
| J05AP52 | dasabuvir, ombitasvir, paritaprevir and ritonavir | ||||
| J05AP53 | ombitasvir, paritaprevir and ritonavir | ||||
| J05AP54 | elbasvir and grazoprevir | ||||
| J05AP55 | sofosbuvir and velpatasvir | ||||
| J05AP56 | sofosbuvir, velpatasvir and voxilaprevir | ||||
| J05AP57 | glecaprevir and pibrentasvir | ||||
| J05AP58 | daclatasvir, asunaprevir and beclabuvir | ||||
| J05AR | Antivirals for treatment of HIV infections, combinations | ||||
| J05AR01 | Zidovudine and lamivudine | ||||
| J05AR02 | Lamivudine and abacavir | ||||
| J05AR03 | Tenofovir disoproxil and emtricitabine | ||||
| J05AR04 | Zidovudine, lamivudine and abacavir | ||||
| J05AR05 | Zidovudine, lamivudine and nevirapine | ||||
| J05AR06 | Emtricitabine, tenofovir disoproxil and efavirenz | ||||
| J05AR07 | Stavudine, lamivudine and nevirapine | ||||
| J05AR08 | Emtricitabine, tenofovir disoproxil and rilpivirine | ||||
| J05AR09 | Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat | ||||
| J05AR10 | Lopinavir and ritonavir | ||||
| J05AR11 | lamivudine, tenofovir disoproxil and efavirenz | ||||
| J05AR12 | lamivudine and tenofovir disoproxil | ||||
| J05AR13 | lamivudine, abacavir and dolutegravir | ||||
| J05AR14 | darunavir and cobicistat | ||||
| J05AR15 | atazanavir and cobicistat | ||||
| J05AR16 | lamivudine and raltegravir | ||||
| J05AR17 | emtricitabine and tenofovir alafenamide | ||||
| J05AR18 | emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat | ||||
| J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine | ||||
| J05AR20 | emtricitabine, tenofovir alafenamide and bictegravir | ||||
| J05AR21 | dolutegravir and rilpivirine | ||||
| J05AR22 | emtricitabine, tenofovir alafenamide, darunavir and cobicistat | ||||
| J05AR23 | atazanavir and ritonavir | ||||
| J05AR24 | lamivudine, tenofovir disoproxil and doravirine | ||||
| J05AR25 | lamivudine and dolutegravir | ||||
| J05AR26 | darunavir and ritonavir | ||||
| J05AR27 | lamivudine, tenofovir disoproxil and dolutegravir | ||||
| J05AR28 | stavudine and lamivudine | ||||
| J05AR29 | emtricitabine, tenofovir alafenamide and dolutegravir | ||||
| J05AX | Other antivirals | ||||
| J05AX01 | Moroxydine | ||||
| J05AX02 | Lysozyme | ||||
| J05AX05 | Inosine pranobex | ||||
| J05AX06 | Pleconaril | ||||
| J05AX07 | Enfuvirtide | ||||
| J05AX08 | Raltegravir (New ATC code J05AJ01) | ||||
| J05AX09 | Maraviroc | ||||
| J05AX10 | Maribavir | ||||
| J05AX11 | Elvitegravir (New ATC code J05AJ02) | ||||
| J05AX12 | dolutegravir (New ATC code J05AJ03) | ||||
| J05AX13 | umifenovir | ||||
| J05AX14 | daclatasvir (New ATC code J05AP07) | ||||
| J05AX15 | sofosbuvir (New ATC code J05AP08) | ||||
| J05AX16 | dasabuvir (New ATC code J05AP09) | ||||
| J05AX17 | enisamium iodide | ||||
| J05AX18 | letermovir | ||||
| J05AX19 | tilorone | ||||
| J05AX21 | pentanedioic acid imidazolyl ethanamide | ||||
| J05AX23 | ibalizumab | ||||
| J05AX24 | tecovirimat | ||||
| J05AX25 | baloxavir marboxil | ||||
| J05AX26 | amenamevir | ||||
| J05AX27 | favipiravir | ||||
| J05AX28 | bulevirtide | ||||
| J05AX29 | fostemsavir | ||||
| J05AX31 | lenacapavir | ||||
| J05AX32 | riamilovir | ||||
| J05AX33 | labuvirtide | ||||
| J05AX65 | sofosbuvir and ledipasvir (New ATC code J05AP51) | ||||
| J05AX66 | dasabuvir, ombitasvir, paritaprevir and ritonavir (New ATC code J05AP52) | ||||
| J05AX67 | ombitasvir, paritaprevir and ritonavir (New ATC code J05AP53) | ||||
| J05AX68 | elbasvir and grazoprevir (New ATC code J05AP54) | ||||
| J05AX69 | sofosbuvir and velpatasvir (New ATC code J05AP55) | ||||
| J06 | Immune sera and immunoglobulins | ||||
| J06A | Immune sera | ||||
| J06AA | Immune sera | ||||
| J06AA01 | Diphtheria antitoxin | ||||
| J06AA02 | Tetanus antitoxin | ||||
| J06AA03 | Snake venom antiserum | ||||
| J06AA04 | Botulinum antitoxin | ||||
| J06AA05 | Gas-gangrene sera | ||||
| J06AA06 | Rabies serum | ||||
| J06B | Immunoglobulins | ||||
| J06BA | Immunoglobulins, normal human | ||||
| J06BA01 | Immunoglobulins, normal human, for extravascular administration | ||||
| J06BA02 | Immunoglobulins, normal human, for intravascular administration | ||||
| J06BB | Specific immunoglobulins | ||||
| J06BB01 | Anti-D (rh) immunoglobulin | ||||
| J06BB02 | Tetanus immunoglobulin | ||||
| J06BB03 | Varicella/zoster immunoglobulin | ||||
| J06BB04 | Hepatitis B immunoglobulin | ||||
| J06BB05 | Rabies immunoglobulin | ||||
| J06BB06 | Rubella immunoglobulin | ||||
| J06BB07 | Vaccinia immunoglobulin | ||||
| J06BB08 | Staphylococcus immunoglobulin | ||||
| J06BB09 | Cytomegalovirus immunoglobulin | ||||
| J06BB10 | Diphtheria immunoglobulin | ||||
| J06BB11 | Hepatitis A immunoglobulin | ||||
| J06BB12 | Encephalitis, tick borne immunoglobulin | ||||
| J06BB13 | Pertussis immunoglobulin | ||||
| J06BB14 | Morbilli immunoglobulin | ||||
| J06BB15 | Parotitis immunoglobulin | ||||
| J06BB16 | Palivizumab (New ATC code J06BD01) | ||||
| J06BB17 | Motavizumab (New ATC code J06BD02) | ||||
| J06BB18 | raxibacumab (New ATC code J06BC02) | ||||
| J06BB21 | bezlotoxumab (New ATC code J06BC03) | ||||
| J06BB22 | obiltoxaximab (New ATC code J06BC04) | ||||
| J06BB30 | Combinations | ||||
| J06BC | Antibacterial monoclonal antibodies | ||||
| J06BC01 | Nebacumab | ||||
| J06BC02 | raxibacumab | ||||
| J06BC03 | bezlotoxumab | ||||
| J06BC04 | obiltoxaximab | ||||
| J06BD | Antiviral monoclonal antibodies | ||||
| J06BD01 | palivizumab | ||||
| J06BD02 | motavizumab | ||||
| J06BD03 | tixagevimab and cilgavimab | ||||
| J06BD04 | ansuvimab | ||||
| J06BD05 | sotrovimab | ||||
| J06BD06 | regdanvimab | ||||
| J06BD07 | casirivimab and imdevimab | ||||
| J06BD08 | nirsevimab | ||||
| J06BD09 | sipavibart | ||||
| J06BD10 | clesrovimab | ||||
| J06BD11 | libevitug | ||||
| J07 | Vaccines | ||||
| J07A | Bacterial vaccines | ||||
| J07AC | Anthrax vaccines | ||||
| J07AC01 | Anthrax antigen | ||||
| J07AD | Brucellosis vaccines | ||||
| J07AD01 | Brucella antigen | ||||
| J07AE | Cholera vaccines | ||||
| J07AE01 | Cholera, inactivated, whole cell | ||||
| J07AE02 | Cholera, live attenuated | ||||
| J07AE51 | Cholera, combinations with typhoid vaccine, inactivated, whole cell | ||||
| J07AF | Diphtheria vaccines | ||||
| J07AF01 | Diphtheria toxoid | ||||
| J07AG | Haemophilus influenzae B vaccines | ||||
| J07AG01 | Hemophilus influenzae B, purified antigen conjugated | ||||
| J07AG51 | Hemophilus influenzae B, combinations with toxoids | ||||
| J07AG52 | Hemophilus influenzae B, combinations with pertussis and toxoids | ||||
| J07AG53 | Hemophilus influenzae B, combinations with meningococcus C, conjugated | ||||
| J07AH | Meningococcal vaccines | ||||
| J07AH01 | Meningococcus A, purified polysaccharides antigen | ||||
| J07AH02 | Other meningococcal monovalent purified polysaccharides antigen | ||||
| J07AH03 | Meningococcus A, C, bivalent purified polysaccharides antigen | ||||
| J07AH04 | Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen | ||||
| J07AH05 | Other meningococcal polyvalent purified polysaccharides antigen | ||||
| J07AH06 | Meningococcus B, outer membrane vesicle vaccine | ||||
| J07AH07 | Meningococcus C, purified polysaccharides antigen conjugated | ||||
| J07AH08 | Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated | ||||
| J07AH09 | Meningococcus B, multicomponent vaccine | ||||
| J07AH10 | Meningococcus A, purified polysaccharides antigen conjugated | ||||
| J07AH11 | meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein | ||||
| J07AJ | Pertussis vaccines | ||||
| J07AJ01 | Pertussis, inactivated, whole cell | ||||
| J07AJ02 | Pertussis, purified antigen | ||||
| J07AJ51 | Pertussis, inactivated, whole cell, combinations with toxoids | ||||
| J07AJ52 | Pertussis, purified antigen, combinations with toxoids | ||||
| J07AK | Plague vaccines | ||||
| J07AK01 | Plague, inactivated, whole cell | ||||
| J07AL | Pneumococcal vaccines | ||||
| J07AL01 | Pneumococcus, purified polysaccharides antigen | ||||
| J07AL02 | Pneumococcus, purified polysaccharides antigen conjugated | ||||
| J07AL52 | Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated | ||||
| J07AM | Tetanus vaccines | ||||
| J07AM01 | Tetanus toxoid | ||||
| J07AM51 | Tetanus toxoid, combinations with diphtheria toxoid | ||||
| J07AM52 | Tetanus toxoid, combinations with tetanus immunoglobulin | ||||
| J07AN | Tuberculosis vaccines | ||||
| J07AN01 | Tuberculosis, live attenuated | ||||
| J07AP | Typhoid vaccines | ||||
| J07AP01 | Typhoid, oral, live attenuated | ||||
| J07AP02 | Typhoid, inactivated, whole cell | ||||
| J07AP03 | Typhoid, purified polysaccharide antigen | ||||
| J07AP10 | Typhoid, combinations with paratyphi types | ||||
| J07AR | Typhus (exanthematicus) vaccines | ||||
| J07AR01 | Typhus exanthematicus, inactivated, whole cell | ||||
| J07AX | Other bacterial vaccines | ||||
| empty | |||||
| J07B | Viral vaccines | ||||
| J07BA | Encephalitis vaccines | ||||
| J07BA01 | Encephalitis, tick borne, inactivated, whole virus | ||||
| J07BA02 | Encephalitis, Japanese, inactivated, whole virus | ||||
| J07BA03 | encephalitis, Japanese, live attenuated | ||||
| J07BB | Influenza vaccines | ||||
| J07BB01 | Influenza, inactivated, whole virus | ||||
| J07BB02 | Influenza, purified antigen | ||||
| J07BB03 | Influenza, live attenuated | ||||
| J07BB04 | influenza, virus like particles | ||||
| J07BB05 | influenza, RNA-based vaccine | ||||
| J07BB55 | influenza and covid-19, RNA-based vaccine | ||||
| J07BC | Hepatitis vaccines | ||||
| J07BC01 | Hepatitis B, purified antigen | ||||
| J07BC02 | Hepatitis A, inactivated, whole virus | ||||
| J07BC20 | Combinations | ||||
| J07BD | Measles vaccines | ||||
| J07BD01 | Measles, live attenuated | ||||
| J07BD51 | Measles, combinations with mumps, live attenuated | ||||
| J07BD52 | Measles, combinations with mumps and rubella, live attenuated | ||||
| J07BD53 | Measles, combinations with rubella, live attenuated | ||||
| J07BD54 | Measles, combinations with mumps, rubella and varicella, live attenuated | ||||
| J07BE | Mumps vaccines | ||||
| J07BE01 | Mumps, live attenuated | ||||
| J07BF | Poliomyelitis vaccines | ||||
| J07BF01 | Poliomyelitis oral, monovalent live attenuated | ||||
| J07BF02 | Poliomyelitis oral, trivalent, live attenuated | ||||
| J07BF03 | Poliomyelitis, trivalent, inactivated, whole virus | ||||
| J07BF04 | Poliomyelitis oral, bivalent, live attenuated | ||||
| J07BG | Rabies vaccines | ||||
| J07BG01 | Rabies, inactivated, whole virus | ||||
| J07BH | Rotavirus diarrhea vaccines | ||||
| J07BH01 | Rota virus, live attenuated | ||||
| J07BH02 | Rota virus, pentavalent, live, reassorted | ||||
| J07BJ | Rubella vaccines | ||||
| J07BJ01 | Rubella, live attenuated | ||||
| J07BJ51 | Rubella, combinations with mumps, live attenuated | ||||
| J07BK | Varicella zoster vaccines | ||||
| J07BK01 | Varicella, live attenuated | ||||
| J07BK02 | Zoster, live attenuated | ||||
| J07BK03 | zoster, purified antigen | ||||
| J07BL | Yellow fever vaccines | ||||
| J07BL01 | Yellow fever, live attenuated | ||||
| J07BM | Papillomavirus vaccines | ||||
| J07BM01 | Papillomavirus (human types 6, 11, 16, 18) (Gardasil) | ||||
| J07BM02 | Papillomavirus (human types 16, 18) (Cervarix) | ||||
| J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) | ||||
| J07BN | Covid-19 vaccines | ||||
| J07BN01 | covid-19, RNA-based vaccine | ||||
| J07BN02 | covid-19, viral vector, non-replicating | ||||
| J07BN03 | covid-19, inactivated virus | ||||
| J07BN04 | covid-19, protein subunit | ||||
| J07BN05 | covid-19, virus-like particles | ||||
| J07BP | Chikungunya vaccines | ||||
| J07BP01 | chikungunya, live attenuated | ||||
| J07BP02 | chikungunya, virus-like particles | ||||
| J07BX | Other viral vaccines | ||||
| J07BX01 | smallpox and monkeypox vaccines | ||||
| J07BX02 | ebola vaccines | ||||
| J07BX03 | covid-19 vaccines (deleted) | ||||
| J07BX04 | dengue virus vaccines | ||||
| J07BX05 | respiratory syncytial virus vaccines | ||||
| J07BX06 | enterovirus 71 vaccines | ||||
| J07C | Bacterial and viral vaccines | ||||
| J07CA | Bacterial and viral vaccines, combined | ||||
| J07CA01 | Diphtheria-poliomyelitis-tetanus | ||||
| J07CA02 | Diphtheria-pertussis-poliomyelitis-tetanus | ||||
| J07CA03 | Diphtheria-rubella-tetanus | ||||
| J07CA04 | Hemophilus influenzae B and poliomyelitis | ||||
| J07CA05 | Diphtheria-hepatitis B-pertussis-tetanus | ||||
| J07CA06 | Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus | ||||
| J07CA07 | Diphtheria-hepatitis B-tetanus | ||||
| J07CA08 | Hemophilus influenzae B and hepatitis B | ||||
| J07CA09 | Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | ||||
| J07CA10 | Typhoid-hepatitis A | ||||
| J07CA11 | Diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B | ||||
| J07CA12 | Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B | ||||
| J07CA13 | Diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C | ||||
| J07X | Other vaccines | ||||
| empty | |||||
| âL | Antineoplastic and immunomodulating agents | ||||
| L01 | Antineoplastic agents | ||||
| L01A | Alkylating agents | ||||
| L01AA | Nitrogen mustard analogues | ||||
| L01AA01 | Cyclophosphamide | ||||
| L01AA02 | Chlorambucil | ||||
| L01AA03 | Melphalan | ||||
| L01AA05 | Chlormethine | ||||
| L01AA06 | Ifosfamide | ||||
| L01AA07 | Trofosfamide | ||||
| L01AA08 | Prednimustine | ||||
| L01AA09 | Bendamustine | ||||
| L01AB | Alkyl sulfonates | ||||
| L01AB01 | Busulfan | ||||
| L01AB02 | Treosulfan | ||||
| L01AB03 | Mannosulfan | ||||
| L01AC | Ethylene imines | ||||
| L01AC01 | Thiotepa | ||||
| L01AC02 | Triaziquone | ||||
| L01AC03 | Carboquone | ||||
| L01AD | Nitrosoureas | ||||
| L01AD01 | Carmustine | ||||
| L01AD02 | Lomustine | ||||
| L01AD03 | Semustine | ||||
| L01AD04 | Streptozocin | ||||
| L01AD05 | Fotemustine | ||||
| L01AD06 | Nimustine | ||||
| L01AD07 | Ranimustine | ||||
| L01AG | Epoxides | ||||
| L01AG01 | Etoglucid | ||||
| L01AX | Other alkylating agents | ||||
| L01AX01 | Mitobronitol | ||||
| L01AX02 | Pipobroman | ||||
| L01AX03 | Temozolomide | ||||
| L01AX04 | Dacarbazine | ||||
| L01B | Antimetabolites | ||||
| L01BA | Folic acid analogues | ||||
| L01BA01 | Methotrexate (New ATC code L04AX03) | ||||
| L01BA03 | Raltitrexed | ||||
| L01BA04 | Pemetrexed | ||||
| L01BA05 | Pralatrexate | ||||
| L01BB | Purine analogues | ||||
| L01BB02 | Mercaptopurine | ||||
| L01BB03 | Tioguanine | ||||
| L01BB04 | Cladribine | ||||
| L01BB05 | Fludarabine | ||||
| L01BB06 | Clofarabine | ||||
| L01BB07 | Nelarabine | ||||
| L01BC | Pyrimidine analogues | ||||
| L01BC01 | Cytarabine | ||||
| L01BC02 | Fluorouracil | ||||
| L01BC03 | Tegafur | ||||
| L01BC04 | Carmofur | ||||
| L01BC05 | Gemcitabine | ||||
| L01BC06 | Capecitabine | ||||
| L01BC07 | Azacitidine | ||||
| L01BC08 | Decitabine | ||||
| L01BC09 | floxuridine | ||||
| L01BC52 | Fluorouracil, combinations | ||||
| L01BC53 | Tegafur, combinations | ||||
| L01BC58 | decitabine, combinations | ||||
| L01BC59 | trifluridine, combinations | ||||
| L01C | Plant alkaloids and other natural products | ||||
| L01CA | Vinca alkaloids and analogues | ||||
| L01CA01 | Vinblastine | ||||
| L01CA02 | Vincristine | ||||
| L01CA03 | Vindesine | ||||
| L01CA04 | Vinorelbine | ||||
| L01CA05 | Vinflunine | ||||
| L01CB | Podophyllotoxin derivatives | ||||
| L01CB01 | Etoposide | ||||
| L01CB02 | Teniposide | ||||
| L01CC | Colchicine derivatives | ||||
| L01CC01 | Demecolcine | ||||
| L01CD | Taxanes | ||||
| L01CD01 | Paclitaxel | ||||
| L01CD02 | Docetaxel | ||||
| L01CD03 | Paclitaxel poliglumex | ||||
| L01CD04 | Cabazitaxel | ||||
| L01CE | Topoisomerase 1 (TOP1) inhibitors | ||||
| L01CE01 | topotecan | ||||
| L01CE02 | irinotecan | ||||
| L01CE03 | etirinotecan pegol | ||||
| L01CE04 | belotecan | ||||
| L01CX | Other plant alkaloids and natural products | ||||
| L01CX01 | Trabectedin | ||||
| L01D | Cytotoxic antibiotics and related substances | ||||
| L01DA | Actinomycines | ||||
| L01DA01 | Dactinomycin | ||||
| L01DB | Anthracyclines and related substances | ||||
| L01DB01 | Doxorubicin | ||||
| L01DB02 | Daunorubicin | ||||
| L01DB03 | Epirubicin | ||||
| L01DB04 | Aclarubicin | ||||
| L01DB05 | Zorubicin | ||||
| L01DB06 | Idarubicin | ||||
| L01DB07 | Mitoxantrone | ||||
| L01DB08 | Pirarubicin | ||||
| L01DB09 | Valrubicin | ||||
| L01DB10 | Amrubicin | ||||
| L01DB11 | Pixantrone | ||||
| L01DC | Other cytotoxic antibiotics | ||||
| L01DC01 | Bleomycin | ||||
| L01DC02 | Plicamycin | ||||
| L01DC03 | Mitomycin | ||||
| L01DC04 | Ixabepilone | ||||
| L01DC05 | utidelone | ||||
| L01E | Protein kinase inhibitors | ||||
| L01EA | BCR-ABL tyrosine kinase inhibitors | ||||
| L01EA01 | imatinib | ||||
| L01EA02 | dasatinib | ||||
| L01EA03 | nilotinib | ||||
| L01EA04 | bosutinib | ||||
| L01EA05 | ponatinib | ||||
| L01EA06 | asciminib | ||||
| L01EB | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors | ||||
| L01EB01 | gefitinib | ||||
| L01EB02 | erlotinib | ||||
| L01EB03 | afatinib | ||||
| L01EB04 | osimertinib | ||||
| L01EB05 | rociletinib | ||||
| L01EB06 | olmutinib | ||||
| L01EB07 | dacomitinib | ||||
| L01EB08 | icotinib | ||||
| L01EB09 | lazertinib | ||||
| L01EB010 | mobocertinib | ||||
| L01EB011 | aumolertinib | ||||
| L01EB012 | firmonertinib | ||||
| L01EC | B-Raf serine-threonine kinase (BRAF) inhibitors | ||||
| L01EC01 | vemurafenib | ||||
| L01EC02 | dabrafenib | ||||
| L01EC03 | encorafenib | ||||
| L01EC04 | tovorafenib | ||||
| L01ED | Anaplastic lymphoma kinase (ALK) inhibitors | ||||
| L01ED01 | crizotinib | ||||
| L01ED02 | ceritinib | ||||
| L01ED03 | alectinib | ||||
| L01ED04 | brigatinib | ||||
| L01ED05 | lorlatinib | ||||
| L01EE | Mitogen-activated protein kinase (MEK) inhibitors | ||||
| L01EE01 | trametinib | ||||
| L01EE02 | cobimetinib | ||||
| L01EE03 | binimetinib | ||||
| L01EE04 | selumetinib | ||||
| L01EE05 | mirdametinib | ||||
| L01EE06 | tunlametinib | ||||
| L01EF | Cyclin-dependent kinase (CDK) inhibitors | ||||
| L01EF01 | palbociclib | ||||
| L01EF02 | ribociclib | ||||
| L01EF03 | abemaciclib | ||||
| L01EG | Mammalian target of rapamycin (mTOR) kinase inhibitors | ||||
| L01EG01 | temsirolimus | ||||
| L01EG02 | everolimus | ||||
| L01EG03 | ridaforolimus | ||||
| L01EH | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors | ||||
| L01EH01 | lapatinib | ||||
| L01EH02 | neratinib | ||||
| L01EH03 | tucatinib | ||||
| L01EH04 | zongertinib | ||||
| L01EH05 | mifanertinib | ||||
| L01EH06 | sevabertinib | ||||
| L01EJ | Janus-associated kinase (JAK) inhibitors | ||||
| L01EJ01 | ruxolitinib | ||||
| L01EJ02 | fedratinib | ||||
| L01EJ03 | pacritinib | ||||
| L01EJ04 | momelotinib | ||||
| L01EK | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors | ||||
| L01EK01 | axitinib | ||||
| L01EK02 | cediranib | ||||
| L01EK03 | tivozanib | ||||
| L01EK04 | fruquintinib | ||||
| L01EK05 | rivoceranib | ||||
| L01EL | Bruton's tyrosine kinase (BTK) inhibitors | ||||
| L01EL01 | ibrutinib | ||||
| L01EL02 | acalabrutinib | ||||
| L01EL03 | zanubrutinib | ||||
| L01EL04 | orelabrutinib | ||||
| L01EL05 | pirtobrutinib | ||||
| L01EL06 | tirabrutinib | ||||
| L01EM | Phosphatidylinositol-3-kinase (Pi3K) inhibitors | ||||
| L01EM01 | idelalisib | ||||
| L01EM02 | copanlisib | ||||
| L01EM03 | alpelisib | ||||
| L01EM04 | duvelisib | ||||
| L01EM05 | parsaclisib | ||||
| L01EM06 | inavolisib | ||||
| L01EN | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors | ||||
| L01EN01 | erdafitinib | ||||
| L01EN02 | pemigatinib | ||||
| L01EN03 | infigratinib | ||||
| L01EN04 | futibatinib | ||||
| L01EP | Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors | ||||
| L01EP03 | savolitinib | ||||
| L01EX | Other protein kinase inhibitors | ||||
| L01EX01 | sunitinib | ||||
| L01EX02 | sorafenib | ||||
| L01EX03 | pazopanib | ||||
| L01EX04 | vandetanib | ||||
| L01EX05 | regorafenib | ||||
| L01EX06 | masitinib | ||||
| L01EX07 | cabozantinib | ||||
| L01EX08 | lenvatinib | ||||
| L01EX09 | nintedanib | ||||
| L01EX10 | midostaurin | ||||
| L01EX11 | quizartinib | ||||
| L01EX12 | larotrectinib | ||||
| L01EX13 | gilteritinib | ||||
| L01EX14 | entrectinib | ||||
| L01EX15 | pexidartinib | ||||
| L01EX16 | erdafitinib (New ATC code L01EN01) | ||||
| L01EX17 | capmatinib | ||||
| L01EX18 | avapritinib | ||||
| L01EX19 | ripretinib | ||||
| L01EX20 | pemigatinib (New ATC code L01EN02) | ||||
| L01EX21 | tepotinib | ||||
| L01EX22 | selpercatinib | ||||
| L01EX23 | pralsetinib | ||||
| L01EX24 | surufatinib | ||||
| L01EX25 | umbralisib | ||||
| L01EX26 | sitravatinib | ||||
| L01EX27 | capivasertib | ||||
| L01EX28 | repotrectinib | ||||
| L01EX29 | vimseltinib | ||||
| L01F | Monoclonal antibodies and antibody drug conjugates | ||||
| L01FA | CD20 (Clusters of Differentiation 20) inhibitors | ||||
| L01FA01 | rituximab | ||||
| L01FA02 | ofatumumab | ||||
| L01FA03 | obinutuzumab | ||||
| L01FB | CD22 (Clusters of Differentiation 22) inhibitors | ||||
| L01FB01 | inotuzumab ozogamicin | ||||
| L01FB02 | moxetumomab pasudotox | ||||
| L01FC | CD38 (Clusters of Differentiation 38) inhibitors | ||||
| L01FC01 | daratumumab | ||||
| L01FC02 | isatuximab | ||||
| L01FD | HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors | ||||
| L01FD01 | trastuzumab | ||||
| L01FD02 | pertuzumab | ||||
| L01FD03 | trastuzumab emtansine | ||||
| L01FD04 | trastuzumab deruxtecan | ||||
| L01FD05 | trastuzumab duocarmazine | ||||
| L01FD06 | margetuximab | ||||
| L01FD07 | zanidatamab | ||||
| L01FE | EGFR (Epidermal Growth Factor Receptor) inhibitors | ||||
| L01FE01 | cetuximab | ||||
| L01FE02 | panitumumab | ||||
| L01FE03 | necitumumab | ||||
| L01FF | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors | ||||
| L01FF01 | nivolumab | ||||
| L01FF02 | pembrolizumab | ||||
| L01FF03 | durvalumab | ||||
| L01FF04 | avelumab | ||||
| L01FF05 | atezolizumab | ||||
| L01FF06 | cemiplimab | ||||
| L01FF07 | dostarlimab | ||||
| L01FF08 | prolgolimab | ||||
| L01FF09 | tislelizumab | ||||
| L01FF10 | retifanlimab | ||||
| L01FF11 | sugemalimab | ||||
| L01FF12 | serplulimab | ||||
| L01FF13 | toripalimab | ||||
| L01FF14 | camrelizumab | ||||
| L01FF15 | envafolimab | ||||
| L01FF16 | sasanlimab | ||||
| L01FG | VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors | ||||
| L01FG01 | bevacizumab | ||||
| L01FG02 | ramucirumab | ||||
| L01FX | Other monoclonal antibodies and antibody drug conjugates | ||||
| L01FX01 | edrecolomab | ||||
| L01FX02 | gemtuzumab ozogamicin | ||||
| L01FX03 | catumaxomab | ||||
| L01FX04 | ipilimumab | ||||
| L01FX05 | brentuximab vedotin | ||||
| L01FX06 | dinutuximab beta | ||||
| L01FX07 | blinatumomab | ||||
| L01FX08 | elotuzumab | ||||
| L01FX09 | mogamulizumab | ||||
| L01FX10 | olaratumab | ||||
| L01FX11 | bermekimab | ||||
| L01FX12 | tafasitamab | ||||
| L01FX13 | enfortumab vedotin | ||||
| L01FX14 | polatuzumab vedotin | ||||
| L01FX15 | belantamab mafodotin | ||||
| L01FX16 | oportuzumab monatox | ||||
| L01FX17 | sacituzumab govitecan | ||||
| L01FX18 | amivantamab | ||||
| L01FX19 | sabatolimab | ||||
| L01FX20 | tremelimumab | ||||
| L01FX21 | naxitamab | ||||
| L01FX22 | loncastuximab tesirine | ||||
| L01FX23 | tisotumab vedotin | ||||
| L01FX24 | teclistamab | ||||
| L01FX25 | mosunetuzumab | ||||
| L01FX26 | mirvetuximab soravtansine | ||||
| L01FX27 | epcoritamab | ||||
| L01FX28 | glofitamab | ||||
| L01FX29 | talquetamab | ||||
| L01FX31 | zolbetuximab | ||||
| L01FX32 | elranatamab | ||||
| L01FX33 | tarlatamab | ||||
| L01FX34 | odronextamab | ||||
| L01FX35 | datopotamab deruxtecan | ||||
| L01FX36 | patritumab deruxtecan | ||||
| L01FX37 | linvoseltamab | ||||
| L01FX38 | ifinatamab deruxtecan | ||||
| L01FX39 | bemarituzumab | ||||
| L01FY | Combinations of monoclonal antibodies and antibody drug conjugates | ||||
| L01FY01 | pertuzumab and trastuzumab | ||||
| L01FY02 | nivolumab and relatlimab | ||||
| L01FY03 | prolgolimab and nurulimab | ||||
| L01X | Other antineoplastic agents | ||||
| L01XA | Platinum compounds | ||||
| L01XA01 | Cisplatin | ||||
| L01XA02 | Carboplatin | ||||
| L01XA03 | Oxaliplatin | ||||
| L01XA04 | Satraplatin | ||||
| L01XA05 | Polyplatillen | ||||
| L01XB | Methylhydrazines | ||||
| L01XB01 | Procarbazine | ||||
| L01XC | Monoclonal antibodies | ||||
| L01XC01 | Edrecolomab (New ATC code L01FX01) | ||||
| L01XC02 | Rituximab (New ATC code L01FA01) | ||||
| L01XC03 | Trastuzumab (New ATC code L01FD01) | ||||
| L01XC04 | Alemtuzumab (New ATC code L04AG06) | ||||
| L01XC05 | Gemtuzumab (New ATC code L01FX02) | ||||
| L01XC06 | Cetuximab (New ATC code L01FE01) | ||||
| L01XC07 | Bevacizumab (New ATC code L01FG01) | ||||
| L01XC08 | Panitumumab (New ATC code L01FE02) | ||||
| L01XC09 | Catumaxomab (New ATC code L01FX03) | ||||
| L01XC10 | Ofatumumab (New ATC code L01FA02) | ||||
| L01XC11 | Ipilimumab (New ATC code L01FX04) | ||||
| L01XC12 | Brentuximab vedotin (New ATC code L01FX05) | ||||
| L01XC13 | Pertuzumab (New ATC code L01FD02) | ||||
| L01XC14 | trastuzumab emtansine (New ATC code L01FD03) | ||||
| L01XC15 | obinutuzumab (New ATC code L01FA03) | ||||
| L01XC16 | dinutuximab beta (New ATC code L01FX06) | ||||
| L01XC17 | nivolumab (New ATC code L01FF01) | ||||
| L01XC18 | pembrolizumab (New ATC code L01FF02) | ||||
| L01XC19 | blinatumomab (New ATC code L01FX07) | ||||
| L01XC21 | ramucirumab (New ATC code L01FG02) | ||||
| L01XC22 | necitumumab (New ATC code L01FE03) | ||||
| L01XC23 | elotuzumab (New ATC code L01FX08) | ||||
| L01XC24 | daratumumab (New ATC code L01FC01) | ||||
| L01XC25 | mogamulizumab (New ATC code L01FX09) | ||||
| L01XC26 | inotuzumab ozogamicin (New ATC code L01FB01) | ||||
| L01XC27 | olaratumab (New ATC code L01FX10) | ||||
| L01XC28 | durvalumab (New ATC code L01FF03) | ||||
| L01XC29 | bermekimab (New ATC code L01FX11) | ||||
| L01XC31 | avelumab (New ATC code L01FF04) | ||||
| L01XC32 | atezolizumab (New ATC code L01FF05) | ||||
| L01XC33 | cemiplimab (New ATC code L01FF06) | ||||
| L01XC34 | moxetumomab pasudotox (New ATC code L01FB02) | ||||
| L01XC35 | tafasitamab (New ATC code L01FX12) | ||||
| L01XC36 | enfortumab vedotin (New ATC code L01FX13) | ||||
| L01XC37 | polatuzumab vedotin (New ATC code L01FX14) | ||||
| L01XC38 | isatuximab (New ATC code L01FC02) | ||||
| L01XC39 | belantamab mafodotin (New ATC code L01FX15) | ||||
| L01XC40 | dostarlimab (New ATC code L01FF07) | ||||
| L01XC41 | trastuzumab deruxtecan (New ATC code L01FD04) | ||||
| L01XD | Sensitizers used in photodynamic/radiation therapy | ||||
| L01XD01 | Porfimer sodium | ||||
| L01XD02 | verteporfin (New ATC code S01LA01) | ||||
| L01XD03 | Methyl aminolevulinate | ||||
| L01XD04 | Aminolevulinic acid | ||||
| L01XD05 | Temoporfin | ||||
| L01XD06 | Efaproxiral | ||||
| L01XD07 | padeliporfin | ||||
| L01XE | Protein kinase inhibitors (Deleted) | ||||
| L01XE01 | Imatinib (New ATC code L01EA01) | ||||
| L01XE02 | Gefitinib (New ATC code L01EB01) | ||||
| L01XE03 | Erlotinib (New ATC code L01EB02) | ||||
| L01XE04 | Sunitinib (New ATC code L01EX01) | ||||
| L01XE05 | Sorafenib (New ATC code L01EX02) | ||||
| L01XE06 | Dasatinib (New ATC code L01EA02) | ||||
| L01XE07 | Lapatinib (New ATC code L01EH01) | ||||
| L01XE08 | Nilotinib (New ATC code L01EA03) | ||||
| L01XE09 | Temsirolimus (New ATC code L01EG01) | ||||
| L01XE10 | Everolimus (New ATC code L04AH02) | ||||
| L01XE11 | Pazopanib (New ATC code L01EX03) | ||||
| L01XE12 | Vandetanib (New ATC code L01EX04) | ||||
| L01XE13 | Afatinib (New ATC code L01EB03) | ||||
| L01XE14 | Bosutinib (New ATC code L01EA04) | ||||
| L01XE15 | Vemurafenib (New ATC code L01EC01) | ||||
| L01XE16 | Crizotinib (New ATC code L01ED01) | ||||
| L01XE17 | Axitinib (New ATC code L01EK01) | ||||
| L01XE18 | Ruxolitinib (New ATC code L01EJ01) | ||||
| L01XE19 | Ridaforolimus (New ATC code L01EG03) | ||||
| L01XE21 | Regorafenib (New ATC code L01EX05) | ||||
| L01XE22 | Masitinib (New ATC code L01EX06) | ||||
| L01XE23 | dabrafenib (New ATC code L01EC02) | ||||
| L01XE24 | ponatinib (New ATC code L01EA05) | ||||
| L01XE25 | trametinib (New ATC code L01EE01) | ||||
| L01XE26 | cabozantinib (New ATC code L01EX07) | ||||
| L01XE27 | ibrutinib (New ATC code L01EL01) | ||||
| L01XE28 | ceritinib (New ATC code L01ED02) | ||||
| L01XE29 | lenvatinib (New ATC code L01EX08) | ||||
| L01XE31 | nintedanib (New ATC code L01EX09) | ||||
| L01XE32 | cediranib (New ATC code L01EK02) | ||||
| L01XE33 | palbociclib (New ATC code L01EF01) | ||||
| L01XE34 | tivozanib (New ATC code L01EK03) | ||||
| L01XE35 | osimertinib (New ATC code L01EB04) | ||||
| L01XE36 | alectinib (New ATC code L01ED03) | ||||
| L01XE37 | rociletinib (New ATC code L01EB05) | ||||
| L01XE38 | cobimetinib (New ATC code L01EE02) | ||||
| L01XE39 | midostaurin (New ATC code L01EX10) | ||||
| L01XE40 | olmutinib (New ATC code L01EB06) | ||||
| L01XE41 | binimetinib (New ATC code L01EE03) | ||||
| L01XE42 | ribociclib (New ATC code L01EF02) | ||||
| L01XE43 | brigatinib (New ATC code L01ED04) | ||||
| L01XE44 | lorlatinib (New ATC code L01ED05) | ||||
| L01XE45 | neratinib (New ATC code L01EH02) | ||||
| L01XE46 | encorafenib (New ATC code L01EC03) | ||||
| L01XE47 | dacomitinib (New ATC code L01EB07) | ||||
| L01XE48 | icotinib (New ATC code L01EB08) | ||||
| L01XE50 | abemaciclib (New ATC code L01EF03) | ||||
| L01XE51 | acalabrutinib (New ATC code L01EL02) | ||||
| L01XE52 | quizartinib (New ATC code L01EX11) | ||||
| L01XE53 | larotrectinib (New ATC code L01EX12) | ||||
| L01XE54 | gilteritinib (New ATC code L01EX13) | ||||
| L01XE56 | entrectinib (New ATC code L01EX14) | ||||
| L01XE57 | fedratinib (New ATC code L01EJ02) | ||||
| L01XF | Retinoids for cancer treatment | ||||
| L01XF01 | tretinoin | ||||
| L01XF02 | alitretinoin | ||||
| L01XF03 | bexarotene | ||||
| L01XG | Proteasome inhibitors | ||||
| L01XG01 | bortezomib | ||||
| L01XG02 | carfilzomib | ||||
| L01XG03 | ixazomib | ||||
| L01XH | Histone deacetylase (HDAC) inhibitors | ||||
| L01XH01 | vorinostat | ||||
| L01XH02 | romidepsin | ||||
| L01XH03 | panobinostat | ||||
| L01XH04 | belinostat | ||||
| L01XH05 | entinostat | ||||
| L01XH06 | tucidinostat | ||||
| L01XH07 | resminostat | ||||
| L01XJ | Hedgehog pathway inhibitors | ||||
| L01XJ01 | vismodegib | ||||
| L01XJ02 | sonidegib | ||||
| L01XJ03 | glasdegib | ||||
| L01XK | Poly (ADP-ribose) polymerase (PARP) inhibitors | ||||
| L01XK01 | olaparib | ||||
| L01XK02 | niraparib | ||||
| L01XK03 | rucaparib | ||||
| L01XK04 | talazoparib | ||||
| L01XK05 | veliparib | ||||
| L01XK06 | pamiparib | ||||
| L01XK07 | senaparib | ||||
| L01XK52 | niraparib and abiraterone | ||||
| L01XL | Antineoplastic cell and gene therapy | ||||
| L01XL01 | sitimagene ceradenovec | ||||
| L01XL02 | talimogene laherparepvec | ||||
| L01XL03 | axicabtagene ciloleucel | ||||
| L01XL04 | tisagenlecleucel | ||||
| L01XL05 | ciltacabtagene autoleucel | ||||
| L01XL06 | brexucabtagene autoleucel | ||||
| L01XL07 | idecabtagene vicleucel | ||||
| L01XL08 | lisocabtagene maraleucel | ||||
| L01XL09 | tabelecleucel | ||||
| L01XL10 | nadofaragene firadenovec | ||||
| L01XL11 | lifileucel | ||||
| L01XL12 | obecabtagene autoleucel | ||||
| L01XM | Isocitrate dehydrogenase (IDH) inhibitors | ||||
| L01XM01 | enasidenib | ||||
| L01XM02 | ivosidenib | ||||
| L01XM03 | olutasidenib | ||||
| L01XM04 | vorasidenib | ||||
| L01XX | Other antineoplastic agents | ||||
| L01XX01 | Amsacrine | ||||
| L01XX02 | Asparaginase | ||||
| L01XX03 | Altretamine | ||||
| L01XX05 | Hydroxycarbamide | ||||
| L01XX07 | Lonidamine | ||||
| L01XX08 | Pentostatin | ||||
| L01XX09 | Miltefosine (New ATC code P01CX04) | ||||
| L01XX10 | Masoprocol | ||||
| L01XX11 | Estramustine | ||||
| L01XX14 | Tretinoin (New ATC code L01XF01) | ||||
| L01XX16 | Mitoguazone | ||||
| L01XX17 | Topotecan (New ATC code L01CE01) | ||||
| L01XX18 | Tiazofurine | ||||
| L01XX19 | Irinotecan (New ATC code L01CE02) | ||||
| L01XX22 | Alitretinoin (New ATC code L01XF02) | ||||
| L01XX23 | Mitotane | ||||
| L01XX24 | Pegaspargase | ||||
| L01XX25 | Bexarotene (New ATC code L01XF03) | ||||
| L01XX27 | Arsenic trioxide | ||||
| L01XX28 | imatinib (New ATC code L01EA01) | ||||
| L01XX29 | Denileukin diftitox | ||||
| L01XX31 | gefitinib (New ATC code L01EB01) | ||||
| L01XX32 | Bortezomib (New ATC code L01XG01) | ||||
| L01XX33 | Celecoxib | ||||
| L01XX34 | erlotinib (New ATC code L01EB02) | ||||
| L01XX35 | Anagrelide | ||||
| L01XX36 | Oblimersen | ||||
| L01XX37 | Sitimagene ceradenovec (New ATC code L01XL01) | ||||
| L01XX38 | Vorinostat (New ATC code L01XH01) | ||||
| L01XX39 | Romidepsin (New ATC code L01XH02) | ||||
| L01XX40 | Omacetaxine mepesuccinate | ||||
| L01XX41 | Eribulin | ||||
| L01XX42 | Panobinostat (New ATC code L01XH03) | ||||
| L01XX43 | Vismodegib (New ATC code L01XJ01) | ||||
| L01XX44 | aflibercept | ||||
| L01XX45 | carfilzomib (New ATC code L01XG02) | ||||
| L01XX46 | olaparib (New ATC code L01XK01) | ||||
| L01XX47 | idelalisib (New ATC code L01EM01) | ||||
| L01XX48 | sonidegib (New ATC code L01XJ02) | ||||
| L01XX49 | belinostat (New ATC code L01XH04) | ||||
| L01XX50 | ixazomib (New ATC code L01XG03) | ||||
| L01XX51 | talimogene laherparepvec (New ATC code L01XL02) | ||||
| L01XX52 | venetoclax | ||||
| L01XX53 | vosaroxin | ||||
| L01XX54 | niraparib (New ATC code L01XK02) | ||||
| L01XX55 | rucaparib (New ATC code L01XK03) | ||||
| L01XX56 | etirinotecan pegol (New ATC code L01CE03) | ||||
| L01XX57 | plitidepsin | ||||
| L01XX58 | epacadostat | ||||
| L01XX59 | enasidenib (New ATC code L01XM01) | ||||
| L01XX60 | talazoparib (New ATC code L01XK04) | ||||
| L01XX61 | copanlisib (New ATC code L01EM02) | ||||
| L01XX62 | ivosidenib (New ATC code L01XM02) | ||||
| L01XX63 | glasdegib (New ATC code L01XJ03) | ||||
| L01XX64 | entinostat (New ATC code L01XH05) | ||||
| L01XX65 | alpelisib (New ATC code L01EM03) | ||||
| L01XX66 | selinexor | ||||
| L01XX67 | tagraxofusp | ||||
| L01XX68 | belotecan (New ATC code L01CE04) | ||||
| L01XX69 | lurbinectedin | ||||
| L01XX70 | axicabtagene ciloleucel (New ATC code L01XL03) | ||||
| L01XX71 | tisagenlecleucel (New ATC code L01XL04) | ||||
| L01XX72 | tazemetostat | ||||
| L01XX73 | sotorasib | ||||
| L01XX74 | belzutifan | ||||
| L01XX75 | tebentafusp | ||||
| L01XX77 | adagrasib | ||||
| L01XX78 | navitoclax | ||||
| L01XX79 | eflornithine | ||||
| L01XX80 | imetelstat | ||||
| L01XX81 | nirogacestat | ||||
| L01XX82 | darinaparsin | ||||
| L01XX83 | para-toluenesulfonamide | ||||
| L01XX84 | pelabresib | ||||
| L01XX85 | idroxioleic acid | ||||
| L01XX86 | calaspargase pegol | ||||
| L01XX87 | revumenib | ||||
| L01XY |
Combinations of antineoplastic agents | ||||
| L01XY01 | cytarabine and daunorubicin | ||||
| L01XY02 | pertuzumab and trastuzumab (New ATC code L01FY01) | ||||
| L01XY03 | nivolumab and relatlimab (New ATC code L01FY02) | ||||
| L01XY04 | bifikafusp alfa and onfekafusp alfa | ||||
| L02 | Endocrine therapy | ||||
| L02A | Hormones and related agents | ||||
| L02AA | Estrogens | ||||
| L02AA01 | Diethylstilbestrol | ||||
| L02AA02 | Polyestradiol phosphate | ||||
| L02AA03 | Ethinylestradiol | ||||
| L02AA04 | Fosfestrol | ||||
| L02AB | Progestogens | ||||
| L02AB01 | Megestrol | ||||
| L02AB02 | Medroxyprogesterone | ||||
| L02AB03 | Gestonorone | ||||
| L02AE | Gonadotropin-releasing hormone analogues | ||||
| L02AE01 | Buserelin | ||||
| L02AE02 | Leuprorelin | ||||
| L02AE03 | Goserelin | ||||
| L02AE04 | Triptorelin | ||||
| L02AE05 | Histrelin | ||||
| L02AX | Other hormones | ||||
| empty | |||||
| L02B | Hormone antagonists and related agents | ||||
| L02BA | Anti-estrogens | ||||
| L02BA01 | Tamoxifen | ||||
| L02BA02 | Toremifene | ||||
| L02BA03 | Fulvestrant | ||||
| L02BA04 | elacestrant | ||||
| L02BA05 | camizestrant | ||||
| L02BB | Anti-androgens | ||||
| L02BB01 | Flutamide | ||||
| L02BB02 | Nilutamide | ||||
| L02BB03 | Bicalutamide | ||||
| L02BB04 | enzalutamide | ||||
| L02BB05 | apalutamide | ||||
| L02BB06 | darolutamide | ||||
| L02BG | Aromatase inhibitors | ||||
| L02BG01 | Aminogluthetimide | ||||
| L02BG02 | Formestane | ||||
| L02BG03 | Anastrozole | ||||
| L02BG04 | Letrozole | ||||
| L02BG05 | Vorozole | ||||
| L02BG06 | Exemestane | ||||
| L02BX | Other hormone antagonists and related agents | ||||
| L02BX01 | Abarelix | ||||
| L02BX02 | Degarelix | ||||
| L02BX03 | Abiraterone | ||||
| L02BX04 | relugolix | ||||
| L02BX53 | abiraterone and corticosteroids | ||||
| L03 | Immunostimulants | ||||
| L03A | Immunostimulants | ||||
| L03AA | Colony stimulating factors | ||||
| L03AA02 | Filgrastim | ||||
| L03AA03 | Molgramostim | ||||
| L03AA09 | Sargramostim | ||||
| L03AA10 | Lenograstim | ||||
| L03AA12 | Ancestim | ||||
| L03AA13 | Pegfilgrastim | ||||
| L03AA14 | Lipegfilgrastim | ||||
| L03AB | Interferons | ||||
| L03AB01 | Interferon alfa natural | ||||
| L03AB02 | Interferon beta natural | ||||
| L03AB03 | Interferon gamma | ||||
| L03AB04 | Interferon alfa-2a | ||||
| L03AB05 | Interferon alfa-2b | ||||
| L03AB06 | Interferon alfa-n1 | ||||
| L03AB07 | Interferon beta-1a | ||||
| L03AB08 | Interferon beta-1b | ||||
| L03AB09 | Interferon alfacon-1 | ||||
| L03AB10 | Peginterferon alfa-2b | ||||
| L03AB11 | Peginterferon alfa-2a | ||||
| L03AB12 | Albinterferon alfa-2b | ||||
| L03AB13 | peginterferon beta-1a | ||||
| L03AB14 | cepeginterferon alfa-2b | ||||
| L03AB15 | ropeginterferon alfa-2b | ||||
| L03AB16 | peginterferon alfacon-2 | ||||
| L03AB17 | sampeginterferon beta-1a | ||||
| L03AB60 | Peginterferon alfa-2b, combinations | ||||
| L03AB61 | Peginterferon alfa-2a, combinations | ||||
| L03AC | Interleukins | ||||
| L03AC01 | Aldesleukin | ||||
| L03AC02 | Oprelvekin | ||||
| L03AC03 | nogapendekin alfa and inbakicept | ||||
| L03AX | Other immunostimulants | ||||
| L03AX01 | Lentinan | ||||
| L03AX02 | Roquinimex | ||||
| L03AX03 | BCG vaccine | ||||
| L03AX04 | Pegademase | ||||
| L03AX05 | Pidotimod | ||||
| L03AX07 | Poly I:C | ||||
| L03AX08 | Poly ICLC | ||||
| L03AX09 | Thymopentin | ||||
| L03AX10 | Immunocyanin | ||||
| L03AX11 | Tasonermin | ||||
| L03AX12 | Melanoma vaccine | ||||
| L03AX13 | Glatiramer acetate | ||||
| L03AX14 | Histamine dihydrochloride | ||||
| L03AX15 | Mifamurtide | ||||
| L03AX16 | Plerixafor | ||||
| L03AX17 | Sipuleucel-T | ||||
| L03AX18 | cridanimod | ||||
| L03AX19 | dasiprotimut-T | ||||
| L03AX21 | elapegademase | ||||
| L03AX22 | leniolisib | ||||
| L03AX23 | motixafortide | ||||
| L03AX24 | mavorixafor | ||||
| L03AX25 | thymalfasin | ||||
| L04 | Immunosuppressants | ||||
| L04A | Immunosuppressants | ||||
| L04AA | Selective immunosuppressants | ||||
| L04AA01 | ciclosporin (New ATC code L04AD01) | ||||
| L04AA02 | Muromonab-CD3 (New ATC code L04AG01) | ||||
| L04AA03 | Antilymphocyte immunoglobulin (horse) | ||||
| L04AA04 | Antithymocyte immunoglobulin (rabbit) | ||||
| L04AA05 | tacrolimus (New ATC code L04AD02) | ||||
| L04AA06 | Mycophenolic acid | ||||
| L04AA08 | daclizumab (New ATC code L04AC01) | ||||
| L04AA09 | basiliximab (New ATC code L04AC02) | ||||
| L04AA10 | Sirolimus (New ATC code L04AH01) | ||||
| L04AA11 | etanercept (New ATC code L04AB01) | ||||
| L04AA12 | infliximab (New ATC code L04AB02) | ||||
| L04AA13 | Leflunomide (New ATC code L04AK01) | ||||
| L04AA14 | anakinra (New ATC code L04AC03) | ||||
| L04AA15 | Alefacept | ||||
| L04AA16 | afelimomab (New ATC code L04AB03) | ||||
| L04AA17 | adalimumab (New ATC code L04AB04) | ||||
| L04AA18 | Everolimus (New ATC code L04AH02) | ||||
| L04AA19 | Gusperimus | ||||
| L04AA21 | Efalizumab (New ATC code L04AG02) | ||||
| L04AA22 | Abetimus | ||||
| L04AA23 | Natalizumab (New ATC code L04AG03) | ||||
| L04AA24 | Abatacept | ||||
| L04AA25 | Eculizumab (New ATC code L04AJ01) | ||||
| L04AA26 | Belimumab (New ATC code L04AG04) | ||||
| L04AA27 | Fingolimod (New ATC code L04AE01) | ||||
| L04AA28 | Belatacept | ||||
| L04AA29 | Tofacitinib (New ATC code L04AF01) | ||||
| L04AA31 | teriflunomide (New ATC code L04AK02) | ||||
| L04AA32 | apremilast | ||||
| L04AA33 | vedolizumab (New ATC code L04AG05) | ||||
| L04AA34 | alemtuzumab (New ATC code L04AG06) | ||||
| L04AA35 | begelomab (New ATC code L04AG07) | ||||
| L04AA36 | ocrelizumab (New ATC code L04AG08) | ||||
| L04AA37 | baricitinib (New ATC code L04AF02) | ||||
| L04AA38 | ozanimod (New ATC code L04AE02) | ||||
| L04AA39 | emapalumab (New ATC code L04AG09) | ||||
| L04AA40 | cladribine | ||||
| L04AA41 | imlifidase | ||||
| L04AA42 | siponimod (New ATC code L04AE03) | ||||
| L04AA43 | ravulizumab (New ATC code L04AJ02) | ||||
| L04AA44 | upadacitinib (New ATC code L04AF03) | ||||
| L04AA45 | filgotinib (New ATC code L04AF04) | ||||
| L04AA46 | itacitinib (New ATC code L04AF05) | ||||
| L04AA47 | inebilizumab (New ATC code L04AG10) | ||||
| L04AA48 | belumosudil | ||||
| L04AA49 | peficitinib (New ATC code L04AF06) | ||||
| L04AA50 | ponesimod (New ATC code L04AE04) | ||||
| L04AA51 | anifrolumab (New ATC code L04AG11) | ||||
| L04AA52 | ofatumumab (New ATC code L04AG12) | ||||
| L04AA53 | teprotumumab (New ATC code L04AG13) | ||||
| L04AA54 | pegcetacoplan (New ATC code L04AJ03) | ||||
| L04AA55 | sutimlimab (New ATC code L04AJ04) | ||||
| L04AA56 | deucravacitinib (New ATC code L04AF07) | ||||
| L04AA57 | ublituximab (New ATC code L04AG14) | ||||
| L04AA58 | efgartigimod alfa | ||||
| L04AA59 | avacopan (New ATC code L04AJ05) | ||||
| L04AA60 | remibrutinib | ||||
| L04AA61 | nerandomilast | ||||
| L04AA62 | tolebrutinib | ||||
| L04AB | Tumor necrosis factor alpha (TNF-α) inhibitors | ||||
| L04AB01 | Etanercept | ||||
| L04AB02 | Infliximab | ||||
| L04AB03 | Afelimomab | ||||
| L04AB04 | Adalimumab | ||||
| L04AB05 | Certolizumab pegol | ||||
| L04AB06 | Golimumab | ||||
| L04AB07 | opinercept | ||||
| L04AC | Interleukin inhibitors | ||||
| L04AC01 | Daclizumab | ||||
| L04AC02 | Basiliximab | ||||
| L04AC03 | Anakinra | ||||
| L04AC04 | Rilonacept | ||||
| L04AC05 | Ustekinumab | ||||
| L04AC06 | Mepolizumab (New ATC code R03DX09) | ||||
| L04AC07 | Tocilizumab | ||||
| L04AC08 | Canakinumab | ||||
| L04AC09 | Briakinumab | ||||
| L04AC10 | Secukinumab | ||||
| L04AC11 | siltuximab | ||||
| L04AC12 | brodalumab | ||||
| L04AC13 | ixekizumab | ||||
| L04AC14 | sarilumab | ||||
| L04AC15 | sirukumab | ||||
| L04AC16 | guselkumab | ||||
| L04AC17 | tildrakizumab | ||||
| L04AC18 | risankizumab | ||||
| L04AC19 | satralizumab | ||||
| L04AC20 | netakimab | ||||
| L04AC21 | bimekizumab | ||||
| L04AC22 | spesolimab | ||||
| L04AC23 | olokizumab | ||||
| L04AC24 | mirikizumab | ||||
| L04AC25 | levilimab | ||||
| L04AC26 | goflikicept | ||||
| L04AC27 | cendakimabL04AE03 | ||||
| L04AD | Calcineurin inhibitors | ||||
| L04AD01 | Ciclosporin | ||||
| L04AD02 | Tacrolimus | ||||
| L04AD03 | Voclosporin | ||||
| L04AE | Sphingosine-1-phosphate (S1P) receptor modulators | ||||
| L04AE01 | fingolimod | ||||
| L04AE02 | ozanimod | ||||
| L04AE03 | siponimod | ||||
| L04AE04 | ponesimod | ||||
| L04AE05 | etrasimod | ||||
| L04AF | Janus-associated kinase (JAK) inhibitors | ||||
| L04AF01 | tofacitinib | ||||
| L04AF02 | baricitinib | ||||
| L04AF03 | upadacitinib | ||||
| L04AF04 | filgotinib | ||||
| L04AF05 | itacitinib | ||||
| L04AF06 | peficitinib | ||||
| L04AF07 | deucravacitinib | ||||
| L04AF08 | ritlecitinib | ||||
| L04AF09 | deuruxolitinib | ||||
| L04AG | Monoclonal antibodies | ||||
| L04AG01 | muromonab-CD3 | ||||
| L04AG02 | efalizumab | ||||
| L04AG03 | natalizumab | ||||
| L04AG04 | belimumab | ||||
| L04AG05 | vedolizumab | ||||
| L04AG06 | alemtuzumab | ||||
| L04AG07 | begelomab | ||||
| L04AG08 | ocrelizumab | ||||
| L04AG09 | emapalumab | ||||
| L04AG10 | inebilizumab | ||||
| L04AG11 | anifrolumab | ||||
| L04AG12 | ofatumumab | ||||
| L04AG13 | teprotumumab | ||||
| L04AG14 | ublituximab | ||||
| L04AG15 | divozilimab | ||||
| L04AG16 | rozanolixizumab | ||||
| L04AG17 | seniprutug | ||||
| L04AG18 | sibeprenlimab | ||||
| L04AG19 | axatilimab | ||||
| L04AH | Mammalian target of rapamycin (mTOR) kinase inhibitors | ||||
| L04AH01 | sirolimus | ||||
| L04AH02 | everolimus | ||||
| L04AJ | Complement inhibitors | ||||
| L04AJ01 | eculizumab | ||||
| L04AJ02 | ravulizumab | ||||
| L04AJ03 | pegcetacoplan | ||||
| L04AJ04 | sutimlimab | ||||
| L04AJ05 | avacopan | ||||
| L04AJ06 | zilucoplan | ||||
| L04AJ07 | crovalimab | ||||
| L04AJ08 | iptacopan | ||||
| L04AJ09 | danicopan | ||||
| L04AJ10 | vilobelimab | ||||
| L04AJ11 | pozelimab | ||||
| L04AK | Dihydroorotate dehydrogenase (DHODH) inhibitors | ||||
| L04AK01 | leflunomide | ||||
| L04AK02 | teriflunomide | ||||
| L04AL | Neonatal fragment crystallizable receptor (FcRn) inhibitors | ||||
| L04AL03 | nipocalimab | ||||
| L04AX | Other immunosuppressants | ||||
| L04AX01 | Azathioprine | ||||
| L04AX02 | Thalidomide | ||||
| L04AX03 | Methotrexate | ||||
| L04AX04 | Lenalidomide | ||||
| L04AX05 | Pirfenidone | ||||
| L04AX06 | pomalidomide | ||||
| L04AX07 | dimethyl fumarate | ||||
| L04AX08 | darvadstrocel | ||||
| L04AX09 | diroximel fumarate | ||||
| L04AX10 | tegomil fumarate | ||||
| L04AX11 | monomethyl fumarate | ||||
| âM | Musculo-skeletal system | ||||
| M01 | Anti-inflammatory and antirheumatic products | ||||
| M01A | Anti-inflammatory and antirheumatic products, non-steroids | ||||
| M01AA | Butylpyrazolidines | ||||
| M01AA01 | Phenylbutazone | ||||
| M01AA02 | Mofebutazone | ||||
| M01AA03 | Oxyphenbutazone | ||||
| M01AA05 | Clofezone | ||||
| M01AA06 | Kebuzone | ||||
| M01AB | Acetic acid derivatives and related substances | ||||
| M01AB01 | Indometacin | ||||
| M01AB02 | Sulindac | ||||
| M01AB03 | Tolmetin | ||||
| M01AB04 | Zomepirac | ||||
| M01AB05 | Diclofenac | ||||
| M01AB06 | Alclofenac | ||||
| M01AB07 | Bumadizone | ||||
| M01AB08 | Etodolac | ||||
| M01AB09 | Lonazolac | ||||
| M01AB10 | Fentiazac | ||||
| M01AB11 | Acemetacin | ||||
| M01AB12 | Difenpiramide | ||||
| M01AB13 | Oxametacin | ||||
| M01AB14 | Proglumetacin | ||||
| M01AB15 | Ketorolac | ||||
| M01AB16 | Aceclofenac | ||||
| M01AB17 | Bufexamac | ||||
| M01AB51 | Indometacin, combinations | ||||
| M01AB55 | Diclofenac, combinations | ||||
| M01AC | Oxicams | ||||
| M01AC01 | Piroxicam | ||||
| M01AC02 | Tenoxicam | ||||
| M01AC04 | Droxicam | ||||
| M01AC05 | Lornoxicam | ||||
| M01AC06 | Meloxicam | ||||
| M01AC56 | Meloxicam, combinations | ||||
| M01AE | Propionic acid derivatives | ||||
| M01AE01 | Ibuprofen | ||||
| M01AE02 | Naproxen | ||||
| M01AE03 | Ketoprofen | ||||
| M01AE04 | Fenoprofen | ||||
| M01AE05 | Fenbufen | ||||
| M01AE06 | Benoxaprofen | ||||
| M01AE07 | Suprofen | ||||
| M01AE08 | Pirprofen | ||||
| M01AE09 | Flurbiprofen | ||||
| M01AE10 | Indoprofen | ||||
| M01AE11 | Tiaprofenic acid | ||||
| M01AE12 | Oxaprozin | ||||
| M01AE13 | Ibuproxam | ||||
| M01AE14 | Dexibuprofen | ||||
| M01AE15 | Flunoxaprofen | ||||
| M01AE16 | Alminoprofen | ||||
| M01AE17 | Dexketoprofen | ||||
| M01AE18 | Naproxcinod | ||||
| M01AE19 | loxoprofen | ||||
| M01AE20 | pelubiprofen | ||||
| M01AE51 | Ibuprofen, combinations (New ATC code N02AJ08) | ||||
| M01AE52 | Naproxen and esomeprazole | ||||
| M01AE53 | Ketoprofen, combinations | ||||
| M01AE56 | Naproxen and misoprostol | ||||
| M01AE57 | naproxen and diphenhydramine | ||||
| M01AG | Fenamates | ||||
| M01AG01 | Mefenamic acid | ||||
| M01AG02 | Tolfenamic acid | ||||
| M01AG03 | Flufenamic acid | ||||
| M01AG04 | Meclofenamic acid | ||||
| M01AH | Coxibs | ||||
| M01AH01 | Celecoxib | ||||
| M01AH02 | Rofecoxib | ||||
| M01AH03 | Valdecoxib | ||||
| M01AH04 | Parecoxib | ||||
| M01AH05 | Etoricoxib | ||||
| M01AH06 | Lumiracoxib | ||||
| M01AX | Other anti-inflammatory and antirheumatic agents, non-steroids | ||||
| M01AX01 | Nabumetone | ||||
| M01AX02 | Niflumic acid | ||||
| M01AX04 | Azapropazone | ||||
| M01AX05 | Glucosamine | ||||
| M01AX07 | Benzydamine | ||||
| M01AX12 | Glucosaminoglycan polysulfate | ||||
| M01AX13 | Proquazone | ||||
| M01AX14 | Orgotein | ||||
| M01AX17 | Nimesulide | ||||
| M01AX18 | Feprazone | ||||
| M01AX21 | Diacerein | ||||
| M01AX22 | Morniflumate | ||||
| M01AX23 | Tenidap | ||||
| M01AX24 | Oxaceprol | ||||
| M01AX25 | Chondroitin sulfate | ||||
| M01AX26 | Avocado and soyabean oil, unsaponifiables | ||||
| M01AX68 | Feprazone, combinations | ||||
| M01B | Anti-inflammatory/antirheumatic agents in combination | ||||
| M01BA | Anti-inflammatory/antirheumatic agents in combination with corticosteroids | ||||
| M01BA01 | Phenylbutazone and corticosteroids | ||||
| M01BA02 | Dipyrocetyl and corticosteroids | ||||
| M01BA03 | Acetylsalicylic acid and corticosteroids | ||||
| M01BX | Other anti-inflammatory/antirheumatic agents in combination with other drugs | ||||
| empty | |||||
| M01C | Specific antirheumatic agents | ||||
| M01CA | Quinolines | ||||
| M01CA03 | Oxycinchophen | ||||
| M01CB | Gold preparations | ||||
| M01CB01 | Sodium aurothiomalate | ||||
| M01CB02 | Sodium aurothiosulfate | ||||
| M01CB03 | Auranofin | ||||
| M01CB04 | Aurothioglucose | ||||
| M01CB05 | Aurotioprol | ||||
| M01CC | Penicillamine and similar agents | ||||
| M01CC01 | Penicillamine | ||||
| M01CC02 | Bucillamine | ||||
| M01CX | Other specific antirheumatic agents | ||||
| empty | |||||
| M02 | Topical products for joint and muscular pain | ||||
| M02A | Topical products for joint and muscular pain | ||||
| M02AA | Anti-inflammatory preparations, non-steroids for topical use | ||||
| M02AA01 | Phenylbutazone | ||||
| M02AA02 | Mofebutazone | ||||
| M02AA03 | Clofezone | ||||
| M02AA04 | Oxyphenbutazone | ||||
| M02AA05 | Benzydamine | ||||
| M02AA06 | Etofenamate | ||||
| M02AA07 | Piroxicam | ||||
| M02AA08 | Felbinac | ||||
| M02AA09 | Bufexamac | ||||
| M02AA10 | Ketoprofen | ||||
| M02AA11 | Bendazac | ||||
| M02AA12 | Naproxen | ||||
| M02AA13 | Ibuprofen | ||||
| M02AA14 | Fentiazac | ||||
| M02AA15 | Diclofenac | ||||
| M02AA16 | Feprazone | ||||
| M02AA17 | Niflumic acid | ||||
| M02AA18 | Meclofenamic acid | ||||
| M02AA19 | Flurbiprofen | ||||
| M02AA21 | Tolmetin | ||||
| M02AA22 | Suxibuzone | ||||
| M02AA23 | Indometacin | ||||
| M02AA24 | Nifenazone | ||||
| M02AA25 | Aceclofenac | ||||
| M02AA26 | Nimesulide | ||||
| M02AB | Capsaicin and similar agents | ||||
| M02AB01 | Capsaicin | ||||
| M02AB02 | Zucapsaicin | ||||
| M02AC | Preparations with salicylic acid derivatives | ||||
| empty | |||||
| M02AX | Other topical products for joint and muscular pain | ||||
| M02AX02 | Tolazoline | ||||
| M02AX03 | Dimethyl sulfoxide | ||||
| M02AX05 | Idrocilamide | ||||
| M02AX10 | Various | ||||
| M03 | Muscle relaxants | ||||
| M03A | Muscle relaxants, peripherally acting agents | ||||
| M03AA | Curare alkaloids | ||||
| M03AA01 | Alcuronium | ||||
| M03AA02 | Tubocurarine | ||||
| M03AA04 | Dimethyltubocurarine | ||||
| M03AB | Choline derivatives | ||||
| M03AB01 | Suxamethonium | ||||
| M03AC | Other quaternary ammonium compounds | ||||
| M03AC01 | Pancuronium | ||||
| M03AC02 | Gallamine | ||||
| M03AC03 | Vecuronium | ||||
| M03AC04 | Atracurium | ||||
| M03AC05 | Hexafluronium | ||||
| M03AC06 | Pipecuronium bromide | ||||
| M03AC07 | Doxacurium chloride | ||||
| M03AC08 | Fazadinium bromide | ||||
| M03AC09 | Rocuronium bromide | ||||
| M03AC10 | Mivacurium chloride | ||||
| M03AC11 | Cisatracurium | ||||
| M03AX | Other muscle relaxants, peripherally acting agents | ||||
| M03AX01 | Botulinum toxin | ||||
| M03B | Muscle relaxants, centrally acting agents | ||||
| M03BA | Carbamic acid esters | ||||
| M03BA01 | Phenprobamate | ||||
| M03BA02 | Carisoprodol | ||||
| M03BA03 | Methocarbamol | ||||
| M03BA04 | Styramate | ||||
| M03BA05 | Febarbamate | ||||
| M03BA51 | Phenprobamate, combinations excluding psycholeptics | ||||
| M03BA52 | Carisoprodol, combinations excluding psycholeptics | ||||
| M03BA53 | Methocarbamol, combinations excluding psycholeptics | ||||
| M03BA71 | Phenprobamate, combinations with psycholeptics | ||||
| M03BA72 | Carisoprodol, combinations with psycholeptics | ||||
| M03BA73 | Methocarbamol, combinations with psycholeptics | ||||
| M03BB | Oxazol, thiazine, and triazine derivatives | ||||
| M03BB02 | Chlormezanone | ||||
| M03BB03 | Chlorzoxazone | ||||
| M03BB52 | Chlormezanone, combinations excluding psycholeptics | ||||
| M03BB53 | Chlorzoxazone, combinations excluding psycholeptics | ||||
| M03BB72 | Chlormezanone, combinations with psycholeptics | ||||
| M03BB73 | Chlorzoxazone, combinations with psycholeptics | ||||
| M03BC | Ethers, chemically close to antihistamines | ||||
| M03BC01 | Orphenadrine (citrate) | ||||
| M03BC51 | Orphenadrine, combinations | ||||
| M03BX | Other centrally acting agents | ||||
| M03BX01 | Baclofen | ||||
| M03BX02 | Tizanidine | ||||
| M03BX03 | Pridinol | ||||
| M03BX04 | Tolperisone | ||||
| M03BX05 | Thiocolchicoside | ||||
| M03BX06 | Mephenesin | ||||
| M03BX07 | Tetrazepam | ||||
| M03BX08 | Cyclobenzaprine | ||||
| M03BX09 | Eperisone | ||||
| M03BX30 | Phenyramidol | ||||
| M03C | Muscle relaxants, directly acting agents | ||||
| M03CA | Dantrolene and derivatives | ||||
| M03CA01 | Dantrolene | ||||
| M04 | Antigout preparations | ||||
| M04A | Antigout preparations | ||||
| M04AA | Preparations inhibiting uric acid production | ||||
| M04AA01 | Allopurinol | ||||
| M04AA02 | Tisopurine | ||||
| M04AA03 | Febuxostat | ||||
| M04AA51 | Allopurinol, combinations | ||||
| M04AB | Preparations increasing uric acid excretion | ||||
| M04AB01 | Probenecid | ||||
| M04AB02 | Sulfinpyrazone | ||||
| M04AB03 | Benzbromarone | ||||
| M04AB04 | Isobromindione | ||||
| M04AB05 | lesinurad | ||||
| M04AB06 | dotinurad | ||||
| M04AC | Preparations with no effect on uric acid metabolism | ||||
| M04AC01 | Colchicine | ||||
| M04AC02 | Cinchophen | ||||
| M04AX | Other antigout preparations | ||||
| M04AX01 | Urate oxidase | ||||
| M04AX02 | Pegloticase | ||||
| M05 | Drugs for treatment of bone diseases | ||||
| M05B | Drugs affecting bone structure and mineralization | ||||
| M05BA | Bisphosphonates | ||||
| M05BA01 | Etidronic acid | ||||
| M05BA02 | Clodronic acid | ||||
| M05BA03 | Pamidronic acid | ||||
| M05BA04 | Alendronic acid | ||||
| M05BA05 | Tiludronic acid | ||||
| M05BA06 | Ibandronic acid | ||||
| M05BA07 | Risedronic acid | ||||
| M05BA08 | Zoledronic acid | ||||
| M05BB | Bisphosphonates, combinations | ||||
| M05BB01 | Etidronic acid and calcium, sequential | ||||
| M05BB02 | Risedronic acid and calcium, sequential | ||||
| M05BB03 | Alendronic acid and colecalciferol | ||||
| M05BB04 | Risedronic acid, calcium and colecalciferol, sequential | ||||
| M05BB05 | Alendronic acid, calcium and colecalciferol, sequential | ||||
| M05BB06 | Alendronic acid and alfacalcidol, sequential | ||||
| M05BC | Bone morphogenetic proteins | ||||
| M05BC01 | Dibotermin alfa | ||||
| M05BC02 | Eptotermin alfa | ||||
| M05BX | Other drugs affecting bone structure and mineralization | ||||
| M05BX01 | Ipriflavone | ||||
| M05BX02 | aluminium chlorohydrate | ||||
| M05BX03 | Strontium ranelate | ||||
| M05BX04 | Denosumab | ||||
| M05BX05 | burosumab | ||||
| M05BX06 | romosozumab | ||||
| M05BX07 | vosoritide | ||||
| M05BX08 | menatetrenone | ||||
| M05BX53 | strontium ranelate and colecalciferol | ||||
| M09 | Other drugs for disorders of the musculo-skeletal system | ||||
| M09A | Other drugs for disorders of the musculo-skeletal system | ||||
| M09AA | Quinine and derivatives | ||||
| M09AA01 | Hydroquinine | ||||
| M09AA72 | Quinine, combinations with psycholeptics | ||||
| M09AB | Enzymes | ||||
| M09AB01 | Chymopapain | ||||
| M09AB02 | Collagenase clostridium histolyticum | ||||
| M09AB52 | Trypsin, combinations | ||||
| M09AX | Other drugs for disorders of the musculo-skeletal system | ||||
| M09AX01 | Hyaluronic acid | ||||
| M09AX02 | Chondrocytes, autologous | ||||
| M09AX03 | ataluren | ||||
| M09AX04 | drisapersen | ||||
| M09AX05 | aceneuramic acid | ||||
| M09AX06 | eteplirsen | ||||
| M09AX07 | nusinersen | ||||
| M09AX08 | golodirsen | ||||
| M09AX09 | onasemnogene abeparvovec | ||||
| M09AX10 | risdiplam | ||||
| M09AX11 | palovarotene | ||||
| M09AX12 | viltolarsen | ||||
| M09AX13 | casimersen | ||||
| M09AX14 | givinostat | ||||
| M09AX15 | delandistrogene moxeparvovec | ||||
| M09AX16 | apitegromab | ||||
| âN | Nervous system | ||||
| N01 | Anesthetics | ||||
| N01A | Anesthetics, general | ||||
| N01AA | Ethers | ||||
| N01AA01 | Diethyl ether | ||||
| N01AA02 | Vinyl ether | ||||
| N01AB | Halogenated hydrocarbons | ||||
| N01AB01 | Halothane | ||||
| N01AB02 | Chloroform | ||||
| N01AB03 | methoxyflurane (New ATC code N02BG09) | ||||
| N01AB04 | Enflurane | ||||
| N01AB05 | Trichloroethylene | ||||
| N01AB06 | Isoflurane | ||||
| N01AB07 | Desflurane | ||||
| N01AB08 | Sevoflurane | ||||
| N01AF | Barbiturates, plain | ||||
| N01AF01 | Methohexital | ||||
| N01AF02 | Hexobarbital | ||||
| N01AF03 | Thiopental | ||||
| N01AG | Barbiturates in combination with other drugs | ||||
| N01AG01 | Narcobarbital | ||||
| N01AH | Opioid anesthetics | ||||
| N01AH01 | Fentanyl | ||||
| N01AH02 | Alfentanil | ||||
| N01AH03 | Sufentanil | ||||
| N01AH04 | Phenoperidine | ||||
| N01AH05 | Anileridine | ||||
| N01AH06 | Remifentanil | ||||
| N01AH51 | Fentanyl, combinations | ||||
| N01AX | Other general anesthetics | ||||
| N01AX01 | droperidol (New ATC code N05AD08) | ||||
| N01AX03 | Ketamine | ||||
| N01AX04 | Propanidid | ||||
| N01AX05 | Alfaxalone | ||||
| N01AX07 | Etomidate | ||||
| N01AX10 | Propofol | ||||
| N01AX11 | Sodium oxybate | ||||
| N01AX13 | Nitrous oxide | ||||
| N01AX14 | Esketamine | ||||
| N01AX15 | Xenon | ||||
| N01AX63 | Nitrous oxide, combinations | ||||
| N01B | Anesthetics, local | ||||
| N01BA | Esters of aminobenzoic acid | ||||
| N01BA01 | Metabutethamine | ||||
| N01BA02 | Procaine | ||||
| N01BA03 | Tetracaine | ||||
| N01BA04 | Chloroprocaine | ||||
| N01BA05 | Benzocaine | ||||
| N01BA52 | Procaine, combinations | ||||
| N01BB | Amides | ||||
| N01BB01 | Bupivacaine | ||||
| N01BB02 | Lidocaine | ||||
| N01BB03 | Mepivacaine | ||||
| N01BB04 | Prilocaine | ||||
| N01BB05 | Butanilicaine | ||||
| N01BB06 | Cinchocaine | ||||
| N01BB07 | Etidocaine | ||||
| N01BB08 | Articaine | ||||
| N01BB09 | Ropivacaine | ||||
| N01BB10 | Levobupivacaine | ||||
| N01BB20 | Combinations | ||||
| N01BB51 | Bupivacaine, combinations | ||||
| N01BB52 | Lidocaine, combinations | ||||
| N01BB53 | Mepivacaine, combinations | ||||
| N01BB54 | Prilocaine, combinations | ||||
| N01BB57 | Etidocaine, combinations | ||||
| N01BB58 | Articaine, combinations | ||||
| N01BC | Esters of benzoic acid | ||||
| N01BC01 | Cocaine | ||||
| N01BX | Other local anesthetics | ||||
| N01BX01 | Ethyl chloride | ||||
| N01BX02 | Dyclonine | ||||
| N01BX03 | Phenol | ||||
| N01BX04 | Capsaicin | ||||
| N02 | Analgesics | ||||
| N02A | Opioids | ||||
| N02AA | Natural opium alkaloids | ||||
| N02AA01 | Morphine | ||||
| N02AA02 | Opium | ||||
| N02AA03 | Hydromorphone | ||||
| N02AA04 | Nicomorphine | ||||
| N02AA05 | Oxycodone | ||||
| N02AA08 | Dihydrocodeine | ||||
| N02AA09 | diamorphine (New ATC code N07BC06) | ||||
| N02AA10 | Papaveretum | ||||
| N02AA51 | Morphine, combinations | ||||
| N02AA55 | Oxycodone, combinations (New ATC code N02AJ17 - N02AJ19) | ||||
| N02AA58 | Dihydrocodeine, combinations (New ATC code N02AJ01 - N02AJ03) | ||||
| N02AA59 | Codeine, combinations excluding psycholeptics (New ATC code N02AJ06 - N02AJ09) | ||||
| N02AA79 | Codeine, combinations with psycholeptics | ||||
| N02AB | Phenylpiperidine derivatives | ||||
| N02AB01 | Ketobemidone | ||||
| N02AB02 | Pethidine | ||||
| N02AB03 | Fentanyl | ||||
| N02AB52 | Pethidine, combinations excluding psycholeptics | ||||
| N02AB72 | Pethidine, combinations with psycholeptics | ||||
| N02AC | Diphenylpropylamine derivatives | ||||
| N02AC01 | Dextromoramide | ||||
| N02AC03 | Piritramide | ||||
| N02AC04 | Dextropropoxyphene | ||||
| N02AC05 | Bezitramide | ||||
| N02AC52 | Methadone, combinations excluding psycholeptics | ||||
| N02AC54 | Dextropropoxyphene, combinations excluding psycholeptics | ||||
| N02AC74 | Dextropropoxyphene, combinations with psycholeptics | ||||
| N02AD | Benzomorphan derivatives | ||||
| N02AD01 | Pentazocine | ||||
| N02AD02 | Phenazocine | ||||
| N02AE | Oripavine derivatives | ||||
| N02AE01 | Buprenorphine | ||||
| N02AF | Morphinan derivatives | ||||
| N02AF01 | Butorphanol | ||||
| N02AF02 | Nalbuphine | ||||
| N02AG | Opioids in combination with antispasmodics | ||||
| N02AG01 | Morphine and antispasmodics | ||||
| N02AG02 | Ketobemidone and antispasmodics | ||||
| N02AG03 | Pethidine and antispasmodics | ||||
| N02AG04 | Hydromorphone and antispasmodics | ||||
| N02AJ | Opioids in combination with non-opioid analgesics | ||||
| N02AJ01 | dihydrocodeine and paracetamol | ||||
| N02AJ02 | dihydrocodeine and acetylsalicylic acid | ||||
| N02AJ03 | dihydrocodeine and other non-opioid analgesics | ||||
| N02AJ06 | codeine and paracetamol | ||||
| N02AJ07 | codeine and acetylsalicylic acid | ||||
| N02AJ08 | codeine and ibuprofen | ||||
| N02AJ09 | codeine and other non-opioid analgesics | ||||
| N02AJ13 | tramadol and paracetamol | ||||
| N02AJ14 | tramadol and dexketoprofen | ||||
| N02AJ15 | tramadol and other non-opioid analgesics | ||||
| N02AJ17 | oxycodone and paracetamol | ||||
| N02AJ18 | oxycodone and acetylsalicylic acid | ||||
| N02AJ19 | oxycodone and ibuprofen | ||||
| N02AX | Other opioids | ||||
| N02AX01 | Tilidine | ||||
| N02AX02 | Tramadol | ||||
| N02AX03 | Dezocine | ||||
| N02AX05 | Meptazinol | ||||
| N02AX06 | Tapentadol | ||||
| N02AX52 | Tramadol, combinations (New ATC code N02AJ13) | ||||
| N02B | Other analgesics and antipyretics | ||||
| N02BA | Salicylic acid and derivatives | ||||
| N02BA01 | Acetylsalicylic acid | ||||
| N02BA02 | Aloxiprin | ||||
| N02BA03 | Choline salicylate | ||||
| N02BA04 | Sodium salicylate | ||||
| N02BA05 | Salicylamide | ||||
| N02BA06 | Salsalate | ||||
| N02BA07 | Ethenzamide | ||||
| N02BA08 | Morpholine salicylate | ||||
| N02BA09 | Dipyrocetyl | ||||
| N02BA10 | Benorilate | ||||
| N02BA11 | Diflunisal | ||||
| N02BA12 | Potassium salicylate | ||||
| N02BA14 | Guacetisal | ||||
| N02BA15 | Carbasalate calcium | ||||
| N02BA16 | Imidazole salicylate | ||||
| N02BA51 | Acetylsalicylic acid, combinations excluding psycholeptics (New ATC code N02AJ02 - N02AJ17) | ||||
| N02BA55 | Salicylamide, combinations excluding psycholeptics | ||||
| N02BA57 | Ethenzamide, combinations excluding psycholeptics | ||||
| N02BA59 | Dipyrocetyl, combinations excluding psycholeptics | ||||
| N02BA65 | Carbasalate calcium combinations excluding psycholeptics | ||||
| N02BA71 | Acetylsalicylic acid, combinations with psycholeptics | ||||
| N02BA75 | Salicylamide, combinations with psycholeptics | ||||
| N02BA77 | Ethenzamide, combinations with psycholeptics | ||||
| N02BA79 | Dipyrocetyl, combinations with psycholeptics | ||||
| N02BB | Pyrazolones | ||||
| N02BB01 | Phenazone | ||||
| N02BB02 | Metamizole | ||||
| N02BB03 | Aminophenazone | ||||
| N02BB04 | Propyphenazone | ||||
| N02BB05 | Nifenazone | ||||
| N02BB51 | Phenazone, combinations excluding psycholeptics | ||||
| N02BB52 | Metamizole sodium, combinations excluding psycholeptics | ||||
| N02BB53 | Aminophenazone, combinations excluding psycholeptics | ||||
| N02BB54 | Propyphenazone, combinations excluding psycholeptics | ||||
| N02BB71 | Phenazone, combinations with psycholeptics | ||||
| N02BB72 | Metamizole sodium, combinations with psycholeptics | ||||
| N02BB73 | Aminophenazone, combinations with psycholeptics | ||||
| N02BB74 | Propyphenazone, combinations with psycholeptics | ||||
| N02BE | Anilides | ||||
| N02BE01 | Paracetamol | ||||
| N02BE03 | Phenacetin | ||||
| N02BE04 | Bucetin | ||||
| N02BE05 | Propacetamol | ||||
| N02BE51 | Paracetamol, combinations excluding psycholeptics | ||||
| N02BE53 | Phenacetin, combinations excluding psycholeptics | ||||
| N02BE54 | Bucetin, combinations excluding psycholeptics | ||||
| N02BE71 | Paracetamol, combinations with psycholeptics | ||||
| N02BE73 | Phenacetin, combinations with psycholeptics | ||||
| N02BE74 | Bucetin, combinations with psycholeptics | ||||
| N02BF | Gabapentinoids | ||||
| N02BF01 | gabapentin | ||||
| N02BF02 | pregabalin | ||||
| N02BF03 | mirogabalin | ||||
| N02BG | Other analgesics and antipyretics | ||||
| N02BG02 | Rimazolium | ||||
| N02BG03 | Glafenine | ||||
| N02BG04 | Floctafenine | ||||
| N02BG05 | Viminol | ||||
| N02BG06 | Nefopam | ||||
| N02BG07 | Flupirtine | ||||
| N02BG08 | Ziconotide | ||||
| N02BG09 | Methoxyflurane | ||||
| N02BG10 | Nabiximols | ||||
| N02BG11 | mirogabalin (New ATC code N02BF03) | ||||
| N02C | Antimigraine preparations | ||||
| N02CA | Ergot alkaloids | ||||
| N02CA01 | Dihydroergotamine | ||||
| N02CA02 | Ergotamine | ||||
| N02CA04 | Methysergide | ||||
| N02CA07 | Lisuride | ||||
| N02CA51 | Dihydroergotamine, combinations | ||||
| N02CA52 | Ergotamine, combinations excluding psycholeptics | ||||
| N02CA72 | Ergotamine, combinations with psycholeptics | ||||
| N02CB | Corticosteroid derivatives | ||||
| N02CB01 | Flumedroxone | ||||
| N02CC | Selective serotonin (5-HT1) agonists | ||||
| N02CC01 | Sumatriptan | ||||
| N02CC02 | Naratriptan | ||||
| N02CC03 | Zolmitriptan | ||||
| N02CC04 | Rizatriptan | ||||
| N02CC05 | Almotriptan | ||||
| N02CC06 | Eletriptan | ||||
| N02CC07 | Frovatriptan | ||||
| N02CD | Calcitonin gene-related peptide (CGRP) antagonists | ||||
| N02CD01 | erenumab | ||||
| N02CD02 | galcanezumab | ||||
| N02CD03 | fremanezumab | ||||
| N02CD04 | ubrogepant | ||||
| N02CD05 | eptinezumab | ||||
| N02CD06 | rimegepant | ||||
| N02CD07 | atogepant | ||||
| N02CD08 | zavegepant | ||||
| N02CX | Other antimigraine preparations | ||||
| N02CX01 | Pizotifen | ||||
| N02CX02 | Clonidine | ||||
| N02CX03 | Iprazochrome | ||||
| N02CX05 | Dimetotiazine | ||||
| N02CX06 | Oxetorone | ||||
| N02CX07 | erenumab (New ATC code N02CD01) | ||||
| N02CX08 | galcanezumab (New ATC code N02CD02) | ||||
| N03 | Antiepileptics | ||||
| N03A | Antiepileptics | ||||
| N03AA | Barbiturates and derivatives | ||||
| N03AA01 | Methylphenobarbital | ||||
| N03AA02 | Phenobarbital | ||||
| N03AA03 | Primidone | ||||
| N03AA04 | Barbexaclone | ||||
| N03AA30 | Metharbital | ||||
| N03AB | Hydantoin derivatives | ||||
| N03AB01 | Ethotoin | ||||
| N03AB02 | Phenytoin | ||||
| 03AB03 | Amino(diphenylhydantoin) valeric acid | ||||
| N03AB04 | Mephenytoin | ||||
| N03AB05 | Fosphenytoin | ||||
| N03AB52 | Phenytoin, combinations | ||||
| N03AB54 | Mephenytoin, combinations | ||||
| N03AC | Oxazolidine derivatives | ||||
| N03AC01 | Paramethadione | ||||
| N03AC02 | Trimethadione | ||||
| N03AC03 | Ethadione | ||||
| N03AD | Succinimide derivatives | ||||
| N03AD01 | Ethosuximide | ||||
| N03AD02 | Phensuximide | ||||
| N03AD03 | Mesuximide | ||||
| N03AD51 | Ethosuximide, combinations | ||||
| N03AE | Benzodiazepine derivatives | ||||
| N03AE01 | Clonazepam | ||||
| N03AF | Carboxamide derivatives | ||||
| N03AF01 | Carbamazepine | ||||
| N03AF02 | Oxcarbazepine | ||||
| N03AF03 | Rufinamide | ||||
| N03AF04 | Eslicarbazepine | ||||
| N03AG | Fatty acid derivatives | ||||
| N03AG01 | Valproic acid | ||||
| N03AG02 | Valpromide | ||||
| N03AG03 | Aminobutyric acid | ||||
| N03AG04 | Vigabatrin | ||||
| N03AG05 | Progabide | ||||
| N03AG06 | Tiagabine | ||||
| N03AX | Other antiepileptics | ||||
| N03AX03 | Sultiame | ||||
| N03AX07 | Phenacemide | ||||
| N03AX09 | Lamotrigine | ||||
| N03AX10 | Felbamate | ||||
| N03AX11 | Topiramate | ||||
| N03AX12 | Gabapentin (New ATC code N02BF01) | ||||
| N03AX13 | Pheneturide | ||||
| N03AX14 | Levetiracetam | ||||
| N03AX15 | Zonisamide | ||||
| N03AX16 | Pregabalin (New ATC code N02BF02) | ||||
| N03AX17 | Stiripentol | ||||
| N03AX18 | Lacosamide | ||||
| N03AX19 | Carisbamate | ||||
| N03AX21 | Retigabine | ||||
| N03AX22 | Perampanel | ||||
| N03AX23 | brivaracetam | ||||
| N03AX24 | cannabidiol | ||||
| N03AX25 | cenobamate | ||||
| N03AX26 | fenfluramine | ||||
| N03AX27 | ganaxolone | ||||
| N03AX30 | Beclamide | ||||
| N04 | Anti-parkinson drugs | ||||
| N04A | Anticholinergic agents | ||||
| N04AA | Tertiary amines | ||||
| N04AA01 | Trihexyphenidyl | ||||
| N04AA02 | Biperiden | ||||
| N04AA03 | Metixene | ||||
| N04AA04 | Procyclidine | ||||
| N04AA05 | Profenamine | ||||
| N04AA08 | Dexetimide | ||||
| N04AA09 | Phenglutarimide | ||||
| N04AA10 | Mazaticol | ||||
| N04AA11 | Bornaprine | ||||
| N04AA12 | Tropatepine | ||||
| N04AB | Ethers chemically close to antihistamines | ||||
| N04AB01 | Etanautine | ||||
| N04AB02 | Orphenadrine (chloride) | ||||
| N04AC | Ethers of tropine or tropine derivatives | ||||
| N04AC01 | Benzatropine | ||||
| N04AC30 | Etybenzatropine | ||||
| N04B | Dopaminergic agents | ||||
| N04BA | Dopa and dopa derivatives | ||||
| N04BA01 | Levodopa | ||||
| N04BA02 | Levodopa and decarboxylase inhibitor | ||||
| N04BA03 | Levodopa, decarboxylase inhibitor and COMT inhibitor | ||||
| N04BA04 | Melevodopa | ||||
| N04BA05 | Melevodopa and decarboxylase inhibitor | ||||
| N04BA06 | Etilevodopa and decarboxylase inhibitor | ||||
| N04BA07 | foslevodopa and decarboxylase inhibitor | ||||
| N04BB | Adamantane derivatives | ||||
| N04BB01 | Amantadine | ||||
| N04BC | Dopamine agonists | ||||
| N04BC01 | Bromocriptine | ||||
| N04BC02 | Pergolide | ||||
| N04BC03 | Dihydroergocryptine mesylate | ||||
| N04BC04 | Ropinirole | ||||
| N04BC05 | Pramipexole | ||||
| N04BC06 | Cabergoline | ||||
| N04BC07 | Apomorphine | ||||
| N04BC08 | Piribedil | ||||
| N04BC09 | Rotigotine | ||||
| N04BD | Monoamine oxidase B inhibitors | ||||
| N04BD01 | Selegiline | ||||
| N04BD02 | Rasagiline | ||||
| N04BD03 | safinamide | ||||
| N04BX | Other dopaminergic agents | ||||
| N04BX01 | Tolcapone | ||||
| N04BX02 | Entacapone | ||||
| N04BX03 | Budipine | ||||
| N05 | Psycholeptics | ||||
| N05A | Antipsychotics | ||||
| N05AA | Phenothiazines with aliphatic side-chain | ||||
| N05AA01 | Chlorpromazine | ||||
| N05AA02 | Levomepromazine | ||||
| N05AA03 | Promazine | ||||
| N05AA04 | Acepromazine | ||||
| N05AA05 | Triflupromazine | ||||
| N05AA06 | Cyamemazine | ||||
| N05AA07 | Chlorproethazine | ||||
| N05AB | Phenothiazines with piperazine structure | ||||
| N05AB01 | Dixyrazine | ||||
| N05AB02 | Fluphenazine | ||||
| N05AB03 | Perphenazine | ||||
| N05AB04 | Prochlorperazine | ||||
| N05AB05 | Thiopropazate | ||||
| N05AB06 | Trifluoperazine | ||||
| N05AB07 | Acetophenazine | ||||
| N05AB08 | Thioproperazine | ||||
| N05AB09 | Butaperazine | ||||
| N05AB10 | Perazine | ||||
| N05AC | Phenothiazines with piperidine structure | ||||
| N05AC01 | Periciazine | ||||
| N05AC02 | Thioridazine | ||||
| N05AC03 | Mesoridazine | ||||
| N05AC04 | Pipotiazine | ||||
| N05AD | Butyrophenone derivatives | ||||
| N05AD01 | Haloperidol | ||||
| N05AD02 | Trifluperidol | ||||
| N05AD03 | Melperone | ||||
| N05AD04 | Moperone | ||||
| N05AD05 | Pipamperone | ||||
| N05AD06 | Bromperidol | ||||
| N05AD07 | Benperidol | ||||
| N05AD08 | Droperidol | ||||
| N05AD09 | Fluanisone | ||||
| N05AE | Indole derivatives | ||||
| N05AE01 | Oxypertine | ||||
| N05AE02 | Molindone | ||||
| N05AE03 | Sertindole | ||||
| N05AE04 | Ziprasidone | ||||
| N05AE05 | Lurasidone | ||||
| N05AF | Thioxanthene derivative | ||||
| N05AF01 | Flupentixol | ||||
| N05AF02 | Clopenthixol | ||||
| N05AF03 | Chlorprothixene | ||||
| N05AF04 | Thiothixene | ||||
| N05AF05 | Zuclopenthixol | ||||
| N05AG | Diphenylbutylpiperidine derivatives | ||||
| N05AG01 | Fluspirilene | ||||
| N05AG02 | Pimozide | ||||
| N05AG03 | Penfluridol | ||||
| N05AH | Diazepines, oxazepines, thiazepines and oxepines | ||||
| N05AH01 | Loxapine | ||||
| N05AH02 | Clozapine | ||||
| N05AH03 | Olanzapine | ||||
| N05AH04 | Quetiapine | ||||
| N05AH05 | Asenapine | ||||
| N05AH06 | Clotiapine | ||||
| N05AK | Neuroleptics, in tardive dyskinesia | ||||
| N05AK01 | tetrabenazine (New ATC code N07XX06) | ||||
| N05AL | Benzamides | ||||
| N05AL01 | Sulpiride | ||||
| N05AL02 | Sultopride | ||||
| N05AL03 | Tiapride | ||||
| N05AL04 | Remoxipride | ||||
| N05AL05 | Amisulpride | ||||
| N05AL06 | Veralipride | ||||
| N05AL07 | Levosulpiride | ||||
| N05AN | Lithium | ||||
| N05AN01 | Lithium | ||||
| N05AX | Other antipsychotics | ||||
| N05AX07 | Prothipendyl | ||||
| N05AX08 | Risperidone | ||||
| N05AX09 | clotiapine (New ATC code N05AH06) | ||||
| N05AX10 | Mosapramine | ||||
| N05AX11 | Zotepine | ||||
| N05AX12 | Aripiprazole | ||||
| N05AX13 | Paliperidone | ||||
| N05AX14 | Iloperidone | ||||
| N05AX15 | cariprazine | ||||
| N05AX16 | brexpiprazole | ||||
| N05AX17 | pimavanserin | ||||
| N05AX50 | xanomeline and trospium | ||||
| N05B | Anxiolytics | ||||
| N05BA | Benzodiazepine derivatives | ||||
| N05BA01 | Diazepam | ||||
| N05BA02 | Chlordiazepoxide | ||||
| N05BA03 | Medazepam | ||||
| N05BA04 | Oxazepam | ||||
| N05BA05 | Potassium clorazepate | ||||
| N05BA06 | Lorazepam | ||||
| N05BA07 | Adinazolam | ||||
| N05BA08 | Bromazepam | ||||
| N05BA09 | Clobazam | ||||
| N05BA10 | Ketazolam | ||||
| N05BA11 | Prazepam | ||||
| N05BA12 | Alprazolam | ||||
| N05BA13 | Halazepam | ||||
| N05BA14 | Pinazepam | ||||
| N05BA15 | Camazepam | ||||
| N05BA16 | Nordazepam | ||||
| N05BA17 | Fludiazepam | ||||
| N05BA18 | Ethyl loflazepate | ||||
| N05BA19 | Etizolam | ||||
| N05BA21 | Clotiazepam | ||||
| N05BA22 | Cloxazolam | ||||
| N05BA23 | Tofisopam | ||||
| N05BA56 | Lorazepam, combinations | ||||
| N05BB | Diphenylmethane derivatives | ||||
| N05BB01 | Hydroxyzine | ||||
| N05BB02 | Captodiame | ||||
| N05BB51 | Hydroxyzine, combinations | ||||
| N05BC | Carbamates | ||||
| N05BC01 | Meprobamate | ||||
| N05BC03 | Emylcamate | ||||
| N05BC04 | Mebutamate | ||||
| N05BC51 | Meprobamate, combinations | ||||
| N05BD | Dibenzo-bicyclo-octadiene derivatives | ||||
| N05BD01 | Benzoctamine | ||||
| N05BE | Azaspirodecanedione derivatives | ||||
| N05BE01 | Buspirone | ||||
| N05BX | Other anxiolytics | ||||
| N05BX01 | Mephenoxalone | ||||
| N05BX02 | Gedocarnil | ||||
| N05BX03 | Etifoxine | ||||
| N05C | Hypnotics and sedatives | ||||
| N05CA | Barbiturates, plain | ||||
| N05CA01 | Pentobarbital | ||||
| N05CA02 | Amobarbital | ||||
| N05CA03 | Butobarbital | ||||
| N05CA04 | Barbital | ||||
| N05CA05 | Aprobarbital | ||||
| N05CA06 | Secobarbital | ||||
| N05CA07 | Talbutal | ||||
| N05CA08 | Vinylbital | ||||
| N05CA09 | Vinbarbital | ||||
| N05CA10 | Cyclobarbital | ||||
| N05CA11 | Heptabarbital | ||||
| N05CA12 | Reposal | ||||
| N05CA15 | Methohexital | ||||
| N05CA16 | Hexobarbital | ||||
| N05CA19 | Thiopental | ||||
| N05CA20 | Ethallobarbital | ||||
| N05CA21 | Allobarbital | ||||
| N05CA22 | Proxibarbal | ||||
| N05CB | Barbiturates, combinations | ||||
| N05CB01 | Combinations of barbiturates | ||||
| N05CB02 | Barbiturates in combination with other drugs | ||||
| N05CC | Aldehydes and derivatives | ||||
| N05CC01 | Chloral hydrate | ||||
| N05CC02 | Chloralodol | ||||
| N05CC03 | Acetylglycinamide chloral hydrate | ||||
| N05CC04 | Dichloralphenazone | ||||
| N05CC05 | Paraldehyde | ||||
| N05CD | Benzodiazepine derivatives | ||||
| N05CD01 | Flurazepam | ||||
| N05CD02 | Nitrazepam | ||||
| N05CD03 | Flunitrazepam | ||||
| N05CD04 | Estazolam | ||||
| N05CD05 | Triazolam | ||||
| N05CD06 | Lormetazepam | ||||
| N05CD07 | Temazepam | ||||
| N05CD08 | Midazolam | ||||
| N05CD09 | Brotizolam | ||||
| N05CD10 | Quazepam | ||||
| N05CD11 | Loprazolam | ||||
| N05CD12 | Doxefazepam | ||||
| N05CD13 | Cinolazepam | ||||
| N05CD14 | remimazolam | ||||
| N05CD15 | nimetazepam | ||||
| N05CD16 | dimdazenil | ||||
| N05CE | Piperidinedione derivatives | ||||
| N05CE01 | Glutethimide | ||||
| N05CE02 | Methyprylon | ||||
| N05CE03 | Pyrithyldione | ||||
| N05CF | Benzodiazepine related drugs | ||||
| N05CF01 | Zopiclone | ||||
| N05CF02 | Zolpidem | ||||
| N05CF03 | Zaleplon | ||||
| N05CF04 | Eszopiclone | ||||
| N05CH | Melatonin receptor agonists | ||||
| N05CH01 | Melatonin | ||||
| N05CH02 | Ramelteon | ||||
| N05CH03 | tasimelteon | ||||
| N05CJ | Orexin receptor antagonists | ||||
| N05CJ01 | suvorexant | ||||
| N05CJ02 | lemborexant | ||||
| N05CJ03 | daridorexant | ||||
| N05CM | Other hypnotics and sedatives | ||||
| N05CM01 | Methaqualone | ||||
| N05CM02 | Clomethiazole | ||||
| N05CM03 | Bromisoval | ||||
| N05CM04 | Carbromal | ||||
| N05CM05 | Scopolamine | ||||
| N05CM06 | Propiomazine | ||||
| N05CM07 | Triclofos | ||||
| N05CM08 | Ethchlorvynol | ||||
| N05CM09 | Valerianae radix | ||||
| N05CM10 | Hexapropymate | ||||
| N05CM11 | Bromides | ||||
| N05CM12 | Apronal | ||||
| N05CM13 | Valnoctamide | ||||
| N05CM15 | Methylpentynol | ||||
| N05CM16 | Niaprazine | ||||
| N05CM17 | melatonin (New ATC code N05CH01) | ||||
| N05CM18 | Dexmedetomidine | ||||
| N05CM19 | suvorexant (New ATC code N05CJ01) | ||||
| N05CM21 | lemborexant (New ATC code N05CJ02) | ||||
| N05CX | Hypnotics and sedatives in combination, excluding barbiturates | ||||
| N05CX01 | Meprobamate, combinations | ||||
| N05CX02 | Methaqualone, combinations | ||||
| N05CX03 | Methylpentynol, combinations | ||||
| N05CX04 | Clomethiazole, combinations | ||||
| N05CX05 | Emepronium, combinations | ||||
| N05CX06 | Dipiperonylaminoethanol, combinations | ||||
| N06 | Psychoanaleptics | ||||
| N06A | Antidepressants | ||||
| N06AA | Non-selective monoamine reuptake inhibitors | ||||
| N06AA01 | Desipramine | ||||
| N06AA02 | Imipramine | ||||
| N06AA03 | Imipramine oxide | ||||
| N06AA04 | Clomipramine | ||||
| N06AA05 | Opipramol | ||||
| N06AA06 | Trimipramine | ||||
| N06AA07 | Lofepramine | ||||
| N06AA08 | Dibenzepin | ||||
| N06AA09 | Amitriptyline | ||||
| N06AA10 | Nortriptyline | ||||
| N06AA11 | Protriptyline | ||||
| N06AA12 | Doxepin | ||||
| N06AA13 | Iprindole | ||||
| N06AA14 | Melitracen | ||||
| N06AA15 | Butriptyline | ||||
| N06AA16 | Dosulepin | ||||
| N06AA17 | Amoxapine | ||||
| N06AA18 | Dimetacrine | ||||
| N06AA19 | Amineptine | ||||
| N06AA21 | Maprotiline | ||||
| N06AA23 | Quinupramine | ||||
| N06AB | Selective serotonin reuptake inhibitors | ||||
| N06AB02 | Zimelidine | ||||
| N06AB03 | Fluoxetine | ||||
| N06AB04 | Citalopram | ||||
| N06AB05 | Paroxetine | ||||
| N06AB06 | Sertraline | ||||
| N06AB07 | Alaproclate | ||||
| N06AB08 | Fluvoxamine | ||||
| N06AB09 | Etoperidone | ||||
| N06AB10 | Escitalopram | ||||
| N06AF | Monoamine oxidase inhibitors, non-selective | ||||
| N06AF01 | Isocarboxazid | ||||
| N06AF02 | Nialamide | ||||
| N06AF03 | Phenelzine | ||||
| N06AF04 | Tranylcypromine | ||||
| N06AF05 | Iproniazide | ||||
| N06AF06 | Iproclozide | ||||
| N06AG | Monoamine oxidase A inhibitors | ||||
| N06AG02 | Moclobemide | ||||
| N06AG03 | Toloxatone | ||||
| N06AX | Other antidepressants | ||||
| N06AX01 | Oxitriptan | ||||
| N06AX02 | Tryptophan | ||||
| N06AX03 | Mianserin | ||||
| N06AX04 | Nomifensine | ||||
| N06AX05 | Trazodone | ||||
| N06AX06 | Nefazodone | ||||
| N06AX07 | Minaprine | ||||
| N06AX08 | Bifemelane | ||||
| N06AX09 | Viloxazine | ||||
| N06AX10 | Oxaflozane | ||||
| N06AX11 | Mirtazapine | ||||
| N06AX12 | Bupropion | ||||
| N06AX13 | Medifoxamine | ||||
| N06AX14 | Tianeptine | ||||
| N06AX15 | Pivagabine | ||||
| N06AX16 | Venlafaxine | ||||
| N06AX17 | Milnacipran | ||||
| N06AX18 | Reboxetine | ||||
| N06AX19 | Gepirone | ||||
| N06AX21 | Duloxetine | ||||
| N06AX22 | Agomelatine | ||||
| N06AX23 | Desvenlafaxine | ||||
| N06AX24 | Vilazodone | ||||
| N06AX25 | Hyperici herba | ||||
| N06AX26 | vortioxetine | ||||
| N06AX27 | esketamine | ||||
| N06AX28 | levomilnacipran | ||||
| N06AX29 | brexanolone | ||||
| N06AX31 | zuranolone | ||||
| N06AX62 | bupropion and dextromethorphan | ||||
| N06B | Psychostimulants, agents used for ADHD and nootropics | ||||
| N06BA | Centrally acting sympathomimetics | ||||
| N06BA01 | Amphetamine | ||||
| N06BA02 | Dexamphetamine | ||||
| N06BA03 | Dextromethamphetamine | ||||
| N06BA04 | Methylphenidate | ||||
| N06BA05 | Pemoline | ||||
| N06BA06 | Fencamfamin | ||||
| N06BA07 | Modafinil | ||||
| N06BA08 | Fenozolone | ||||
| N06BA09 | Atomoxetine | ||||
| N06BA10 | Fenetylline | ||||
| N06BA11 | Dexmethylphenidate | ||||
| N06BA12 | Lisdexamfetamine | ||||
| N06BA13 | armodafinil | ||||
| N06BA14 | solriamfetol | ||||
| N06BC | Xanthine derivatives | ||||
| N06BC01 | Caffeine | ||||
| N06BC02 | Propentofylline | ||||
| N06BX | Other psychostimulants and nootropics | ||||
| N06BX01 | Meclofenoxate | ||||
| N06BX02 | Pyritinol | ||||
| N06BX03 | Piracetam | ||||
| N06BX04 | Deanol | ||||
| N06BX05 | Fipexide | ||||
| N06BX06 | Citicoline | ||||
| N06BX07 | Oxiracetam | ||||
| N06BX08 | Pirisudanol | ||||
| N06BX09 | Linopirdine | ||||
| N06BX10 | Nizofenone | ||||
| N06BX11 | Aniracetam | ||||
| N06BX12 | Acetylcarnitine | ||||
| N06BX13 | Idebenone | ||||
| N06BX14 | Prolintane | ||||
| N06BX15 | Pipradrol | ||||
| N06BX16 | Pramiracetam | ||||
| N06BX17 | Adrafinil | ||||
| N06BX18 | Vinpocetine | ||||
| N06BX21 | temgicoluril | ||||
| N06BX22 | phenibut | ||||
| N06BX53 | piracetam and cinnarizine | ||||
| N06C | Psycholeptics and psychoanaleptics in combination | ||||
| N06CA | Antidepressants in combination with psycholeptics | ||||
| N06CA01 | Amitriptyline and psycholeptics | ||||
| N06CA02 | Melitracen and psycholeptics | ||||
| N06CA03 | Fluoxetine and psycholeptics | ||||
| N06CB | Psychostimulants in combination with psycholeptics | ||||
| empty | |||||
| N06D | Anti-dementia drugs | ||||
| N06DA | Anticholinesterases | ||||
| N06DA01 | Tacrine | ||||
| N06DA02 | Donepezil | ||||
| N06DA03 | Rivastigmine | ||||
| N06DA04 | Galantamine | ||||
| N06DA05 | ipidacrine | ||||
| N06DA06 | benzgalantamine | ||||
| N06DA52 | Donepezil and memantine | ||||
| N06DA53 | donepezil, memantine and Ginkgo folium | ||||
| N06DX | Other anti-dementia drugs | ||||
| N06DX01 | Memantine | ||||
| N06DX02 | Ginkgo folium | ||||
| N06DX03 | aducanumab | ||||
| N06DX04 | lecanemab | ||||
| N06DX05 | donanemab | ||||
| N06DX06 | blarcamesine | ||||
| N06DX07 | hydromethylthionine | ||||
| N06DX30 | combinations | ||||
| N07 | Other nervous system drugs | ||||
| N07A | Parasympathomimetics | ||||
| N07AA | Anticholinesterases | ||||
| N07AA01 | Neostigmine | ||||
| N07AA02 | Pyridostigmine | ||||
| N07AA03 | Distigmine | ||||
| N07AA30 | Ambenonium | ||||
| N07AA51 | Neostigmine, combinations | ||||
| N07AB | Choline esters | ||||
| N07AB01 | Carbachol | ||||
| N07AB02 | Bethanechol | ||||
| N07AX | Other parasympathomimetics | ||||
| N07AX01 | Pilocarpine | ||||
| N07AX02 | Choline alfoscerate | ||||
| N07AX03 | Cevimeline | ||||
| N07B | Drugs used in addictive disorders | ||||
| N07BA | Drugs used in nicotine dependence | ||||
| N07BA01 | Nicotine | ||||
| N07BA02 | bupropion (New ATC code N06AX12) | ||||
| N07BA03 | Varenicline | ||||
| N07BB | Drugs used in alcohol dependence | ||||
| N07BB01 | Disulfiram | ||||
| N07BB02 | Calcium carbimide | ||||
| N07BB03 | Acamprosate | ||||
| N07BB04 | Naltrexone | ||||
| N07BB05 | nalmefene | ||||
| N07BB06 | nalmefene | ||||
| N07BC | Drugs used in opioid dependence | ||||
| N07BC01 | Buprenorphine | ||||
| N07BC02 | Methadone | ||||
| N07BC03 | Levacetylmethadol | ||||
| N07BC04 | Lofexidine | ||||
| N07BC05 | Levomethadone | ||||
| N07BC06 | Diamorphine | ||||
| N07BC51 | Buprenorphine, combinations | ||||
| N07C | Antivertigo preparations | ||||
| N07CA | Antivertigo preparations | ||||
| N07CA01 | Betahistine | ||||
| N07CA02 | Cinnarizine | ||||
| N07CA03 | Flunarizine | ||||
| N07CA04 | Acetylleucine | ||||
| N07CA52 | Cinnarizine, combinations | ||||
| N07X | Other nervous system drugs | ||||
| N07XA | Gangliosides and ganglioside derivatives | ||||
| empty | |||||
| N07XX | Other nervous system drugs | ||||
| N07XX01 | Tirilazad | ||||
| N07XX02 | Riluzole | ||||
| N07XX03 | Xaliproden | ||||
| N07XX04 | Sodium oxybate | ||||
| N07XX05 | Amifampridine | ||||
| N07XX06 | Tetrabenazine | ||||
| N07XX07 | Fampridine | ||||
| N07XX08 | Tafamidis | ||||
| N07XX09 | dimethyl fumarate (New ATC code L04AX07) | ||||
| N07XX10 | laquinimod | ||||
| N07XX11 | pitolisant | ||||
| N07XX12 | patisiran | ||||
| N07XX13 | valbenazine | ||||
| N07XX14 | edaravone | ||||
| N07XX15 | inotersen | ||||
| N07XX16 | deutetrabenazine | ||||
| N07XX17 | arimoclomol | ||||
| N07XX18 | vutrisiran | ||||
| N07XX19 | sodium phenylbutyrate and ursodoxicoltaurine | ||||
| N07XX21 | eplontersen | ||||
| N07XX22 | tofersen | ||||
| N07XX23 | troriluzole | ||||
| N07XX24 | trofinetide | ||||
| N07XX25 | omaveloxolone | ||||
| N07XX26 | pridopidine | ||||
| N07XX27 | levacetylleucine | ||||
| N07XX59 | Dextromethorphan, combinations | ||||
| âP | Antiparasitic products, insecticides and repellents | ||||
| P01 | Antiprotozoals | ||||
| P01A | Agents against amoebiasis and other protozoal diseases | ||||
| P01AA | Hydroxyquinoline derivatives | ||||
| P01AA01 | Broxyquinoline | ||||
| P01AA02 | Clioquinol | ||||
| P01AA04 | Chlorquinaldol | ||||
| P01AA05 | Tilbroquinol | ||||
| P01AA52 | Clioquinol, combinations | ||||
| P01AB | Nitroimidazole derivatives | ||||
| P01AB01 | Metronidazole | ||||
| P01AB02 | Tinidazole | ||||
| P01AB03 | Ornidazole | ||||
| P01AB04 | Azanidazole | ||||
| P01AB05 | Propenidazole | ||||
| P01AB06 | Nimorazole | ||||
| P01AB07 | Secnidazole | ||||
| P01AB08 | satranidazole | ||||
| P01AB51 | metronidazole and furazolidone | ||||
| P01AB52 | metronidazole and diloxanide | ||||
| P01AB53 | tinidazole and diloxanide | ||||
| P01AC | Dichloroacetamide derivatives | ||||
| P01AC01 | Diloxanide | ||||
| P01AC02 | Clefamide | ||||
| P01AC03 | Etofamide | ||||
| P01AC04 | Teclozan | ||||
| P01AR | Arsenic compounds | ||||
| P01AR01 | Arsthinol | ||||
| P01AR02 | Difetarsone | ||||
| P01AR03 | Glycobiarsol | ||||
| P01AR53 | Glycobiarsol, combinations | ||||
| P01AX | Other agents against amoebiasis and other protozoal diseases | ||||
| P01AX01 | Chiniofon | ||||
| P01AX02 | Emetine | ||||
| P01AX04 | Phanquinone | ||||
| P01AX05 | Mepacrine | ||||
| P01AX06 | Atovaquone | ||||
| P01AX07 | Trimetrexate | ||||
| P01AX08 | Tenonitrozole | ||||
| P01AX09 | Dehydroemetine | ||||
| P01AX10 | Fumagillin | ||||
| P01AX52 | Emetine, combinations | ||||
| P01B | Antimalarials | ||||
| P01BA | Aminoquinolines | ||||
| P01BA01 | Chloroquine | ||||
| P01BA02 | Hydroxychloroquine | ||||
| P01BA03 | Primaquine | ||||
| P01BA06 | Amodiaquine | ||||
| P01BB | Biguanides | ||||
| P01BB01 | Proguanil | ||||
| P01BB02 | Cycloguanil embonate | ||||
| P01BB51 | Proguanil, combinations | ||||
| P01BC | Methanolquinolines | ||||
| P01BC01 | Quinine | ||||
| P01BC02 | Mefloquine | ||||
| P01BD | Diaminopyrimidines | ||||
| P01BD01 | Pyrimethamine | ||||
| P01BD51 | Pyrimethamine, combinations | ||||
| P01BE | Artemisinin and derivatives, plain | ||||
| P01BE01 | Artemisinin | ||||
| P01BE02 | Artemether | ||||
| P01BE03 | Artesunate | ||||
| P01BE04 | Artemotil | ||||
| P01BE05 | Artenimol | ||||
| P01BE52 | artemether and lumefantrine (New ATC code P01BF01) | ||||
| P01BF | Artemisinin and derivatives, combinations | ||||
| P01BF01 | Artemether and lumefantrine | ||||
| P01BF02 | Artesunate and mefloquine | ||||
| P01BF03 | Artesunate and amodiaquine | ||||
| P01BF04 | Artesunate, sulphamethopyrazine and pyrimethamine | ||||
| P01BF05 | Artenimol and piperaquine | ||||
| P01BF06 | Artesunate and pyronaridine | ||||
| P01BX | Other antimalarials | ||||
| P01BX01 | Halofantrine | ||||
| P01C | Agents against leishmaniasis and trypanosomiasis | ||||
| P01CA | Nitroimidazole derivatives | ||||
| P01CA02 | Benznidazole | ||||
| P01CB | Antimony compounds | ||||
| P01CB01 | Meglumine antimonate | ||||
| P01CB02 | Sodium stibogluconate | ||||
| P01CC | Nitrofuran derivatives | ||||
| P01CC01 | Nifurtimox | ||||
| P01CC02 | Nitrofural | ||||
| P01CD | Arsenic compounds | ||||
| P01CD01 | Melarsoprol | ||||
| P01CD02 | Acetarsol | ||||
| P01CX | Other agents against leishmaniasis and trypanosomiasis | ||||
| P01CX01 | Pentamidine isethionate | ||||
| P01CX02 | Suramin sodium | ||||
| P01CX03 | Eflornithine | ||||
| P01CX04 | miltefosine | ||||
| P02 | Anthelmintics | ||||
| P02B | Antitrematodals | ||||
| P02BA | Quinoline derivatives and related substances | ||||
| P02BA01 | Praziquantel | ||||
| P02BA02 | Oxamniquine | ||||
| P02BB | Organophosphorous compounds | ||||
| P02BB01 | Metrifonate | ||||
| P02BX | Other antitrematodal agents | ||||
| P02BX01 | Bithionol | ||||
| P02BX02 | Niridazole | ||||
| P02BX03 | Stibophen | ||||
| P02BX04 | Triclabendazole | ||||
| P02C | Antinematodal agents | ||||
| P02CA | Benzimidazole derivatives | ||||
| P02CA01 | Mebendazole | ||||
| P02CA02 | Tiabendazole | ||||
| P02CA03 | Albendazole | ||||
| P02CA04 | Ciclobendazole | ||||
| P02CA05 | Flubendazole | ||||
| P02CA06 | Fenbendazole | ||||
| P02CA51 | Mebendazole, combinations | ||||
| P02CA53 | albendazole and ivermectin | ||||
| P02CB | Piperazine and derivatives | ||||
| P02CB01 | Piperazine | ||||
| P02CB02 | Diethylcarbamazine | ||||
| P02CC | Tetrahydropyrimidine derivatives | ||||
| P02CC01 | Pyrantel | ||||
| P02CC02 | Oxantel | ||||
| P02CE | Imidazothiazole derivatives | ||||
| P02CE01 | Levamisole | ||||
| P02CF | Avermectines | ||||
| P02CF01 | Ivermectin | ||||
| P02CX | Other antinematodals | ||||
| P02CX01 | Pyrvinium | ||||
| P02CX02 | Bephenium | ||||
| P02D | Anticestodals | ||||
| P02DA | Salicylic acid derivatives | ||||
| P02DA01 | Niclosamide | ||||
| P02DX | Other anticestodals | ||||
| P02DX01 | Desaspidin | ||||
| P02DX02 | Dichlorophen | ||||
| P03 | Ectoparasiticides, including scabicides, insecticides and repellents | ||||
| P03A | Ectoparasiticides, including scabicides | ||||
| P03AA | Sulfur containing products | ||||
| P03AA01 | Dixanthogen | ||||
| P03AA02 | Potassium polysulfide | ||||
| P03AA03 | Mesulfen | ||||
| P03AA04 | Disulfiram | ||||
| P03AA05 | Thiram | ||||
| P03AA54 | Disulfiram, combinations | ||||
| P03AB | Chlorine containing products | ||||
| P03AB01 | Clofenotane | ||||
| P03AB02 | Lindane | ||||
| P03AB51 | Clofenotane, combinations | ||||
| P03AC | Pyrethrines, including synthetic compounds | ||||
| P03AC01 | Pyrethrum | ||||
| P03AC02 | Bioallethrin | ||||
| P03AC03 | Phenothrin | ||||
| P03AC04 | Permethrin | ||||
| P03AC51 | Pyrethrum, combinations | ||||
| P03AC52 | Bioallethrin, combinations | ||||
| P03AC53 | Phenothrin, combinations | ||||
| P03AC54 | Permethrin, combinations | ||||
| P03AX | Other ectoparasiticides, including scabicides | ||||
| P03AX01 | Benzyl benzoate | ||||
| P03AX02 | Copper oleinate | ||||
| P03AX03 | Malathion | ||||
| P03AX04 | Quassia | ||||
| P03AX05 | Dimeticone | ||||
| P03B | Insecticides and repellents | ||||
| P03BA | Pyrethrines | ||||
| P03BA01 | Cyfluthrin | ||||
| P03BA02 | Cypermethrin | ||||
| P03BA03 | Decamethrin | ||||
| P03BA04 | Tetramethrin | ||||
| P03BX | Other insecticides and repellents | ||||
| P03BX01 | Diethyltoluamide | ||||
| P03BX02 | Dimethylphthalate | ||||
| P03BX03 | Dibutylphthalate | ||||
| P03BX04 | Dibutylsuccinate | ||||
| P03BX05 | Dimethylcarbate | ||||
| P03BX06 | Etohexadiol | ||||
| âR | Respiratory system | ||||
| R01 | Nasal preparations | ||||
| R01A | Decongestants and other nasal preparations for topical use | ||||
| R01AA | Sympathomimetics, plain | ||||
| R01AA02 | Cyclopentamine | ||||
| R01AA03 | Ephedrine | ||||
| R01AA04 | Phenylephrine | ||||
| R01AA05 | Oxymetazoline | ||||
| R01AA06 | Tetryzoline | ||||
| R01AA07 | Xylometazoline | ||||
| R01AA08 | Naphazoline | ||||
| R01AA09 | Tramazoline | ||||
| R01AA10 | Metizoline | ||||
| R01AA11 | Tuaminoheptane | ||||
| R01AA12 | Fenoxazoline | ||||
| R01AA13 | Tymazoline | ||||
| R01AA14 | Epinephrine | ||||
| R01AB | Sympathomimetics, combinations excluding corticosteroids | ||||
| R01AB01 | Phenylephrine | ||||
| R01AB02 | Naphazoline | ||||
| R01AB03 | Tetryzoline | ||||
| R01AB05 | Ephedrine | ||||
| R01AB06 | Xylometazoline | ||||
| R01AB07 | Oxymetazoline | ||||
| R01AB08 | Tuaminoheptane | ||||
| R01AC | Antiallergic agents, excluding corticosteroids | ||||
| R01AC01 | Cromoglicic acid | ||||
| R01AC02 | Levocabastine | ||||
| R01AC03 | Azelastine | ||||
| R01AC04 | Antazoline | ||||
| R01AC05 | Spaglumic acid | ||||
| R01AC06 | Thonzylamine | ||||
| R01AC07 | Nedocromil | ||||
| R01AC08 | Olopatadine | ||||
| R01AC51 | Cromoglicic acid, combinations | ||||
| R01AD | Corticosteroids | ||||
| R01AD01 | Beclometasone | ||||
| R01AD02 | Prednisolone | ||||
| R01AD03 | Dexamethasone | ||||
| R01AD04 | Flunisolide | ||||
| R01AD05 | Budesonide | ||||
| R01AD06 | Betamethasone | ||||
| R01AD07 | Tixocortol | ||||
| R01AD08 | Fluticasone | ||||
| R01AD09 | Mometasone furoate | ||||
| R01AD11 | Triamcinolone | ||||
| R01AD12 | Fluticasone furoate | ||||
| R01AD13 | Ciclesonide | ||||
| R01AD52 | Prednisolone, combinations | ||||
| R01AD53 | Dexamethasone, combinations | ||||
| R01AD57 | Tixocortol, combinations | ||||
| R01AD58 | Fluticasone, combinations | ||||
| R01AD59 | mometasone, combinations | ||||
| R01AD60 | Hydrocortisone, combinations | ||||
| R01AX | Other nasal preparations | ||||
| R01AX01 | Calcium hexamine thiocyanate | ||||
| R01AX02 | Retinol | ||||
| R01AX03 | Ipratropium bromide | ||||
| R01AX05 | Ritiometan | ||||
| R01AX06 | Mupirocin | ||||
| R01AX07 | Hexamidine | ||||
| R01AX08 | Framycetin | ||||
| R01AX09 | Hyaluronic acid | ||||
| R01AX10 | Various | ||||
| R01AX30 | Combinations | ||||
| R01B | Nasal decongestants for systemic use | ||||
| R01BA | Sympathomimetics | ||||
| R01BA01 | Phenylpropanolamine | ||||
| R01BA02 | Pseudoephedrine | ||||
| R01BA03 | Phenylephrine | ||||
| R01BA51 | Phenylpropanolamine, combinations | ||||
| R01BA52 | Pseudoephedrine, combinations | ||||
| R01BA53 | Phenylephrine, combinations | ||||
| R02 | Throat preparations | ||||
| R02A | Throat preparations | ||||
| R02AA | Antiseptics | ||||
| R02AA01 | Ambazone | ||||
| R02AA02 | Dequalinium | ||||
| R02AA03 | Dichlorobenzyl alcohol | ||||
| R02AA05 | Chlorhexidine | ||||
| R02AA06 | Cetylpyridinium | ||||
| R02AA09 | Benzethonium | ||||
| R02AA10 | Myristyl-benzalkonium | ||||
| R02AA11 | Chlorquinaldol | ||||
| R02AA12 | Hexylresorcinol | ||||
| R02AA13 | Acriflavinium chloride | ||||
| R02AA14 | Oxyquinoline | ||||
| R02AA15 | Povidone-iodine | ||||
| R02AA16 | Benzalkonium | ||||
| R02AA17 | Cetrimonium | ||||
| R02AA18 | Hexamidine | ||||
| R02AA19 | Phenol | ||||
| R02AA20 | Various | ||||
| R02AB | Antibiotics | ||||
| R02AB01 | Neomycin | ||||
| R02AB02 | Tyrothricin | ||||
| R02AB03 | Fusafungine | ||||
| R02AB04 | Bacitracin | ||||
| R02AB30 | Gramicidin | ||||
| R02AD | Anesthetics, local | ||||
| R02AD01 | Benzocaine | ||||
| R02AD02 | Lidocaine | ||||
| R02AD03 | Cocaine | ||||
| R02AD04 | Dyclonine | ||||
| R02AX | Other throat preparations | ||||
| R02AX01 | Flurbiprofen | ||||
| R02AX02 | ibuprofen | ||||
| R02AX03 | benzydamine | ||||
| R03 | Drugs for obstructive airway diseases | ||||
| R03A | Adrenergics, inhalants | ||||
| R03AA | Alpha- and beta-adrenoreceptor agonists | ||||
| R03AA01 | Epinephrine | ||||
| R03AB | Non-selective beta-adrenoreceptor agonists | ||||
| R03AB02 | Isoprenaline | ||||
| R03AB03 | Orciprenaline | ||||
| R03AC | Selective beta-2-adrenoreceptor agonists | ||||
| R03AC02 | Salbutamol | ||||
| R03AC03 | Terbutaline | ||||
| R03AC04 | Fenoterol | ||||
| R03AC05 | Rimiterol | ||||
| R03AC06 | Hexoprenaline | ||||
| R03AC07 | Isoetarine | ||||
| R03AC08 | Pirbuterol | ||||
| R03AC09 | Tretoquinol | ||||
| R03AC10 | Carbuterol | ||||
| R03AC11 | Tulobuterol | ||||
| R03AC12 | Salmeterol | ||||
| R03AC13 | Formoterol | ||||
| R03AC14 | Clenbuterol | ||||
| R03AC15 | Reproterol | ||||
| R03AC16 | Procaterol | ||||
| R03AC17 | Bitolterol | ||||
| R03AC18 | Indacaterol | ||||
| R03AH | Combinations of adrenergics | ||||
| empty | |||||
| R03AK | Adrenergics and other drugs for obstructive airway diseases | ||||
| R03AK01 | Epinephrine and other drugs for obstructive airway diseases | ||||
| R03AK02 | Isoprenaline and other drugs for obstructive airway diseases | ||||
| R03AK03 | Fenoterol and other drugs for obstructive airway diseases (New ATC code R03AL01) | ||||
| R03AK04 | Salbutamol and other drugs for obstructive airway diseases (New ATC code R03AL02) | ||||
| R03AK05 | reproterol and sodium cromoglicate | ||||
| R03AK06 | salmeterol and fluticasone | ||||
| R03AK07 | formoterol and budesonide (××ק ××ס×××× ×××©× ×¢×ר ×ק×× ××ש R03AK08, R03AK09) | ||||
| R03AK08 | formoterol and beclometasone | ||||
| R03AK09 | formoterol and mometasone | ||||
| R03AK10 | vilanterol and fluticasone furoate | ||||
| R03AK11 | formoterol and fluticasone | ||||
| R03AK12 | salmeterol and budesonide | ||||
| R03AK13 | salbutamol and beclometasone | ||||
| R03AK14 | indacaterol and mometasone | ||||
| R03AL | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids | ||||
| R03AL01 | fenoterol and ipratropium bromide | ||||
| R03AL02 | salbutamol and ipratropium bromide | ||||
| R03AL03 | vilanterol and umeclidinium bromide | ||||
| R03AL04 | indacaterol and glycopyrronium bromide | ||||
| R03AL05 | formoterol and aclidinium bromide | ||||
| R03AL06 | olodaterol and tiotropium bromide | ||||
| R03AL07 | formoterol and glycopyrronium bromide | ||||
| R03AL08 | vilanterol, umeclidinium bromide and fluticasone furoate | ||||
| R03AL09 | formoterol, glycopyrronium bromide and beclometasone | ||||
| R03AL10 | formoterol and tiotropium bromide | ||||
| R03AL11 | formoterol, glycopyrronium bromide and budesonide | ||||
| R03AL12 | indacaterol, glycopyrronium bromide and mometasone | ||||
| R03B | Other drugs for obstructive airway diseases, inhalants | ||||
| R03BA | Glucocorticoids | ||||
| R03BA01 | Beclometasone | ||||
| R03BA02 | Budesonide | ||||
| R03BA03 | Flunisolide | ||||
| R03BA04 | Betamethasone | ||||
| R03BA05 | Fluticasone | ||||
| R03BA06 | Triamcinolone | ||||
| R03BA07 | Mometasone | ||||
| R03BA08 | Ciclesonide | ||||
| R03BB | Anticholinergics | ||||
| R03BB01 | Ipratropium bromide | ||||
| R03BB02 | Oxitropium bromide | ||||
| R03BB03 | Stramoni preparations | ||||
| R03BB04 | Tiotropium bromide | ||||
| R03BB05 | Aclidinium bromide | ||||
| R03BB06 | Glycopyrronium bromide | ||||
| R03BC | Antiallergic agents, excluding corticosteroids | ||||
| R03BC01 | Cromoglicic acid | ||||
| R03BC03 | Nedocromil | ||||
| R03BX | Other drugs for obstructive airway diseases, inhalants | ||||
| R03BX01 | Fenspiride | ||||
| R03BX02 | ensifentrine | ||||
| R03C | Adrenergics for systemic use | ||||
| R03CA | Alpha- and beta-adrenoreceptor agonists | ||||
| R03CA02 | Ephedrine (New ATC code C01CA26) | ||||
| R03CB | Non-selective beta-adrenoreceptor agonists | ||||
| R03CB01 | Isoprenaline | ||||
| R03CB02 | Methoxyphenamine | ||||
| R03CB03 | Orciprenaline | ||||
| R03CB51 | Isoprenaline, combinations | ||||
| R03CB53 | Orciprenaline, combinations | ||||
| R03CC | Selective beta-2-adrenoreceptor agonists | ||||
| R03CC02 | Salbutamol | ||||
| R03CC03 | Terbutaline | ||||
| R03CC04 | Fenoterol | ||||
| R03CC05 | Hexoprenaline | ||||
| R03CC06 | Isoetarine | ||||
| R03CC07 | Pirbuterol | ||||
| R03CC08 | Procaterol | ||||
| R03CC09 | Tretoquinol | ||||
| R03CC10 | Carbuterol | ||||
| R03CC11 | Tulobuterol | ||||
| R03CC12 | Bambuterol | ||||
| R03CC13 | Clenbuterol | ||||
| R03CC14 | Reproterol | ||||
| R03CC53 | Terbutaline, combinations | ||||
| R03CK | Adrenergics and other drugs for obstructive airway diseases | ||||
| empty | |||||
| R03D | Other systemic drugs for obstructive airway diseases | ||||
| R03DA | Xanthines | ||||
| R03DA01 | Diprophylline | ||||
| R03DA02 | Choline theophyllinate | ||||
| R03DA03 | Proxyphylline | ||||
| R03DA04 | Theophylline | ||||
| R03DA05 | Aminophylline | ||||
| R03DA06 | Etamiphylline | ||||
| R03DA07 | Theobromine | ||||
| R03DA08 | Bamifylline | ||||
| R03DA09 | Acefylline piperazine | ||||
| R03DA10 | Bufylline | ||||
| R03DA11 | Doxofylline | ||||
| R03DA20 | Combinations of xanthines | ||||
| R03DA51 | Diprophylline, combinations | ||||
| R03DA54 | Theophylline, combinations excluding psycholeptics | ||||
| R03DA55 | Aminophylline, combinations | ||||
| R03DA57 | Theobromine, combinations | ||||
| R03DA74 | Theophylline, combinations with psycholeptics | ||||
| R03DB | Xanthines and adrenergics | ||||
| R03DB01 | Diprophylline and adrenergics | ||||
| R03DB02 | Choline theophyllinate and adrenergics | ||||
| R03DB03 | Proxyphylline and adrenergics | ||||
| R03DB04 | Theophylline and adrenergics | ||||
| R03DB05 | Aminophylline and adrenergics | ||||
| R03DB06 | Etamiphylline and adrenergics | ||||
| R03DC | Leukotriene receptor antagonists | ||||
| R03DC01 | Zafirlukast | ||||
| R03DC02 | Pranlukast | ||||
| R03DC03 | Montelukast | ||||
| R03DC04 | Ibudilast | ||||
| R03DX | Other systemic drugs for obstructive airway diseases | ||||
| R03DX01 | Amlexanox | ||||
| R03DX02 | Eprozinol | ||||
| R03DX03 | Fenspiride | ||||
| R03DX05 | Omalizumab | ||||
| R03DX06 | Seratrodast | ||||
| R03DX07 | Roflumilast | ||||
| R03DX08 | Reslizumab | ||||
| R03DX09 | Mepolizumab | ||||
| R03DX10 | Benralizumab | ||||
| R03DX11 | tezepelumab | ||||
| R03DX12 | depemokimab | ||||
| R05 | Cough and cold preparations | ||||
| R05C | Expectorants, excluding combinations with cough suppressants | ||||
| R05CA | Expectorants | ||||
| R05CA01 | Tyloxapol | ||||
| R05CA02 | Potassium iodide | ||||
| R05CA03 | Guaifenesin | ||||
| R05CA04 | Ipecacuanha | ||||
| R05CA05 | Althea root | ||||
| R05CA06 | Senega | ||||
| R05CA07 | Antimony pentasulfide | ||||
| R05CA08 | Creosote | ||||
| R05CA09 | Guaiacolsulfonate | ||||
| R05CA10 | Combinations | ||||
| R05CA11 | Levoverbenone | ||||
| R05CA12 | Hederae helicis folium | ||||
| R05CB | Mucolytics | ||||
| R05CB01 | Acetylcysteine | ||||
| R05CB02 | Bromhexine | ||||
| R05CB03 | Carbocisteine | ||||
| R05CB04 | Eprazinone | ||||
| R05CB05 | Mesna | ||||
| R05CB06 | Ambroxol | ||||
| R05CB07 | Sobrerol | ||||
| R05CB08 | Domiodol | ||||
| R05CB09 | Letosteine | ||||
| R05CB10 | Combinations | ||||
| R05CB11 | Stepronin | ||||
| R05CB12 | Tiopronin (New ATC code G04BX16) | ||||
| R05CB13 | Dornase alfa (desoxyribonuclease) | ||||
| R05CB14 | Neltenexine | ||||
| R05CB15 | Erdosteine | ||||
| R05CB16 | Mannitol | ||||
| R05D | Cough suppressants, excluding combinations with expectorants | ||||
| R05DA | Opium alkaloids and derivatives | ||||
| R05DA01 | Ethylmorphine | ||||
| R05DA03 | Hydrocodone | ||||
| R05DA04 | Codeine | ||||
| R05DA05 | Opium alkaloids with morphine | ||||
| R05DA06 | Normethadone | ||||
| R05DA07 | Noscapine | ||||
| R05DA08 | Pholcodine | ||||
| R05DA09 | Dextromethorphan | ||||
| R05DA10 | Thebacon | ||||
| R05DA11 | Dimemorfan | ||||
| R05DA12 | Acetyldihydrocodeine | ||||
| R05DA20 | Combinations | ||||
| R05DB | Other cough suppressants | ||||
| R05DB01 | Benzonatate | ||||
| R05DB02 | Benproperine | ||||
| R05DB03 | Clobutinol | ||||
| R05DB04 | Isoaminile | ||||
| R05DB05 | Pentoxyverine | ||||
| R05DB07 | Oxolamine | ||||
| R05DB09 | Oxeladin | ||||
| R05DB10 | Clofedanol | ||||
| R05DB11 | Pipazetate | ||||
| R05DB12 | Bibenzonium bromide | ||||
| R05DB13 | Butamirate | ||||
| R05DB14 | Fedrilate | ||||
| R05DB15 | Zipeprol | ||||
| R05DB16 | Dibunate | ||||
| R05DB17 | Droxypropine | ||||
| R05DB18 | Prenoxdiazine | ||||
| R05DB19 | Dropropizine | ||||
| R05DB20 | Combinations | ||||
| R05DB21 | Cloperastine | ||||
| R05DB22 | Meprotixol | ||||
| R05DB23 | Piperidione | ||||
| R05DB24 | Tipepidine | ||||
| R05DB25 | Morclofone | ||||
| R05DB26 | Nepinalone | ||||
| R05DB27 | Levodropropizine | ||||
| R05DB28 | Dimethoxanate | ||||
| R05F | Cough suppressants and expectorants, combinations | ||||
| R05FA | Opium derivatives and expectorants | ||||
| R05FA01 | Opium derivatives and mucolytics | ||||
| R05FA02 | Opium derivatives and expectorants | ||||
| R05FB | Other cough suppressants and expectorants | ||||
| R05FB01 | Cough suppressants and mucolytics | ||||
| R05FB02 | Cough suppressants and expectorants | ||||
| R05X | Other cold preparations | ||||
| Empty group | |||||
| R06 | Antihistamines for systemic use | ||||
| R06A | Antihistamines for systemic use | ||||
| R06AA | Aminoalkyl ethers | ||||
| R06AA01 | Bromazine | ||||
| R06AA02 | Diphenhydramine | ||||
| R06AA04 | Clemastine | ||||
| R06AA06 | Chlorphenoxamine | ||||
| R06AA07 | Diphenylpyraline | ||||
| R06AA08 | Carbinoxamine | ||||
| R06AA09 | Doxylamine | ||||
| R06AA10 | trimethobenzamide | ||||
| R06AA11 | dimenhydrinate | ||||
| R06AA52 | Diphenhydramine, combinations | ||||
| R06AA54 | Clemastine, combinations | ||||
| R06AA56 | Chlorphenoxamine, combinations | ||||
| R06AA57 | Diphenylpyraline, combinations | ||||
| R06AA59 | Doxylamine, combinations | ||||
| R06AA61 | dimenhydrinate, combinations | ||||
| R06AB | Substituted alkylamines | ||||
| R06AB01 | Brompheniramine | ||||
| R06AB02 | Dexchlorpheniramine | ||||
| R06AB03 | Dimetindene | ||||
| R06AB04 | Chlorphenamine | ||||
| R06AB05 | Pheniramine | ||||
| R06AB06 | Dexbrompheniramine | ||||
| R06AB07 | Talastine | ||||
| R06AB51 | Brompheniramine, combinations | ||||
| R06AB52 | Dexchlorpheniramine, combinations | ||||
| R06AB54 | Chlorphenamine, combinations | ||||
| R06AB56 | Dexbrompheniramine, combinations | ||||
| R06AC | Substituted ethylene diamines | ||||
| R06AC01 | Mepyramine | ||||
| R06AC02 | Histapyrrodine | ||||
| R06AC03 | Chloropyramine | ||||
| R06AC04 | Tripelennamine | ||||
| R06AC05 | Methapyrilene | ||||
| R06AC06 | Thonzylamine | ||||
| R06AC52 | Histapyrrodine, combinations | ||||
| R06AC53 | Chloropyramine, combinations | ||||
| R06AD | Phenothiazine derivatives | ||||
| R06AD01 | Alimemazine | ||||
| R06AD02 | Promethazine | ||||
| R06AD03 | Thiethylperazine | ||||
| R06AD04 | Methdilazine | ||||
| R06AD05 | Hydroxyethylpromethazine | ||||
| R06AD06 | Thiazinam | ||||
| R06AD07 | Mequitazine | ||||
| R06AD08 | Oxomemazine | ||||
| R06AD09 | Isothipendyl | ||||
| R06AD52 | Promethazine, combinations | ||||
| R06AD55 | Hydroxyethylpromethazine, combinations | ||||
| R06AE | Piperazine derivatives | ||||
| R06AE01 | Buclizine | ||||
| R06AE03 | Cyclizine | ||||
| R06AE04 | Chlorcyclizine | ||||
| R06AE05 | Meclozine | ||||
| R06AE06 | Oxatomide | ||||
| R06AE07 | Cetirizine | ||||
| R06AE09 | Levocetirizine | ||||
| R06AE51 | Buclizine, combinations | ||||
| R06AE53 | Cyclizine, combinations | ||||
| R06AE55 | Meclozine, combinations | ||||
| R06AK | Combinations of antihistamines | ||||
| Empty group | |||||
| R06AX | Other antihistamines for systemic use | ||||
| R06AX01 | Bamipine | ||||
| R06AX02 | Cyproheptadine | ||||
| R06AX03 | Thenalidine | ||||
| R06AX04 | Phenindamine | ||||
| R06AX05 | Antazoline | ||||
| R06AX07 | Triprolidine | ||||
| R06AX08 | Pyrrobutamine | ||||
| R06AX09 | Azatadine | ||||
| R06AX11 | Astemizole | ||||
| R06AX12 | Terfenadine | ||||
| R06AX13 | Loratadine | ||||
| R06AX15 | Mebhydrolin | ||||
| R06AX16 | Deptropine | ||||
| R06AX17 | Ketotifen | ||||
| R06AX18 | Acrivastine | ||||
| R06AX19 | Azelastine | ||||
| R06AX21 | Tritoqualine | ||||
| R06AX22 | Ebastine | ||||
| R06AX23 | Pimethixene | ||||
| R06AX24 | Epinastine | ||||
| R06AX25 | Mizolastine | ||||
| R06AX26 | Fexofenadine | ||||
| R06AX27 | Desloratadine | ||||
| R06AX28 | Rupatadine | ||||
| R06AX29 | Bilastine | ||||
| R06AX31 | Quifenadine | ||||
| R06AX53 | Thenalidine, combinations | ||||
| R06AX58 | Pyrrobutamine, combinations | ||||
| R07 | Other respiratory system products | ||||
| R07A | Other respiratory system products | ||||
| R07AA | Lung surfactants | ||||
| R07AA01 | Colfosceril palmitate | ||||
| R07AA02 | Natural phospholipids | ||||
| R07AA30 | Combinations | ||||
| R07AB | Respiratory stimulants | ||||
| R07AB01 | Doxapram | ||||
| R07AB02 | Nikethamide | ||||
| R07AB03 | Pentetrazol | ||||
| R07AB04 | Etamivan | ||||
| R07AB05 | Bemegride | ||||
| R07AB06 | Prethcamide | ||||
| R07AB07 | Almitrine | ||||
| R07AB08 | Dimefline | ||||
| R07AB09 | Mepixanox | ||||
| R07AB52 | Nikethamide, combinations | ||||
| R07AB53 | Pentetrazol, combinations | ||||
| R07AX | Other respiratory system products | ||||
| R07AX01 | Nitric oxide | ||||
| R07AX02 | Ivacaftor | ||||
| R07AX30 | ivacaftor and lumacaftor | ||||
| R07AX31 | ivacaftor and tezacaftor | ||||
| R07AX32 | ivacaftor, tezacaftor and elexacaftor | ||||
| R07AX33 | deutivacaftor, tezacaftor and vanzacaftor | ||||
| âS | Sensory organs | ||||
| S01 | Ophthalmologicals | ||||
| S01A | Anti-infectives | ||||
| S01AA | Antibiotics | ||||
| S01AA01 | Chloramphenicol | ||||
| S01AA02 | Chlortetracycline | ||||
| S01AA03 | Neomycin | ||||
| S01AA04 | Oxytetracycline | ||||
| S01AA05 | Tyrothricin | ||||
| S01AA07 | Framycetin | ||||
| S01AA09 | Tetracycline | ||||
| S01AA10 | Natamycin | ||||
| S01AA11 | Gentamicin | ||||
| S01AA12 | Tobramycin | ||||
| S01AA13 | Fusidic acid | ||||
| S01AA14 | Benzylpenicillin | ||||
| S01AA15 | Dihydrostreptomycin | ||||
| S01AA16 | Rifamycin | ||||
| S01AA17 | Erythromycin | ||||
| S01AA18 | Polymyxin B | ||||
| S01AA19 | Ampicillin | ||||
| S01AA20 | Antibiotics in combination with other drugs | ||||
| S01AA21 | Amikacin | ||||
| S01AA22 | Micronomicin | ||||
| S01AA23 | Netilmicin | ||||
| S01AA24 | Kanamycin | ||||
| S01AA25 | Azidamfenicol | ||||
| S01AA26 | Azithromycin | ||||
| S01AA27 | Cefuroxime | ||||
| S01AA30 | Combinations of different antibiotics | ||||
| S01AB | Sulfonamides | ||||
| S01AB01 | Sulfamethizole | ||||
| S01AB02 | Sulfafurazole | ||||
| S01AB03 | Sulfadicramide | ||||
| S01AB04 | Sulfacetamide | ||||
| S01AB05 | Sulfafenazol | ||||
| S01AD | Antivirals | ||||
| S01AD01 | Idoxuridine | ||||
| S01AD02 | Trifluridine | ||||
| S01AD03 | Aciclovir | ||||
| S01AD05 | Interferon | ||||
| S01AD06 | Vidarabine | ||||
| S01AD07 | Famciclovir | ||||
| S01AD08 | Fomivirsen | ||||
| S01AD09 | Ganciclovir | ||||
| S01AE | Fluoroquinolones | ||||
| S01AE01 | Ofloxacin | ||||
| S01AE02 | Norfloxacin | ||||
| S01AE03 | Ciprofloxacin | ||||
| S01AE04 | Lomefloxacin | ||||
| S01AE05 | Levofloxacin | ||||
| S01AE06 | Gatifloxacin | ||||
| S01AE07 | Moxifloxacin | ||||
| S01AE08 | Besifloxacin | ||||
| S01AX | Other anti-infectives | ||||
| S01AX01 | Mercury compounds | ||||
| S01AX02 | Silver compounds | ||||
| S01AX03 | Zinc compounds | ||||
| S01AX04 | Nitrofural | ||||
| S01AX05 | Bibrocathol | ||||
| S01AX06 | Resorcinol | ||||
| S01AX07 | Sodium borate | ||||
| S01AX08 | Hexamidine | ||||
| S01AX09 | Chlorhexidine | ||||
| S01AX10 | Sodium propionate | ||||
| S01AX11 | ofloxacin (New ATC code S01AE01) | ||||
| S01AX12 | norfloxacin (New ATC code S01AE02) | ||||
| S01AX13 | ciprofloxacin (New ATC code S01AE03) | ||||
| S01AX14 | Dibrompropamidine | ||||
| S01AX15 | Propamidine | ||||
| S01AX16 | Picloxydine | ||||
| S01AX17 | lomefloxacin (New ATC code S01AE04) | ||||
| S01AX18 | Povidone-iodine | ||||
| S01AX19 | levofloxacin (New ATC code S01AE05) | ||||
| S01AX21 | gatifloxacin (New ATC code S01AE06) | ||||
| S01AX22 | moxifloxacin (New ATC code S01AE07) | ||||
| S01AX23 | besifloxacin (New ATC code S01AE08) | ||||
| S01AX24 | polihexanide | ||||
| S01AX25 | lotilaner | ||||
| S01AX26 | cethexonium | ||||
| S01B | Anti-inflammatory agents | ||||
| S01BA | Corticosteroids, plain | ||||
| S01BA01 | Dexamethasone | ||||
| S01BA02 | Hydrocortisone | ||||
| S01BA03 | Cortisone | ||||
| S01BA04 | Prednisolone | ||||
| S01BA05 | Triamcinolone | ||||
| S01BA06 | Betamethasone | ||||
| S01BA07 | Fluorometholone | ||||
| S01BA08 | Medrysone | ||||
| S01BA09 | Clobetasone | ||||
| S01BA10 | Alclometasone | ||||
| S01BA11 | Desonide | ||||
| S01BA12 | Formocortal | ||||
| S01BA13 | Rimexolone | ||||
| S01BA14 | Loteprednol | ||||
| S01BA15 | Fluocinolone acetonide | ||||
| S01BA16 | difluprednate | ||||
| S01BA17 | clobetasol | ||||
| S01BB | Corticosteroids and mydriatics in combination | ||||
| S01BB01 | Hydrocortisone and mydriatics | ||||
| S01BB02 | Prednisolone and mydriatics | ||||
| S01BB03 | Fluorometholone and mydriatics | ||||
| S01BB04 | Betamethasone and mydriatics | ||||
| S01BC | Anti-inflammatory agents, non-steroids | ||||
| S01BC01 | Indometacin | ||||
| S01BC02 | Oxyphenbutazone | ||||
| S01BC03 | Diclofenac | ||||
| S01BC04 | Flurbiprofen | ||||
| S01BC05 | Ketorolac | ||||
| S01BC06 | Piroxicam | ||||
| S01BC07 | Bendazac | ||||
| S01BC08 | Salicylic acid | ||||
| S01BC09 | Pranoprofen | ||||
| S01BC10 | Nepafenac | ||||
| S01BC11 | Bromfenac | ||||
| S01C | Anti-inflammatory agents and anti-infectives in combination | ||||
| S01CA | Corticosteroids and anti-infectives in combination | ||||
| S01CA01 | Dexamethasone and antiinfectives | ||||
| S01CA02 | Prednisolone and antiinfectives | ||||
| S01CA03 | Hydrocortisone and antiinfectives | ||||
| S01CA04 | Fluocortolone and antiinfectives | ||||
| S01CA05 | Betamethasone and antiinfectives | ||||
| S01CA06 | Fludrocortisone and antiinfectives | ||||
| S01CA07 | Fluorometholone and antiinfectives | ||||
| S01CA08 | Methylprednisolone and antiinfectives | ||||
| S01CA09 | Chloroprednisone and antiinfectives | ||||
| S01CA10 | Fluocinolone acetonide and antiinfectives | ||||
| S01CA11 | Clobetasone and antiinfectives | ||||
| S01CB | Corticosteroids/anti-infectives/mydriatics in combination | ||||
| S01CB01 | Dexamethasone | ||||
| S01CB02 | Prednisolone | ||||
| S01CB03 | Hydrocortisone | ||||
| S01CB04 | Betamethasone | ||||
| S01CB05 | Fluorometholone | ||||
| S01CC | Anti-inflammatory agents, non-steroids and anti-infectives in combination | ||||
| S01CC01 | Diclofenac and antiinfectives | ||||
| S01E | Antiglaucoma preparations and miotics | ||||
| S01EA | Sympathomimetics in glaucoma therapy | ||||
| S01EA01 | Epinephrine | ||||
| S01EA02 | Dipivefrine | ||||
| S01EA03 | Apraclonidine | ||||
| S01EA04 | Clonidine | ||||
| S01EA05 | Brimonidine | ||||
| S01EA51 | Epinephrine, combinations | ||||
| S01EA55 | brimonidine and ripasudil | ||||
| S01EB | Parasympathomimetics | ||||
| S01EB01 | Pilocarpine | ||||
| S01EB02 | Carbachol | ||||
| S01EB03 | Ecothiopate | ||||
| S01EB04 | Demecarium | ||||
| S01EB05 | Physostigmine | ||||
| S01EB06 | Neostigmine | ||||
| S01EB07 | Fluostigmine | ||||
| S01EB08 | Aceclidine | ||||
| S01EB09 | Acetylcholine | ||||
| S01EB10 | Paraoxon | ||||
| S01EB51 | Pilocarpine, combinations | ||||
| S01EB58 | Aceclidine, combinations | ||||
| S01EC | Carbonic anhydrase inhibitors | ||||
| S01EC01 | Acetazolamide | ||||
| S01EC02 | Diclofenamide | ||||
| S01EC03 | Dorzolamide | ||||
| S01EC04 | Brinzolamide | ||||
| S01EC05 | Methazolamide | ||||
| S01ED | Beta blocking agents | ||||
| S01ED01 | Timolol | ||||
| S01ED02 | Betaxolol | ||||
| S01ED03 | Levobunolol | ||||
| S01ED04 | Metipranolol | ||||
| S01ED05 | Carteolol | ||||
| S01ED06 | Befunolol | ||||
| S01ED51 | Timolol, combinations | ||||
| S01ED52 | Betaxolol, combinations | ||||
| S01ED54 | Metipranolol, combinations | ||||
| S01ED55 | Carteolol, combinations | ||||
| S01EE | Prostaglandin analogues | ||||
| S01EE01 | Latanoprost | ||||
| S01EE02 | Unoprostone | ||||
| S01EE03 | Bimatoprost | ||||
| S01EE04 | Travoprost | ||||
| S01EE05 | Tafluprost | ||||
| S01EE06 | latanoprostene bunod | ||||
| S01EE51 | latanoprost and netarsudil | ||||
| S01EE52 | latanoprost and dorzolamide | ||||
| S01EX | Other antiglaucoma preparations | ||||
| S01EX01 | Guanethidine | ||||
| S01EX02 | Dapiprazole | ||||
| S01F | Mydriatics and cycloplegics | ||||
| S01FA | Anticholinergics | ||||
| S01FA01 | Atropine | ||||
| S01FA02 | Scopolamine | ||||
| S01FA03 | Methylscopolamine | ||||
| S01FA04 | Cyclopentolate | ||||
| S01FA05 | Homatropine | ||||
| S01FA06 | Tropicamide | ||||
| S01FA56 | Tropicamide, combinations | ||||
| S01FB | Sympathomimetics excluding antiglaucoma preparations | ||||
| S01FB01 | Phenylephrine | ||||
| S01FB02 | Ephedrine | ||||
| S01FB03 | Ibopamine | ||||
| S01G | Decongestants and antiallergics | ||||
| S01GA | Sympathomimetics used as decongestants | ||||
| S01GA01 | Naphazoline | ||||
| S01GA02 | Tetryzoline | ||||
| S01GA03 | Xylometazoline | ||||
| S01GA04 | Oxymetazoline | ||||
| S01GA05 | Phenylephrine | ||||
| S01GA06 | Oxedrine | ||||
| S01GA51 | Naphazoline, combinations | ||||
| S01GA52 | Tetryzoline, combinations | ||||
| S01GA53 | Xylometazoline, combinations | ||||
| S01GA55 | Phenylephrine, combinations | ||||
| S01GA56 | Oxedrine, combinations | ||||
| S01GX | Other antiallergics | ||||
| S01GX01 | Cromoglicic acid | ||||
| S01GX02 | Levocabastine | ||||
| S01GX03 | Spaglumic acid | ||||
| S01GX04 | Nedocromil | ||||
| S01GX05 | Lodoxamide | ||||
| S01GX06 | Emedastine | ||||
| S01GX07 | Azelastine | ||||
| S01GX08 | Ketotifen | ||||
| S01GX09 | Olopatadine | ||||
| S01GX10 | Epinastine | ||||
| S01GX11 | Alcaftadine | ||||
| S01GX51 | Cromoglicic acid, combinations | ||||
| S01H | Local anesthetics | ||||
| S01HA | Local anesthetics | ||||
| S01HA01 | Cocaine | ||||
| S01HA02 | Oxybuprocaine | ||||
| S01HA03 | Tetracaine | ||||
| S01HA04 | Proxymetacaine | ||||
| S01HA05 | Procaine | ||||
| S01HA06 | Cinchocaine | ||||
| S01HA07 | Lidocaine | ||||
| S01HA30 | Combinations | ||||
| S01J | Diagnostic agents | ||||
| S01JA | Colouring agents | ||||
| S01JA01 | Fluorescein | ||||
| S01JA02 | Rose bengal sodium | ||||
| S01JA51 | Fluorescein, combinations | ||||
| S01JX | Other ophthalmological diagnostic agents | ||||
| empty | |||||
| S01K | Surgical aids | ||||
| S01KA | Viscoelastic substances | ||||
| S01KA01 | Hyaluronic acid | ||||
| S01KA02 | Hypromellose | ||||
| S01KA51 | Hyaluronic acid, combinations | ||||
| S01KX | Other surgical aids | ||||
| S01KX01 | Chymotrypsin | ||||
| S01L | Ocular vascular disorder agents | ||||
| S01LA | Antineovascularisation agents | ||||
| S01LA01 | Verteporfin | ||||
| S01LA02 | Anecortave | ||||
| S01LA03 | Pegaptanib | ||||
| S01LA04 | Ranibizumab | ||||
| S01LA05 | Aflibercept | ||||
| S01LA06 | brolucizumab | ||||
| S01LA07 | abicipar pegol | ||||
| S01LA08 | bevacizumab | ||||
| S01LA09 | faricimab | ||||
| S01X | Other ophthalmologicals | ||||
| S01XA | Other ophthalmologicals | ||||
| S01XA01 | Guaiazulene | ||||
| S01XA02 | Retinol | ||||
| S01XA03 | Sodium chloride, hypertonic | ||||
| S01XA04 | Potassium iodide | ||||
| S01XA05 | Sodium edetate | ||||
| S01XA06 | Ethylmorphine | ||||
| S01XA07 | Alum | ||||
| S01XA08 | Acetylcysteine | ||||
| S01XA09 | Iodoheparinate | ||||
| S01XA10 | Inosine | ||||
| S01XA11 | Nandrolone | ||||
| S01XA12 | Dexpanthenol | ||||
| S01XA13 | Alteplase | ||||
| S01XA14 | Heparin | ||||
| S01XA15 | Ascorbic acid | ||||
| S01XA16 | anecortave (New ATC code S01LA02) | ||||
| S01XA17 | pegaptanib (New ATC code S01LA03) | ||||
| S01XA18 | Ciclosporin | ||||
| S01XA19 | Limbal stem cells, autologous | ||||
| S01XA20 | Artificial tears and other indifferent preparations | ||||
| S01XA21 | mercaptamine | ||||
| S01XA22 | ocriplasmin | ||||
| S01XA23 | sirolimus | ||||
| S01XA24 | cenegermin | ||||
| S01XA25 | lifitegrast | ||||
| S01XA26 | riboflavin | ||||
| S01XA27 | voretigene neparvovec | ||||
| S01XA28 | varenicline | ||||
| S01XA29 | sepofarsen | ||||
| S01XA31 | pegcetacoplan | ||||
| S01XA32 | avacincaptad pegol | ||||
| S01XA33 | diquafosol | ||||
| S02 | Otologicals | ||||
| S02A | Anti-infectives | ||||
| S02AA | Anti-infectives | ||||
| S02AA01 | Chloramphenicol | ||||
| S02AA02 | Nitrofural | ||||
| S02AA03 | Boric acid | ||||
| S02AA04 | Aluminium acetotartrate | ||||
| S02AA05 | Clioquinol | ||||
| S02AA06 | Hydrogen peroxide | ||||
| S02AA07 | Neomycin | ||||
| S02AA08 | Tetracycline | ||||
| S02AA09 | Chlorhexidine | ||||
| S02AA10 | Acetic acid | ||||
| S02AA11 | Polymyxin B | ||||
| S02AA12 | Rifamycin | ||||
| S02AA13 | Miconazole | ||||
| S02AA14 | Gentamicin | ||||
| S02AA15 | Ciprofloxacin | ||||
| S02AA16 | Ofloxacin | ||||
| S02AA30 | Antiinfectives, combinations | ||||
| S02B | Corticosteroids | ||||
| S02BA | Corticosteroids | ||||
| S02BA01 | Hydrocortisone | ||||
| S02BA03 | Prednisolone | ||||
| S02BA06 | Dexamethasone | ||||
| S02BA07 | Betamethasone | ||||
| S02BA08 | Fluocinolone acetonide | ||||
| S02C | Corticosteroids and anti-infectives in combination | ||||
| S02CA | Corticosteroids and anti-infectives in combination | ||||
| S02CA01 | Prednisolone and antiinfectives | ||||
| S02CA02 | Flumetasone and antiinfectives | ||||
| S02CA03 | Hydrocortisone and antiinfectives | ||||
| S02CA04 | Triamcinolone and antiinfectives | ||||
| S02CA05 | Fluocinolone acetonide and antiinfectives | ||||
| S02CA06 | Dexamethasone and antiinfectives | ||||
| S02CA07 | Fludrocortisone and antiinfectives | ||||
| S02D | Other otologicals | ||||
| S02DA | Analgesics and anesthetics | ||||
| S02DA01 | Lidocaine | ||||
| S02DA02 | Cocaine | ||||
| S02DA03 | Phenazone | ||||
| S02DA04 | Cinchocaine | ||||
| S02DA30 | Combinations | ||||
| S02DC | Indifferent preparations | ||||
| Empty group | |||||
| S03 | Ophthalmological and otological preparations | ||||
| S03A | Anti-infectives | ||||
| S03AA | Anti-infectives | ||||
| S03AA01 | Neomycin | ||||
| S03AA02 | Tetracycline | ||||
| S03AA03 | Polymyxin B | ||||
| S03AA04 | Chlorhexidine | ||||
| S03AA05 | Hexamidine | ||||
| S03AA06 | Gentamicin | ||||
| S03AA07 | Ciprofloxacin | ||||
| S03AA08 | Chloramphenicol | ||||
| S03AA30 | Antiinfectives, combinations | ||||
| S03B | Corticosteroids | ||||
| S03BA | Corticosteroids | ||||
| S03BA01 | Dexamethasone | ||||
| S03BA02 | Prednisolone | ||||
| S03BA03 | Betamethasone | ||||
| S03C | Corticosteroids and anti-infectives in combination | ||||
| S03CA | Corticosteroids and anti-infectives in combination | ||||
| S03CA01 | Dexamethasone and antiinfectives | ||||
| S03CA02 | Prednisolone and antiinfectives | ||||
| S03CA04 | Hydrocortisone and antiinfectives | ||||
| S03CA05 | Fludrocortisone and antiinfectives | ||||
| S03CA06 | Betamethasone and antiinfectives | ||||
| S03D | Other ophthalmological and otological preparations | ||||
| Empty group | |||||
| âV | Various | ||||
| V01 | Allergens | ||||
| V01A | Allergens | ||||
| V01AA | Allergen extracts | ||||
| V01AA01 | Feather | ||||
| V01AA02 | Grass pollen | ||||
| V01AA03 | House dust mites | ||||
| V01AA04 | Mould fungus and yeast fungus | ||||
| V01AA05 | Tree pollen | ||||
| V01AA07 | Insects | ||||
| V01AA08 | Food | ||||
| V01AA09 | Textiles | ||||
| V01AA10 | Flowers | ||||
| V01AA11 | Animals | ||||
| V01AA20 | Various | ||||
| V03 | All other therapeutic products | ||||
| V03A | All other therapeutic products | ||||
| V03AB | Antidotes | ||||
| V03AB01 | Ipecacuanha | ||||
| V03AB02 | Nalorphine | ||||
| V03AB03 | Edetates | ||||
| V03AB04 | Pralidoxime | ||||
| V03AB05 | Prednisolone and promethazine | ||||
| V03AB06 | Thiosulfate | ||||
| V03AB08 | Sodium nitrite | ||||
| V03AB09 | Dimercaprol | ||||
| V03AB13 | Obidoxime | ||||
| V03AB14 | Protamine | ||||
| V03AB15 | Naloxone | ||||
| V03AB16 | Ethanol | ||||
| V03AB17 | Methylthioninium chloride | ||||
| V03AB18 | Potassium permanganate | ||||
| V03AB19 | Physostigmine | ||||
| V03AB20 | Copper sulfate | ||||
| V03AB21 | Potassium iodide | ||||
| V03AB22 | Amyl nitrite | ||||
| V03AB23 | Acetylcysteine | ||||
| V03AB24 | Digitalis antitoxin | ||||
| V03AB25 | Flumazenil | ||||
| V03AB26 | Methionine | ||||
| V03AB27 | 4-dimethylaminophenol | ||||
| V03AB29 | Cholinesterase | ||||
| V03AB31 | Prussian blue | ||||
| V03AB32 | Glutathione | ||||
| V03AB33 | Hydroxocobalamin | ||||
| V03AB34 | Fomepizole | ||||
| V03AB35 | Sugammadex | ||||
| V03AB36 | Phentolamine | ||||
| V03AB37 | idarucizumab | ||||
| V03AB38 | andexanet alfa | ||||
| V03AC | Iron chelating agents | ||||
| V03AC01 | Deferoxamine | ||||
| V03AC02 | Deferiprone | ||||
| V03AC03 | Deferasirox | ||||
| V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia | ||||
| V03AE01 | Polystyrene sulfonate | ||||
| V03AE02 | Sevelamer | ||||
| V03AE03 | Lanthanum carbonate | ||||
| V03AE04 | Calcium acetate and magnesium carbonate | ||||
| V03AE05 | sucroferric oxyhydroxide | ||||
| V03AE06 | colestilan | ||||
| V03AE07 | calcium acetate | ||||
| V03AE08 | ferric citrate | ||||
| V03AE09 | patiromer calcium | ||||
| V03AE10 | sodium zirconium cyclosilicate | ||||
| V03AF | Detoxifying agents for antineoplastic treatment | ||||
| V03AF01 | Mesna | ||||
| V03AF02 | Dexrazoxane | ||||
| V03AF03 | Calcium folinate | ||||
| V03AF04 | Calcium levofolinate | ||||
| V03AF05 | Amifostine | ||||
| V03AF06 | Sodium folinate | ||||
| V03AF07 | Rasburicase | ||||
| V03AF08 | Palifermin | ||||
| V03AF09 | Glucarpidase | ||||
| V03AF10 | Sodium levofolinate | ||||
| V03AF11 | arginine and lysine | ||||
| V03AG | Drugs for treatment of hypercalcemia | ||||
| V03AG01 | Sodium cellulose phosphate | ||||
| V03AH | Drugs for treatment of hypoglycaemia | ||||
| V03AH01 | Diazoxide | ||||
| V03AK | Tissue adhesives | ||||
| empty | |||||
| V03AM | Drugs for embolisation | ||||
| empty | |||||
| V03AN | Medical gases | ||||
| V03AN01 | Oxygen | ||||
| V03AN02 | Carbon dioxide | ||||
| V03AN03 | Helium | ||||
| V03AN04 | Nitrogen | ||||
| V03AN05 | Medical air | ||||
| V03AX | Other therapeutic products | ||||
| V03AX02 | Nalfurafine | ||||
| V03AX03 | Cobicistat | ||||
| V03AX04 | difelikefalin | ||||
| V03AZ | Nerve depressants | ||||
| V03AZ01 | Ethanol | ||||
| V04 | Diagnostic agents | ||||
| V04B | Urine tests | ||||
| Empty group | |||||
| V04C | Other diagnostic agents | ||||
| V04CA | Tests for diabetes | ||||
| V04CA01 | Tolbutamide | ||||
| V04CA02 | Glucose | ||||
| V04CB | Tests for fat absorption | ||||
| V04CB01 | Vitamin A concentrates | ||||
| V04CC | Tests for bile duct patency | ||||
| V04CC01 | Sorbitol | ||||
| V04CC02 | Magnesium sulfate | ||||
| V04CC03 | Sincalide | ||||
| V04CC04 | Ceruletide | ||||
| V04CD | Tests for pituitary function | ||||
| V04CD01 | Metyrapone | ||||
| V04CD03 | Sermorelin | ||||
| V04CD04 | Corticorelin | ||||
| V04CD05 | Somatorelin | ||||
| V04CD06 | macimorelin | ||||
| V04CE | Tests for liver functional capacity | ||||
| V04CE01 | Galactose | ||||
| V04CE02 | Sulfobromophthalein | ||||
| V04CE03 | methacetin (13C) | ||||
| V04CF | Tuberculosis diagnostics | ||||
| V04CF01 | Tuberculin | ||||
| V04CF02 | mycobacterium tuberculosis, recombinant antigens | ||||
| V04CG | Tests for gastric secretion | ||||
| V04CG01 | Cation exchange resins | ||||
| V04CG02 | Betazole | ||||
| V04CG03 | Histamine phosphate | ||||
| V04CG04 | Pentagastrin | ||||
| V04CG05 | Methylthioninium chloride | ||||
| V04CG30 | Caffeine and sodium benzoate | ||||
| V04CH | Tests for renal function and ureteral injuries | ||||
| V04CH01 | Inulin and other polyfructosans | ||||
| V04CH02 | Indigo carmine | ||||
| V04CH03 | Phenolsulfonphthalein | ||||
| V04CH04 | Alsactide | ||||
| V04CH05 | relmapirazin | ||||
| V04CH30 | Aminohippuric acid | ||||
| V04CJ | Tests for thyreoidea function | ||||
| V04CJ01 | Thyrotropin | ||||
| V04CJ02 | Protirelin | ||||
| V04CK | Tests for pancreatic function | ||||
| V04CK01 | Secretin | ||||
| V04CK02 | Pancreozymin (cholecystokinin) | ||||
| V04CK03 | Bentiromide | ||||
| V04CL | Tests for allergic diseases | ||||
| Empty group | |||||
| V04CM | Tests for fertility disturbances | ||||
| V04CM01 | Gonadorelin | ||||
| V04CX | Other diagnostic agents | ||||
| V04CX01 | indocyanine green | ||||
| V04CX02 | folic acid | ||||
| V04CX03 | methacholine | ||||
| V04CX04 | mannitol | ||||
| V04CX05 | 13C-urea | ||||
| V04CX06 | hexaminolevulinate | ||||
| V04CX07 | edrophonium | ||||
| V04CX08 | carbon monoxide | ||||
| V04CX09 | patent blue | ||||
| V04CX10 | pafolacianine | ||||
| V04CX11 | lithium chloride | ||||
| V04CX12 | xenon | ||||
| V04CX13 | pegulicianine | ||||
| V06 | General nutrients | ||||
| V06A | Diet formulations for treatment of obesity | ||||
| V06AA | Low-energy diets | ||||
| Empty group | |||||
| V06B | Protein supplements | ||||
| Empty group | |||||
| V06C | Infant formulas | ||||
| V06CA | Nutrients without phenylalanine | ||||
| Empty group | |||||
| V06D | Other nutrients | ||||
| V06DA | Carbohydrates/proteins/minerals/vitamins, combinations | ||||
| Empty group | |||||
| V06DB | Fat/carbohydrates/proteins/minerals/vitamins, combinations | ||||
| Empty group | |||||
| V06DC | Carbohydrates | ||||
| V06DC01 | Glucose | ||||
| V06DC02 | Fructose | ||||
| V06DD | Amino acids, including combinations with polypeptides | ||||
| Empty group | |||||
| V06DE | Amino acids/carbohydrates/minerals/vitamins, combinations | ||||
| Empty group | |||||
| V06DF | Milk substitutes | ||||
| Empty group | |||||
| V06DX | Other combinations of nutrients | ||||
| Empty group | |||||
| V07 | All other non-therapeutic products | ||||
| V07A | All other non-therapeutic products | ||||
| V07AA | Plasters | ||||
| Empty group | |||||
| V07AB | Solvents and diluting agents, including irrigating solutions | ||||
| Empty group | |||||
| V07AC | Blood transfusion, auxiliary products | ||||
| Empty group | |||||
| V07AD | Blood tests, auxiliary products | ||||
| Empty group | |||||
| V07AN | Incontinence equipment | ||||
| Empty group | |||||
| V07AR | Sensitivity tests, discs and tablets | ||||
| Empty group | |||||
| V07AS | Stoma equipment | ||||
| Empty group | |||||
| V07AT | Cosmetics | ||||
| Empty group | |||||
| V07AV | Technical disinfectants | ||||
| Empty group | |||||
| V07AX | Washing agents etc. | ||||
| Empty group | |||||
| V07AY | Other non-therapeutic auxiliary products | ||||
| Empty group | |||||
| V07AZ | Chemicals and reagents for analysis | ||||
| V08 | Contrast media | ||||
| V08A | X-ray contrast media, iodinated | ||||
| V08AA | Water-soluble, nephrotropic, high osmolar X-ray contrast media | ||||
| V08AA01 | Diatrizoic acid | ||||
| V08AA02 | Metrizoic acid | ||||
| V08AA03 | Iodamide | ||||
| V08AA04 | Iotalamic acid | ||||
| V08AA05 | Ioxitalamic acid | ||||
| V08AA06 | Ioglicic acid | ||||
| V08AA07 | Acetrizoic acid | ||||
| V08AA08 | Iocarmic acid | ||||
| V08AA09 | Methiodal | ||||
| V08AA10 | Diodone | ||||
| V08AB | Water-soluble, nephrotropic, low osmolar X-ray contrast media | ||||
| V08AB01 | Metrizamide | ||||
| V08AB02 | Iohexol | ||||
| V08AB03 | Ioxaglic acid | ||||
| V08AB04 | Iopamidol | ||||
| V08AB05 | Iopromide | ||||
| V08AB06 | Iotrolan | ||||
| V08AB07 | Ioversol | ||||
| V08AB08 | Iopentol | ||||
| V08AB09 | Iodixanol | ||||
| V08AB10 | Iomeprol | ||||
| V08AB11 | Iobitridol | ||||
| V08AB12 | Ioxilan | ||||
| V08AC | Water-soluble, hepatotropic X-ray contrast media | ||||
| V08AC01 | Iodoxamic acid | ||||
| V08AC02 | Iotroxic acid | ||||
| V08AC03 | Ioglycamic acid | ||||
| V08AC04 | Adipiodone | ||||
| V08AC05 | Iobenzamic acid | ||||
| V08AC06 | Iopanoic acid | ||||
| V08AC07 | Iocetamic acid | ||||
| V08AC08 | Sodium iopodate | ||||
| V08AC09 | Tyropanoic acid | ||||
| V08AC10 | Calcium iopodate | ||||
| V08AD | Non-watersoluble X-ray contrast media | ||||
| V08AD01 | Ethyl esters of iodised fatty acids | ||||
| V08AD02 | Iopydol | ||||
| V08AD03 | Propyliodone | ||||
| V08AD04 | Iofendylate | ||||
| V08B | X-ray contrast media, non-iodinated | ||||
| V08BA | Barium sulfate containing X-ray contrast media | ||||
| V08BA01 | Barium sulfate with suspending agents | ||||
| V08BA02 | Barium sulfate without suspending agents | ||||
| V08C | Magnetic resonance imaging contrast media | ||||
| V08CA | Paramagnetic contrast media | ||||
| V08CA01 | Gadopentetic acid | ||||
| V08CA02 | Gadoteric acid | ||||
| V08CA03 | Gadodiamide | ||||
| V08CA04 | Gadoteridol | ||||
| V08CA05 | Mangafodipir | ||||
| V08CA06 | Gadoversetamide | ||||
| V08CA07 | Ferric ammonium citrate | ||||
| V08CA08 | Gadobenic acid | ||||
| V08CA09 | Gadobutrol | ||||
| V08CA10 | Gadoxetic acid | ||||
| V08CA11 | Gadofosveset | ||||
| V08CA12 | gadopiclenol | ||||
| V08CA13 | gadoquatrane | ||||
| V08CB | Superparamagnetic contrast media | ||||
| V08CB01 | Ferumoxsil | ||||
| V08CB02 | Ferristene | ||||
| V08CB03 | Iron oxide, nanoparticles | ||||
| V08CX | Other magnetic resonance imaging contrast media | ||||
| V08CX01 | Perflubron | ||||
| V08D | Ultrasound contrast media | ||||
| V08DA | Ultrasound contrast media | ||||
| V08DA01 | perflutren, human albumin microspheres | ||||
| V08DA02 | microparticles of galactose | ||||
| V08DA03 | Perflenapent | ||||
| V08DA04 | perflutren, phospholipid microspheres | ||||
| V08DA05 | sulfur hexafluoride, phospholipid microspheres | ||||
| V08DA06 | perflubutane, phospholipid microspheres | ||||
| V09 | Diagnostic radiopharmaceuticals | ||||
| V09A | Central nervous system | ||||
| V09AA | Technetium (99mTc) compounds | ||||
| V09AA01 | Technetium (99mTc) exametazime | ||||
| V09AA02 | Technetium (99mTc) bicisate | ||||
| V09AB | Iodine (123I) compounds | ||||
| V09AB01 | Iodine iofetamine (123I) | ||||
| V09AB02 | Iodine iolopride (123I) | ||||
| V09AB03 | Iodine ioflupane (123I) | ||||
| V09AX | Other central nervous system diagnostic radiopharmaceuticals | ||||
| V09AX01 | Indium (111In) pentetic acid | ||||
| V09AX02 | fludeoxyglucose (New ATC code V09IX04) | ||||
| V09AX03 | Iodine (124I) 2β-carbomethoxy-3β-(4-iodophenyl)-tropane | ||||
| V09AX04 | Flutemetamol (18F) | ||||
| V09AX05 | Florbetapir (18F) | ||||
| V09B | Skeleton | ||||
| V09BA | Technetium (99mTc) compounds | ||||
| V09BA01 | Technetium (99mTc) oxidronic acid | ||||
| V09BA02 | Technetium (99mTc) medronic acid | ||||
| V09BA03 | Technetium (99mTc) pyrophosphate | ||||
| V09BA04 | Technetium (99mTc) butedronic acid | ||||
| V09C | Renal system | ||||
| V09CA | Technetium (99mTc) compounds | ||||
| V09CA01 | Technetium (99mTc) pentetic acid | ||||
| V09CA02 | Technetium (99mTc) succimer | ||||
| V09CA03 | Technetium (99mTc) mertiatide | ||||
| V09CA04 | Technetium (99mTc) gluceptate | ||||
| V09CA05 | Technetium (99mTc) gluconate | ||||
| V09CA06 | Technetium (99mTc) ethylenedicysteine | ||||
| V09CX | Other renal system diagnostic radiopharmaceuticals | ||||
| V09CX01 | Sodium iodohippurate (123I) | ||||
| V09CX02 | Sodium iodohippurate (131I) | ||||
| V09CX03 | Sodium iothalamate (125I) | ||||
| V09CX04 | Chromium (51Cr) edetate | ||||
| V09D | Hepatic and reticulo endothelial system | ||||
| V09DA | Technetium (99mTc) compounds | ||||
| V09DA01 | Technetium (99mTc) disofenin | ||||
| V09DA02 | Technetium (99mTc) etifenin | ||||
| V09DA03 | Technetium (99mTc) lidofenin | ||||
| V09DA04 | Technetium (99mTc) mebrofenin | ||||
| V09DA05 | Technetium (99mTc) galtifenin | ||||
| V09DB | Technetium (99mTc), particles and colloids | ||||
| V09DB01 | Technetium (99mTc) nanocolloid | ||||
| V09DB02 | Technetium (99mTc) microcolloid | ||||
| V09DB03 | Technetium (99mTc) millimicrospheres | ||||
| V09DB04 | Technetium (99mTc) tin colloid | ||||
| V09DB05 | Technetium (99mTc) sulfur colloid | ||||
| V09DB06 | Technetium (99mTc) rheniumsulfide colloid | ||||
| V09DB07 | Technetium (99mTc) phytate | ||||
| V09DX | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals | ||||
| V09DX01 | Selenium (75Se) tauroselcholic acid | ||||
| V09E | Respiratory system | ||||
| V09EA | Technetium (99mTc) inhalants | ||||
| V09EA01 | Technetium (99mTc) pentetic acid | ||||
| V09EA02 | Technetium (99mTc) technegas | ||||
| V09EA03 | Technetium (99mTc) nanocolloid | ||||
| V09EB | Technetium (99mTc) particles for injection | ||||
| V09EB01 | Technetium (99mTc) macrosalb | ||||
| V09EB02 | Technetium (99mTc) microspheres | ||||
| V09EX | Other respiratory system diagnostic radiopharmaceuticals | ||||
| V09EX01 | Krypton (81mKr) gas | ||||
| V09EX02 | Xenon (127Xe) gas | ||||
| V09EX03 | Xenon (133Xe) gas | ||||
| V09F | Thyroid | ||||
|
V09FX |
Various thyroid diagnostic radiopharmaceuticals | ||||
| V09FX01 | Technetium (99mTc) pertechnetate | ||||
| V09FX02 | Sodium iodide (123I) | ||||
| V09FX03 | Sodium iodide (131I) | ||||
| V09FX04 | Sodium iodide (124I) | ||||
| V09G | Cardiovascular system | ||||
| V09GA | Technetium (99mTc) compounds | ||||
| V09GA01 | Technetium (99mTc) sestamibi | ||||
| V09GA02 | Technetium (99mTc) tetrofosmin | ||||
| V09GA03 | Technetium (99mTc) teboroxime | ||||
| V09GA04 | Technetium (99mTc) human albumin | ||||
| V09GA05 | Technetium (99mTc) furifosmin | ||||
| V09GA06 | Technetium (99mTc) stannous agent labelled cells | ||||
| V09GA07 | Technetium (99mTc) apcitide | ||||
| V09GB | Iodine (125I) compounds | ||||
| V09GB01 | Fibrinogen (125I) | ||||
| V09GB02 | Iodine (125I) human albumin | ||||
| V09GX | Other cardiovascular system diagnostic radiopharmaceuticals | ||||
| V09GX01 | Thallium (201Tl) chloride | ||||
| V09GX02 | Indium (111In) imciromab | ||||
| V09GX03 | Chromium (51Cr) chromate labelled cells | ||||
| V09GX04 | Rubidium (82Rb) chloride | ||||
| V09GX05 | ammonia (13N) | ||||
| V09GX06 | flurpiridaz (18F) | ||||
| V09H | Inflammation and infection detection | ||||
| V09HA | Technetium (99mTc) compounds | ||||
| V09HA01 | Technetium (99mTc) human immunoglobulin | ||||
| V09HA02 | Technetium (99mTc) exametazime labelled cells | ||||
| V09HA03 | Technetium (99mTc) antigranulocyte antibody | ||||
| V09HA04 | Technetium (99mTc) sulesomab | ||||
| V09HB | Indium (111In) compounds | ||||
| V09HB01 | Indium (111In) oxinate labelled cells | ||||
| V09HB02 | Indium (111In) tropolonate labelled cells | ||||
| V09HX | Other diagnostic radiopharmaceuticals for inflammation and infection detection | ||||
| V09HX01 | Gallium (67Ga) citrate | ||||
| V09I | Tumour detection | ||||
| V09IA | Technetium (99mTc) compounds | ||||
| V09IA01 | Technetium (99mTc) antiCarcinoEmbryonicAntigen antibody | ||||
| V09IA02 | Technetium (99mTc) antimelanoma antibody | ||||
| V09IA03 | Technetium (99mTc) pentavalent succimer | ||||
| V09IA04 | Technetium (99mTc) votumumab | ||||
| V09IA05 | Technetium (99mTc) depreotide | ||||
| V09IA06 | Technetium (99mTc) arcitumomab | ||||
| V09IA07 | Technetium (99mTc) hynic-octreotide | ||||
| V09IB | Indium (111In) compounds | ||||
| V09IB01 | Indium (111In) pentetreotide | ||||
| V09IB02 | Indium (111In) satumomab pendetide | ||||
| V09IB03 | Indium (111In) antiovariumcarcinoma antibody | ||||
| V09IB04 | Indium (111In) capromab pendetide | ||||
| V09IX | Other diagnostic radiopharmaceuticals for tumour detection | ||||
| V09IX01 | Iobenguane (123I) | ||||
| V09IX02 | Iobenguane (131I) | ||||
| V09IX03 | Iodine (125I) CC49-monoclonal antibody | ||||
| V09IX04 | Fludeoxyglucose (18F) | ||||
| V09IX05 | Fluorodopa (18F) | ||||
| V09IX06 | Sodium fluoride (18F) | ||||
| V09IX07 | Fluoromethylcholine (18F) | ||||
| V09IX08 | Fluoroethylcholine (18F) | ||||
| V09IX09 | gallium (68Ga) edotreotide | ||||
| V09IX10 | fluoroethyl-L-tyrosine (18F) | ||||
| V09IX11 | fluoroestradiol (18F) | ||||
| V09IX12 | fluciclovine (18F) | ||||
| V09IX13 | methionine (11C) | ||||
| V09IX14 | gallium (68Ga) gozetotide | ||||
| V09IX15 | copper (64Cu) dotatate | ||||
| V09IX16 | piflufolastat (18F) | ||||
| V09IX17 | PSMA-1007 (18F) | ||||
| V09IX18 | flotufolastat (18F) | ||||
| V09IX19 | vidoflufolastat (18F) | ||||
| V09X | Other diagnostic radiopharmaceuticals | ||||
| V09XA | Iodine (131I) compounds | ||||
| V09XA01 | Iodine (131I) norcholesterol | ||||
| V09XA02 | Iodocholesterol (131I) | ||||
| V09XA03 | Iodine (131I) human albumin | ||||
| V09XX | Various diagnostic radiopharmaceuticals | ||||
| V09XX01 | Cobalt (57Co) cyanocobalamine | ||||
| V09XX02 | Cobalt (58Co) cyanocobalamine | ||||
| V09XX03 | Selenium (75Se) norcholesterol | ||||
| V09XX04 | Ferric (59Fe) citrate | ||||
| V10 | Therapeutic radiopharmaceuticals | ||||
| V10A | Anti-inflammatory agents | ||||
| V10AA | Yttrium (90Y) compounds | ||||
| V10AA01 | Yttrium (90Y) citrate colloid | ||||
| V10AA02 | Yttrium (90Y) ferrihydroxide colloid | ||||
| V10AA03 | Yttrium (90Y) silicate colloid | ||||
| V10AX | Other anti-inflammatory therapeutic radiopharmaceuticals | ||||
| V10AX01 | Phosphorus (32P) chromicphosphate colloid | ||||
| V10AX02 | Samarium (153Sm) hydroxyapatite colloid | ||||
| V10AX03 | Dysprosium (165Dy) colloid | ||||
| V10AX04 | Erbium (169Er) citrate colloid | ||||
| V10AX05 | Rhenium (186Re) sulfide colloid | ||||
| V10AX06 | Gold (198Au) colloidal | ||||
| V10B | Pain palliation (bone seeking agents) | ||||
| V10BX | Various pain palliation radiopharmaceuticals | ||||
| V10BX01 | Strontium (89Sr) chloride | ||||
| V10BX02 | Samarium (153Sm) lexidronam | ||||
| V10BX03 | Rhenium (186Re) etidronic acid | ||||
| V10X | Other therapeutic radiopharmaceuticals | ||||
| V10XA | Iodine (131I) compounds | ||||
| V10XA01 | Sodium iodide (131I) | ||||
| V10XA02 | Iobenguane (131I) | ||||
| V10XA03 | iodine (131I) omburtamab | ||||
| V10XA04 | iodine (131I) apamistamab | ||||
| V10XA53 | Tositumomab/iodine (131I) tositumomab | ||||
| V10XX | Various therapeutic radiopharmaceuticals | ||||
| V10XX01 | Sodium phosphate (32P) | ||||
| V10XX02 | Ibritumomab tiuxetan (90Y) | ||||
| V10XX03 | radium (223Ra) dichloride | ||||
| V10XX04 | lutetium (177Lu) oxodotreotide | ||||
| V10XX05 | lutetium (177Lu) vipivotide tetraxetan | ||||
| V20 | Surgical dressings | ||||
| empty |
השינוי האחרון נעשה בֹ־7 בינואר 2026 ב־01:08